<SEC-DOCUMENT>0001683168-21-005906.txt : 20211122
<SEC-HEADER>0001683168-21-005906.hdr.sgml : 20211122
<ACCEPTANCE-DATETIME>20211122162051
ACCESSION NUMBER:		0001683168-21-005906
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20211118
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20211122
DATE AS OF CHANGE:		20211122

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			LANTRONIX INC
		CENTRAL INDEX KEY:			0001114925
		STANDARD INDUSTRIAL CLASSIFICATION:	COMPUTER COMMUNICATIONS EQUIPMENT [3576]
		IRS NUMBER:				330362767
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-16027
		FILM NUMBER:		211432758

	BUSINESS ADDRESS:	
		STREET 1:		7535 IRVINE CENTER DR., SUITE 100
		CITY:			IRVINE
		STATE:			CA
		ZIP:			92618
		BUSINESS PHONE:		9494533990

	MAIL ADDRESS:	
		STREET 1:		7535 IRVINE CENTER DR., SUITE 100
		CITY:			IRVINE
		STATE:			CA
		ZIP:			92618
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>lantronix_i8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:us-roles="http://fasb.org/us-roles/2021-01-31" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:LTRX="http://lantronix.com/20211110">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02A_US%2DGAAP%2D2021 -->
<!-- Field: Set; Name: xdx; ID: xdx_038_LTRX_lantronix.com_20211110 -->
<!-- Field: Set; Name: xdx; ID: xdx_040_20211118_20211118_zjexoUAuZjr9 -->
<!-- Field: Set; Name: xdx; ID: xdx_056_edei%2D%2DEntityCentralIndexKey_0001114925 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2021-11-18to2021-11-18" name="dei:EntityCentralIndexKey">0001114925</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-11-18to2021-11-18" format="ixt:booleanfalse" name="dei:AmendmentFlag">false</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="ltrx-20211110.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2021-11-18to2021-11-18">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114925</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-18</xbrli:startDate>
        <xbrli:endDate>2021-11-18</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 18pt"><b>UNITED STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 18pt"><b>SECURITIES AND
EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Washington, D.C.&#160; 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<hr style="border-width: 0; background-color: black; height: 1px; width: 25%; color: black" />

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 18pt"><b>FORM <span id="xdx_904_edei--DocumentType_c20211118__20211118_zW1bz4Bdaw5"><ix:nonNumeric contextRef="From2021-11-18to2021-11-18" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<hr style="border-width: 0; background-color: black; height: 1px; width: 25%; color: black" />

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Pursuant to Section 13 or 15(d) of the<br />
Securities Exchange Act of 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of Report (Date of earliest event reported):
<span id="xdx_903_edei--DocumentPeriodEndDate_c20211118__20211118_z83r3j7b29m7"><ix:nonNumeric contextRef="From2021-11-18to2021-11-18" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">November 18, 2021</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_907_edei--EntityRegistrantName_c20211118__20211118_z9am6MskfFs9" style="font-size: 18pt"><b><ix:nonNumeric contextRef="From2021-11-18to2021-11-18" name="dei:EntityRegistrantName">LANTRONIX,
INC.</ix:nonNumeric></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Exact Name of Registrant as Specified in Charter)
</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 34%; text-align: center"><b><span id="xdx_902_edei--EntityIncorporationStateCountryCode_c20211118__20211118_ze2OXjAj4J5a"><ix:nonNumeric contextRef="From2021-11-18to2021-11-18" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></td>
    <td style="vertical-align: bottom; width: 1%">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 31%; text-align: center"><b><span id="xdx_90D_edei--EntityFileNumber_c20211118__20211118_zPZyGlsbG6Z4"><ix:nonNumeric contextRef="From2021-11-18to2021-11-18" name="dei:EntityFileNumber">1-16027</ix:nonNumeric></span></b></td>
    <td style="vertical-align: top; width: 1%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 33%; text-align: center"><b><span id="xdx_909_edei--EntityTaxIdentificationNumber_c20211118__20211118_zHO4w8GW7XVl"><ix:nonNumeric contextRef="From2021-11-18to2021-11-18" name="dei:EntityTaxIdentificationNumber">33-0362767</ix:nonNumeric></span></b></td></tr>
  <tr>
    <td style="vertical-align: top; text-align: center">(State or other jurisdiction<br />
of incorporation)</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center">(Commission File Number)</td>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td style="vertical-align: top; text-align: center">(IRS Employer<br />
Identification No.)</td></tr>
  <tr>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td colspan="5" style="text-align: center"><b><span id="xdx_90A_edei--EntityAddressAddressLine1_c20211118__20211118_zhkNkY0Tv1gg"><ix:nonNumeric contextRef="From2021-11-18to2021-11-18" name="dei:EntityAddressAddressLine1">7535 Irvine Center Drive</ix:nonNumeric></span>, <span id="xdx_904_edei--EntityAddressAddressLine2_c20211118__20211118_zo6aNS0V6ybj"><ix:nonNumeric contextRef="From2021-11-18to2021-11-18" name="dei:EntityAddressAddressLine2">Suite 100</ix:nonNumeric></span></b><br />
<b><span id="xdx_90D_edei--EntityAddressCityOrTown_c20211118__20211118_z7IDKKJIzlz"><ix:nonNumeric contextRef="From2021-11-18to2021-11-18" name="dei:EntityAddressCityOrTown">Irvine</ix:nonNumeric></span>, <span id="xdx_904_edei--EntityAddressStateOrProvince_c20211118__20211118_z5iIJhQ5yqO9"><ix:nonNumeric contextRef="From2021-11-18to2021-11-18" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince">California</ix:nonNumeric></span>&#160;<span id="xdx_901_edei--EntityAddressPostalZipCode_c20211118__20211118_zF0BaysxJco1"><ix:nonNumeric contextRef="From2021-11-18to2021-11-18" name="dei:EntityAddressPostalZipCode">92618</ix:nonNumeric></span></b></td></tr>
  <tr style="vertical-align: top">
    <td colspan="5" style="border-top: black 1pt solid; text-align: center">(Address of Principal Executive Offices, including zip code)</td></tr>
  <tr>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td colspan="5" style="text-align: center">Registrant&#8217;s telephone number, including area code: &#160;<b>(<span id="xdx_90B_edei--CityAreaCode_c20211118__20211118_z1ju1Xvk0XZ3"><ix:nonNumeric contextRef="From2021-11-18to2021-11-18" name="dei:CityAreaCode">949</ix:nonNumeric></span>)&#160;<span id="xdx_908_edei--LocalPhoneNumber_c20211118__20211118_zMJAUqD4tBXi"><ix:nonNumeric contextRef="From2021-11-18to2021-11-18" name="dei:LocalPhoneNumber">453-3990</ix:nonNumeric></span></b></td></tr>
  <tr style="vertical-align: top">
    <td colspan="5" style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td colspan="5" style="text-align: center"><b>Not Applicable</b></td></tr>
  <tr style="vertical-align: top">
    <td colspan="5" style="text-align: center">(Former name or former address, if changed since last report)</td></tr>
  </table>

<hr style="border-width: 0; background-color: black; height: 1px; width: 25%; color: black" />

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-indent: -24.75pt"><span style="font-family: Wingdings"><span id="xdx_90F_edei--WrittenCommunications_c20211118__20211118_zM62erCJU2Mh"><ix:nonNumeric contextRef="From2021-11-18to2021-11-18" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#168;</ix:nonNumeric></span></span>
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20.25pt; text-indent: -0.25in"><span style="font-family: Wingdings"><span id="xdx_908_edei--SolicitingMaterial_c20211118__20211118_zyKuNCcHTGbb"><ix:nonNumeric contextRef="From2021-11-18to2021-11-18" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#168;</ix:nonNumeric></span></span>
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20.25pt; text-indent: -0.25in"><span style="font-family: Wingdings"><span id="xdx_904_edei--PreCommencementTenderOffer_c20211118__20211118_zAfrR1O5Vm9i"><ix:nonNumeric contextRef="From2021-11-18to2021-11-18" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#168;</ix:nonNumeric></span></span>
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20.25pt; text-indent: -0.25in"><span style="font-family: Wingdings"><span id="xdx_90E_edei--PreCommencementIssuerTenderOffer_c20211118__20211118_zCCtdlHJU0P7"><ix:nonNumeric contextRef="From2021-11-18to2021-11-18" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#168;</ix:nonNumeric></span></span>
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20.25pt; text-align: center; text-indent: -0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20.25pt; text-align: center; text-indent: -0.25in"><b>Securities
registered pursuant to Section 12(b) of the Act:</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20.25pt; text-indent: -0.25in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="text-align: center"><b>Title of each Class</b></td>
    <td colspan="2" style="text-align: center"><b>Trading Symbol</b></td>
    <td style="text-align: center"><b>Name of each exchange on which registered</b></td></tr>
  <tr style="vertical-align: top">
    <td colspan="2" style="border-top: black 1pt solid; text-align: center"><span id="xdx_907_edei--Security12bTitle_c20211118__20211118_zuuYRb5SFbV2"><ix:nonNumeric contextRef="From2021-11-18to2021-11-18" name="dei:Security12bTitle">Common Stock</ix:nonNumeric></span>, $0.0001 par value</td>
    <td style="border-top: black 1pt solid; text-align: center"><span id="xdx_906_edei--TradingSymbol_c20211118__20211118_z0daB7ZDVYZ4"><ix:nonNumeric contextRef="From2021-11-18to2021-11-18" name="dei:TradingSymbol">LTRX</ix:nonNumeric></span></td>
    <td style="border-top: black 1pt solid; text-align: center">The <span id="xdx_90A_edei--SecurityExchangeName_c20211118__20211118_zvQiEAwrqvWk"><ix:nonNumeric contextRef="From2021-11-18to2021-11-18" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Stock Market LLC</td></tr>
  <tr>
    <td style="width: 33%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 28%">&#160;</td>
    <td style="width: 38%">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (17 CFR &#167;230.405) or Rule 12b-2 of the Securities Exchange Act of 1934
(17 CFR &#167;240.12b-2).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Emerging growth company <span style="font-family: Times New Roman, Times, Serif"><span id="xdx_907_edei--EntityEmergingGrowthCompany_c20211118__20211118_zgmqfWmZW5Ki"><ix:nonNumeric contextRef="From2021-11-18to2021-11-18" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 7(a)(2)(B) of Securities Act. <span style="font-family: Times New Roman, Times, Serif">&#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&#160;<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item 8.01 Other Events.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 40.8pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 40.8pt">On November 18, 2021, Lantronix, Inc. (the &#8220;Company&#8221;)
entered into an underwriting agreement (the &#8220;Underwriting Agreement&#8221;) with TL Investment GmbH (&#8220;TL Investment&#8221;)
and Canaccord Genuity LLC, as representative of the several underwriters named therein (together, the &#8220;Underwriters&#8221;), pursuant
to which the Company agreed to sell, and the Underwriters agreed to purchase, 4,700,000 shares (the &#8220;Firm Shares&#8221;) of the
Company&#8217;s common stock, $0.0001 par value per share (the &#8220;Common Stock&#8221;), at an initial price to the public of $7.50
per share. In addition, TL Investment granted the Underwriters a 30-day option to purchase up to an additional 705,000 shares (the &#8220;Option
Shares&#8221;) of Common Stock held by TL Investment at the public offering price, less the underwriting discounts. On November 18, 2021,
the Underwriters exercised their option to purchase the Option Shares from TL Investment in full. On November 22, 2021, the Company issued
and delivered the Firm Shares and TL Investment delivered the Option Shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 40.8pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 40.8pt">Net proceeds to the Company from the offering
of the Firm Shares, after deducting the underwriting discount and estimated offering expenses payable by the Company, were approximately
$32.5 million. The Company intends to use the net proceeds it receives from the sale of the Firm Shares in the offering for working capital
and general corporate purposes, which may include, among other things, the repayment of existing indebtedness. Pending these uses, the
Company may invest the net proceeds in short-term, investment-grade, interest-bearing securities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 40.8pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 40.8pt">A copy of the Underwriting Agreement is filed
as Exhibit 1.1 to this Current Report on Form 8-K and is incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 8%"><b>Item 9.01</b></td>
    <td style="width: 92%"><b>Financial Statements and Exhibits.</b></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(d) Exhibits</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 16%">Exhibit Number</td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 2%">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 76%">Description</td>
    </tr>

<tr style="vertical-align: top">
    <td>1.1</td>
    <td>&#160;</td>
    <td><a href="lantronix_ex0101.htm">Underwriting Agreement dated November 18, 2021 among Lantronix, Inc., TL Investment GmbH and Canaccord Genuity LLC, as representative of the several underwriters named therein.</a></td></tr>
<tr style="vertical-align: top">
    <td>5.1</td>
    <td>&#160;</td>
    <td><a href="lantronix_ex0501.htm">Legal Opinion of O&#8217;Melveny &amp; Myers LLP dated November 22, 2021.</a></td></tr>
<tr style="vertical-align: top">
    <td>23.1</td>
    <td>&#160;</td>
    <td><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><a href="lantronix_ex0501.htm">Consent of O&#8217;Melveny &amp; Myers LLP</a> (included in Exhibit 5.1
above).</p>
</td></tr>
<tr>
    <td style="white-space: nowrap; vertical-align: top; width: 4%; font-size: 10pt">104</td>
    <td style="vertical-align: bottom; width: 1%; font-size: 10pt">&#160;</td>
    <td style="vertical-align: top; width: 95%; font-size: 10pt">Cover Page Interactive Data File (embedded within the Inline XBRL document).</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b></b></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 69.3pt">Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>Date: November 22, 2021</td>
    <td colspan="2"><b>LANTRONIX, INC.</b></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="width: 10%">&#160;</td>
    <td style="width: 40%; text-align: left">&#160;</td>
    <td style="width: 5%">By:</td>
    <td style="border-bottom: black 1pt solid; width: 45%">&#160;/s/ Jeremy Whitaker</td>
    </tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Jeremy Whitaker</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Chief Financial Officer</p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFj91OhDAQRp+Ad5g0XhK2YNYf7pToxsgagpuNtxVmTbO0Q4aC7iP5lpbiZpsmTTvfmTMVIhYbetYdMnw81iXs0PSdcgg1HpDRNugTxctrDv6s8UsPjpV14XoGC/IMemad3Cv/HpKTHrDNQd6tsvUqS0He5tc3UG1FNNcLsgfdonVadaBsCxVTzxqd4tPSYad+yJI5BdMeedBkc0gTuZR/IZNpBm80qW/i4wBlWYgoDisSG6axnzXj4MjAU4fGu4YFvewwShMyuf+EIfvuqDnKREqZVor3qhtxi+YT2QdTmXnnw/8ASx4CEMPVwkCvGKaZOhv+ALWgZUQ= -->


</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>lantronix_ex0101.htm
<DESCRIPTION>UNDERWRITING AGREEMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"><B>Exhibit 1.1</B></P>

<P STYLE="margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>4,700,000 Shares<FONT STYLE="font-family: Times New Roman, Times, Serif"><SUP>1</SUP></FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-variant: small-caps"><B>Lantronix,
Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Common Stock, par value $0.0001 per share </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNDERWRITING AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">November 18, 2021</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">CANACCORD GENUITY LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As Representative of the several</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Underwriters named in Schedule
I hereto</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">c/o Canaccord Genuity LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">99 High Street</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Boston, Massachusetts 02110</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Lantronix, Inc., a Delaware
corporation (the <B><I>&ldquo;Company&rdquo;</I></B>), proposes to sell to the several underwriters named in Schedule I hereto (the <B><I>&ldquo;Underwriters&rdquo;</I></B>)
an aggregate of 4,700,000 shares (the <B><I>&ldquo;Firm Shares&rdquo;</I></B>) of common stock, par value $0.0001 per share (the <B><I>&ldquo;Common
Stock&rdquo;</I></B>), of the Company. TL Investment GmbH, a German limited liability company (the <B><I>&ldquo;Selling Stockholder&rdquo;</I></B>),
has also granted to the Underwriters an option to purchase up to 705,000 additional shares of Common Stock on the terms and for the purposes
set forth in Section&nbsp;3 hereof (the <B><I>&ldquo;Option Shares&rdquo;</I></B>). The Firm Shares and any Option Shares purchased pursuant
to this Underwriting Agreement (this <B><I>&ldquo;Agreement&rdquo;</I></B>) are herein collectively called the <B><I>&ldquo;Securities.&rdquo;
</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company, the Selling Stockholder
and the several Underwriters hereby confirm their agreement with respect to the sale of the Securities by the Company and the Selling
Stockholder, acting severally and not jointly, to the several Underwriters, for whom Canaccord Genuity LLC is acting as representative
(<B><I>&ldquo;you&rdquo;</I></B> or the <B><I>&ldquo;Representative&rdquo;</I></B>), as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Registration Statements and Prospectuses</I></B>. The Company has prepared and filed
with the Securities and Exchange Commission (the <B><I>&ldquo;Commission&rdquo;</I></B>) a registration statement on Form S-3 (File No.
333-259454) under the Securities Act of 1933, as amended (the <B><I>&ldquo;Securities Act&rdquo;</I></B> or the <B><I>&ldquo;Act&rdquo;</I></B>),
and the rules and regulations (the <B><I>&ldquo;Rules and Regulations&rdquo;</I></B>) of the Commission thereunder, and such amendments
to such registration statement as may have been required to the date of this Agreement. Such registration statement has been declared
effective by the Commission. Each part of such registration statement, including the exhibits and any amendments and schedules thereto,
the documents incorporated by reference therein pursuant to Item 12 of Form S-3 under the Securities Act and the documents and information
otherwise deemed to be a part thereof or included therein by Rule 430B under the Securities Act (the <B><I>&ldquo;Rule 430B Information&rdquo;</I></B>)
or otherwise pursuant to the Rules and Regulations, as of the time the registration statement became effective, is herein called the <B><I>&ldquo;Company
Registration Statement.&rdquo;</I></B> The Company has also prepared and filed with the Commission a registration statement on Form S-3
(File No. 333-227127) under the Act and the Rules and Regulations of the Commission thereunder, and such amendments to such registration
statement as may have been required to the date of this Agreement. Such registration statement has been declared effective by the Commission.
Each part of such registration statement, including the amendments, exhibits and any schedules thereto, the documents incorporated by
reference therein pursuant to Item 12 of Form S-3 under the Securities Act and the 430B Information or otherwise pursuant to the Rules
and Regulations, as of the time the registration statement became effective, is herein called the <B><I>&ldquo;Selling Stockholder Registration
Statement&rdquo; </I></B>and together with the Company Registration Statement are collectively called the <B><I>&ldquo;Registration Statements.&rdquo;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">___________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><SUP>1</SUP></FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Plus
an option to purchase up to 705,000 additional shares to cover over-allotments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The prospectuses included
in the Registration Statements in the form in which each has most recently been filed with the Commission on or prior to the date of this
Agreement are herein called the <B><I>&ldquo;Base Prospectuses.&rdquo;</I></B> Each preliminary prospectus supplement to the Base Prospectuses
(including the Base Prospectuses as so supplemented) that describes the Securities and the offering thereof, that omitted the Rule 430B
Information and that was used prior to the filing of the final prospectus supplement referred to in the following sentence is herein called
a <B><I>&ldquo;Preliminary Prospectus.&rdquo;</I></B> Promptly after execution and delivery of this Agreement, the Company will prepare
and file with the Commission a final prospectus supplement to the Base Prospectuses relating to the Securities and the offering thereof
in accordance with the provisions of Rule 430B and Rule 424(b) of the Rules and Regulations. Such final prospectus supplement (including
the Base Prospectuses as so supplemented), in the form filed with the Commission pursuant to Rule 424(b), is herein called the <B><I>&ldquo;Prospectus.&rdquo;</I></B>
Any reference herein to the Base Prospectuses, any Preliminary Prospectus or the Prospectus shall be deemed to include the documents incorporated
by reference therein pursuant to Item 12 of Form S-3 under the Securities Act as of the date of such prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For purposes of this Agreement,
all references to the Registration Statements, the Base Prospectuses, any Preliminary Prospectus, the Prospectus or any amendment or supplement
to any of the foregoing shall be deemed to include the copy filed with the Commission pursuant to its Electronic Data Gathering, Analysis
and Retrieval System or any successor system thereto. All references in this Agreement to financial statements and schedules and other
information which is &ldquo;contained,&rdquo; &ldquo;included&rdquo; or &ldquo;stated&rdquo; in the Registration Statements, the Base
Prospectuses, any Preliminary Prospectus or the Prospectus (or other references of like import) shall be deemed to mean and include all
such financial statements and schedules and other information which is incorporated by reference in or otherwise deemed by the Rules and
Regulations to be a part of or included in the Registration Statements, the Base Prospectuses, any Preliminary Prospectus or the Prospectus,
as the case may be; and all references in this Agreement to amendments or supplements to the Registration Statements, the Base Prospectuses,
any Preliminary Prospectus or the Prospectus shall be deemed to mean and include the subsequent filing of any document under the Securities
Exchange Act of 1934, as amended (the <B><I>&ldquo;Exchange Act&rdquo;</I></B>), which is incorporated by reference therein or otherwise
deemed by the Rules and Regulations to be a part thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Representations
and Warranties of the Company and the Selling Stockholder</I></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Representations
and Warranties of the Company</U></I>. The Company represents and warrants to, and agrees with, the several Underwriters as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Registration
Statements and Prospectuses</U></I>. No order preventing or suspending the use of any Preliminary Prospectus or the Prospectus (or any
supplement thereto) has been issued by the Commission and no proceeding for that purpose has been initiated or is pending or, to the knowledge
of the Company, threatened by the Commission. As of the time each part of the Registration Statements became or becomes effective (including
each deemed effective date with respect to the Underwriters pursuant to Rule 430B or otherwise under the Securities Act), such part conformed
or will conform in all material respects to the requirements of the Act and the Rules and Regulations. Upon the filing or first use within
the meaning of the Rules and Regulations, any Preliminary Prospectus and the Prospectus (or any supplement to either) conformed or will
conform in all material respects to the requirements of the Act and the Rules and Regulations. The Registration Statements have become
effective under the Securities Act and the Company, as of the date of this Agreement, has not filed a post-effective amendment to the
Registration Statements. The Company has complied to the Commission&rsquo;s satisfaction with all requests of the Commission for additional
or supplemental information. No stop order suspending the effectiveness of the Registration Statements or any part thereof is in effect
and no proceedings for such purpose have been instituted or are pending or, to the knowledge of the Company, are threatened by the Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Accurate
Disclosure</U></I>. Each Preliminary Prospectus, at the time of filing thereof or the time of first use within the meaning of the Rules
and Regulations, did not contain an untrue statement of a material fact or omit to state a material fact required to be stated therein
or necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading. Neither the
Registration Statements nor any amendment thereto, at the effective time of each part thereof, at the First Closing Date (as defined below)
or at the Second Closing Date (as defined below), contained, contains or will contain an untrue statement of a material fact or omitted,
omits or will omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading.
As of the Time of Sale (as defined below), neither (A) the Time of Sale Disclosure Package (as defined below) nor (B) any issuer free
writing prospectus (as defined below), when considered together with the Time of Sale Disclosure Package, contained an untrue statement
of a material fact or omitted to state a material fact necessary in order to make the statements therein, in the light of the circumstances
under which they were made, not misleading. Neither the Prospectus nor any supplement thereto, as of its issue date, at the time of any
filing with the Commission pursuant to Rule 424(b) of the Rules and Regulations, at the First Closing Date or at the Second Closing Date,
contained, contains or will contain an untrue statement of a material fact or omitted, omits or will omit to state a material fact necessary
in order to make the statements therein, in the light of the circumstances under which they were made, not misleading. The representations
and warranties in this Section&nbsp;2(a)(ii) shall not apply to statements in or omissions from any Preliminary Prospectus, the Time of
Sale Disclosure Package or the Prospectus (or any supplement thereto) made in reliance upon, and in conformity with, written information
furnished to the Company by you, or by any Underwriter through you, specifically for use in the preparation of such document, it being
understood and agreed that the only such information furnished by any Underwriter consists of the information described as such in Section
6(f).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">Each reference to
an <B><I>&ldquo;issuer free writing prospectus&rdquo;</I></B> herein means an issuer free writing prospectus as defined in Rule 433 of
the Rules and Regulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><B><I>&ldquo;Time of Sale Disclosure
Package&rdquo;</I></B> means the Preliminary Prospectus dated November 17,&nbsp;2021, any free writing prospectus set forth on Schedule
II and the information on Schedule III, all considered together.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Each reference to a <B><I>&ldquo;free
writing prospectus&rdquo;</I></B> herein means a free writing prospectus as defined in Rule 405 of the Rules and Regulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><B><I>&ldquo;Time of Sale&rdquo;</I></B>
means 7:30 a.m. (Eastern time) on the date of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Issuer
Free Writing Prospectuses</U></I>. (A) Each issuer free writing prospectus does not include any information that conflicts with the information
contained in the Registration Statements, any Preliminary Prospectus or the Prospectus. The foregoing sentence does not apply to statements
in or omissions from any issuer free writing prospectus based upon and in conformity with written information furnished to the Company
by you or by any Underwriter through you specifically for use therein, it being understood and agreed that the only such information furnished
by any Underwriter consists of the information described as such in Section 6(f).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(B)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) At
the earliest time after the filing of the Company Registration Statement that the Company or another offering participant made a <I>bona
fide</I> offer (within the meaning of Rule 164(h)(2) under the Securities Act) of the Securities and (2) at the date hereof, the Company
was not and is not an &ldquo;ineligible issuer,&rdquo; as defined in Rule 405 under the Securities Act, including the Company or any subsidiary
in the preceding three years not having been convicted of a felony or misdemeanor or having been made the subject of a judicial or administrative
decree or order as described in Rule 405 of the Rules and Regulations (without taking account of any determination by the Commission pursuant
to Rule 405 of the Rules and Regulations that it is not necessary that the Company be considered an ineligible issuer), nor an &ldquo;excluded
issuer&rdquo; as defined in Rule 164 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(C)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
issuer free writing prospectus satisfied, as of its issue date and at all subsequent times to the Time of Sale, all other conditions to
use thereof as set forth in Rules 164 and 433 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(iv)&nbsp;<B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B><I><U>Testing-the-Waters
Materials</U>. </I>Except as approved in writing by the Representative, (A) the Company has not alone engaged in any oral or written communication
with potential investors in the Securities undertaken in reliance on Rule 163B of the Securities Act (<B><I>&ldquo;Testing-the-Waters
Communication&rdquo;</I></B>), or (B) as of the Time of Sale, the Company has not alone furnished any Testing-the-Waters Communication
that is a written communication related to the Securities within the meaning of Rule 405 under the Securities Act (<B><I>&ldquo;Written
Testing-the-Waters Communications</I></B>&rdquo;) and has not authorized anyone to furnish any Written Testing-the-Waters Communications.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(v) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>No
Other Offering Materials</U></I>. The Company has not distributed and will not distribute any prospectus or other offering material in
connection with the offering and sale of the Securities other than any Preliminary Prospectus, the Time of Sale Disclosure Package or
the Prospectus or other materials permitted by the Act to be distributed by the Company; <I>provided, however,</I> that, except as set
forth on Schedule II, the Company has not made and will not make any offer relating to the Securities that would constitute a free writing
prospectus, except in accordance with the provisions of Section&nbsp;4(a)(xv) of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(vi)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Financial
Statements</U></I>. The financial statements of the Company, together with the related notes, set forth or incorporated by reference in
the Registration Statements, the Time of Sale Disclosure Package and the Prospectus comply in all material respects with the requirements
of the Securities Act and the Exchange Act and fairly present, in all material respects, the financial condition of the Company and its
consolidated subsidiaries as of the dates indicated and the results of operations and changes in cash flows for the periods therein specified
in conformity with generally accepted accounting principles in the United States (<B><I>&ldquo;GAAP&rdquo;</I></B>) consistently applied
throughout the periods involved; the supporting schedules included in the Registration Statements fairly present, in all material respects,
the information required to be stated therein; all non-GAAP financial information included in the Registration Statements, the Time of
Sale Disclosure Package and the Prospectus complies in all material respects with the requirements of Regulation G and Item 10 of Regulation
S-K under the Act; and, except as disclosed in the Time of Sale Disclosure Package and the Prospectus, there are no material off-balance
sheet arrangements (as defined in Regulation S-K under the Act, Item 303(a)(4)(ii)) or any other relationships with unconsolidated entities
or other persons, that may have a material current or, to the Company&rsquo;s knowledge, material future effect on the Company&rsquo;s
financial condition, results of operations, liquidity, capital expenditures, capital resources or significant components of revenue or
expenses. No other financial statements or schedules are required to be included in the Registration Statements, the Time of Sale Disclosure
Package or the Prospectus. To the Company&rsquo;s knowledge, Baker Tilly US, LLP, which has expressed its opinion with respect to the
Company&rsquo;s audited financial statements and schedules filed as a part of the Registration Statements and included in the Registration
Statements, the Time of Sale Disclosure Package and the Prospectus, is (x) an independent public accounting firm with respect to the Company
within the meaning of the Act and the Rules and Regulations, (y) a registered public accounting firm (as defined in Section 2(a)(12) of
the Sarbanes-Oxley Act of 2002 (the <B><I>&ldquo;Sarbanes-Oxley Act&rdquo;</I></B>)) and (z) to the Company&rsquo;s knowledge, not in
violation of the auditor independence requirements of the Sarbanes-Oxley Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(vii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Organization
and Good Standing</U></I>. Each of the Company and its &ldquo;<B>Significant Subsidiaries</B>&rdquo; (as defined in Rule 1-02(w) of Regulation
S-X) has been duly organized and is validly existing as an entity in good standing under the laws of its jurisdiction of organization.
Each of the Company and its Significant Subsidiaries has full corporate power and authority to own its properties and conduct its business
as currently being carried on and as described in the Registration Statements, the Time of Sale Disclosure Package and the Prospectus,
and is duly qualified to do business as a foreign entity in good standing in each jurisdiction in which it owns or leases real property
or in which the conduct of its business makes such qualification necessary and in which the failure to so qualify would, individually
or in the aggregate, reasonably be expected to have a material adverse effect upon the business, business prospects, management, properties,
condition (financial or otherwise) or consolidated results of operations of the Company and its subsidiaries, taken as a whole (<B><I>&ldquo;Material
Adverse Effect&rdquo;</I></B>).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(viii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Absence
of Certain Events</U></I>. Except as contemplated in the Time of Sale Disclosure Package and in the Prospectus, subsequent to the respective
dates as of which information is given in the Time of Sale Disclosure Package and the Prospectus, neither the Company nor any of its subsidiaries
has incurred any material liabilities or obligations, direct or contingent, or entered into any material transactions, or declared or
paid any dividends or made any distribution of any kind with respect to its capital stock; and there has not been any change in the capital
stock (other than a change in the number of outstanding shares of Common Stock due to the issuance of shares upon the exercise or settlement
of outstanding options, restricted stock units or warrants or conversion of convertible securities or due to the cancellation or redemption
of shares under existing equity incentive plans), or any material change in the short-term or long-term debt (other than as a result of
the conversion of convertible securities), or any issuance of options, warrants, convertible securities or other rights to purchase the
capital stock of the Company or any of its subsidiaries, which, individually or in the aggregate, would reasonably be expected to have
a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(ix)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Absence
of Proceedings</U></I>. Except as set forth in the Time of Sale Disclosure Package and in the Prospectus, there is not pending or, to
the knowledge of the Company, threatened or contemplated, any action, suit or proceeding (a) to which the Company or any of its subsidiaries
is a party or (b) which has as the subject thereof any officer or director of the Company or any subsidiary, any employee benefit plan
sponsored by the Company or any subsidiary or any property or assets owned or leased by the Company or any subsidiary before or by any
court or Governmental Authority (as defined below), or any arbitrator, which, individually or in the aggregate, would reasonably be expected
to have a Material Adverse Effect. There are no current or, to the knowledge of the Company, pending, legal, governmental or regulatory
actions, suits or proceedings (x) to which the Company or any of its subsidiaries is subject or (y) which has as the subject thereof any
officer or director of the Company or any subsidiary, any employee plan sponsored by the Company or any subsidiary or any property or
assets owned or leased by the Company or any subsidiary, that are required to be described in the Registration Statements, the Time of
Sale Disclosure Package and the Prospectus by the Act or by the Rules and Regulations and that have not been so described.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(x)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>[Reserved]</U></I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(xi)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Authorization;
No Conflicts; Authority</U></I>. This Agreement has been duly authorized, executed and delivered by the Company, and constitutes a valid,
legal and binding obligation of the Company, enforceable in accordance with its terms, except as rights to indemnity hereunder may be
limited by federal or state securities laws and except as such enforceability may be limited by bankruptcy, insolvency, reorganization
or similar laws affecting the rights of creditors generally and subject to general principles of equity. The execution, delivery and performance
of this Agreement and the consummation of the transactions herein contemplated will not (A) conflict with or result in a breach or violation
of any of the terms or provisions of, or constitute a default under, or result in the creation or imposition of any lien, charge or encumbrance
upon any property or assets of the Company or any of its subsidiaries pursuant to any indenture, mortgage, deed of trust, loan agreement
or other material agreement or instrument to which the Company or any of its subsidiaries is a party or by which the Company or any of
its subsidiaries is bound or to which any of the property or assets of the Company or any of its subsidiaries is subject, (B) result in
any violation of the provisions of the Company&rsquo;s charter or by-laws or (C) result in the violation of any law or statute or any
judgment, order, rule, regulation or decree of any court or arbitrator or federal, state, local or foreign governmental agency or regulatory
authority having jurisdiction over the Company or any of its subsidiaries or any of their properties or assets (each, a <B><I>&ldquo;Governmental
Authority&rdquo;</I></B>), except in the case of clauses (A) and (C) as would not, individually or in the aggregate, reasonably be expected
to result in a Material Adverse Effect. No consent, approval, authorization or order of, or registration or filing with any Governmental
Authority is required for the execution, delivery and performance of this Agreement or for the consummation of the transactions contemplated
hereby, including the issuance or sale of the Securities by the Company, except such as may be required under the Act, the rules of the
Financial Industry Regulatory Authority (<B><I>&ldquo;FINRA&rdquo;</I></B>), the rules of The Nasdaq Stock Market LLC or state securities
or blue sky laws; and the Company has full power and authority to enter into this Agreement and to consummate the transactions contemplated
hereby, including the authorization, issuance and sale of the Securities as contemplated by this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(xii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Capitalization;
the Securities; Registration Rights</U></I>. All of the issued and outstanding shares of capital stock of the Company are duly authorized
and validly issued, fully paid and nonassessable, have been issued in compliance with all federal and state and foreign securities laws,
were not issued in violation of or subject to any preemptive rights or other rights to subscribe for or purchase securities that have
not been waived in writing (a copy of which has been delivered to counsel to the Underwriters), and the holders thereof are not subject
to personal liability by reason of being such holders; the Securities which may be sold hereunder by the Company have been duly authorized
and, when issued, delivered and paid for in accordance with the terms of this Agreement, will have been validly issued and will be fully
paid and nonassessable, and the holders thereof will not be subject to personal liability by reason of being such holders; and the capital
stock of the Company, including the Common Stock and the Securities to be purchased pursuant to this Agreement, conforms to the description
thereof in the Time of Sale Disclosure Package and in the Prospectus. Except as otherwise stated in the Registration Statements, in the
Time of Sale Disclosure Package and in the Prospectus, (A) there are no preemptive rights or other rights to subscribe for or to purchase,
or any restriction upon the voting or transfer of, any shares of Common Stock pursuant to the Company&rsquo;s charter, by-laws or any
agreement or other instrument to which the Company or any of its subsidiaries is a party or by which the Company or any of its subsidiaries
is bound; and (B)&nbsp;neither the filing of the Registration Statements nor the offering or sale of the Securities as contemplated by
this Agreement gives rise to any rights for or relating to the registration of any shares of Common Stock or other securities of the Company.
All of the issued and outstanding shares of capital stock of each of the Company&rsquo;s subsidiaries have been duly and validly authorized
and issued and are fully paid and nonassessable, and, except as otherwise described in the Registration Statements, in the Time of Sale
Disclosure Package and in the Prospectus, the Company owns of record and beneficially, free and clear of any security interests, claims,
liens, proxies, equities or other encumbrances, all of the issued and outstanding shares of such stock. The Company has an authorized
and outstanding capitalization as set forth in the Time of Sale Disclosure Package and in the Prospectus (other than a change in the number
of outstanding shares of Common Stock due to the issuance of shares upon the exercise or settlement of outstanding options, restricted
stock units or warrants or conversion of convertible securities or due to the cancellation or redemption of shares under existing equity
incentive plans).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(xiii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Stock
Options</U></I>. Except as described in the Registration Statements, in the Time of Sale Disclosure Package and in the Prospectus or as
<FONT STYLE="background-color: white">would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect</FONT>,
there are no options, warrants, agreements, contracts or other rights in existence to purchase or acquire from the Company or any subsidiary
of the Company any shares of the capital stock of the Company or any subsidiary of the Company. The description of the Company&rsquo;s
stock option, stock bonus and other stock plans or arrangements (the <B><I>&ldquo;Company Stock Plans&rdquo;</I></B>), and the options
or other rights granted thereunder (collectively, the <B><I>&ldquo;Awards&rdquo;</I></B>), set forth in the Time of Sale Disclosure Package
and the Prospectus presents accurately and fairly in all material respects the information required to be shown with respect to such Company
Stock Plans, arrangements and Awards. Each grant of an Award (A) was duly authorized no later than the date on which the grant of such
Award was by its terms to be effective by all necessary corporate action, including, as applicable, approval by the board of directors
of the Company (or a duly constituted and authorized committee thereof) and any required stockholder approval by the necessary number
of votes or written consents, and the award agreement governing such grant (if any) was duly executed and delivered by each party thereto
and (B)&nbsp;was made in accordance with the terms of the applicable Company Stock Plan, and all applicable laws and regulatory rules
or requirements, including all applicable federal securities laws, except, in each case, as <FONT STYLE="background-color: white">would
not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect</FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(xiv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Compliance
with Laws</U></I>. <FONT STYLE="background-color: white">Except where such failure would not, individually or in the aggregate, reasonably
be expected to have a Material Adverse Effect, in each case, (i)</FONT> to the Company&rsquo;s knowledge, the Company and each of its
subsidiaries holds, and is operating in compliance with, all franchises, grants, authorizations, licenses, permits, easements, consents,
certificates and orders of any Governmental Authority or self-regulatory body required for the conduct of its business and all such franchises,
grants, authorizations, licenses, permits, easements, consents, certifications and orders are valid and in full force and effect, (ii)
neither the Company nor any of its subsidiaries has received notice of any revocation or modification of any material franchise, grant,
authorization, license, permit, easement, consent, certification or order or has reason to believe that any such material franchise, grant,
authorization, license, permit, easement, consent, certification or order will not be renewed in the ordinary course, and (iii) the Company
and each of its subsidiaries is in compliance with all applicable federal, state, local and foreign laws, regulations, orders and decrees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(xv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Ownership
of Assets</U></I>. The Company and its subsidiaries have rights to lease or otherwise use all items of real and personal property that
are material to the business of the Company and its subsidiaries taken as a whole (other than with respect to intellectual property, title
to which is addressed in subsection (xvi)), in each case free and clear of all liens, claims, security interests, other encumbrances or
defects except such as are described in the Registration Statements, in the Time of Sale Disclosure Package and in the Prospectus or as
<FONT STYLE="background-color: white">would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect</FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(xvi)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Intellectual
Property</U></I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1in">(A)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To
the knowledge of the Company, the Company and each of its subsidiaries owns or has the right to use pursuant to a valid and enforceable
written license or other legally enforceable right, all Intellectual Property (as defined below) necessary for the conduct of the Company&rsquo;s
and its subsidiaries&rsquo; businesses as now conducted or as described in the Registration Statements, the Time of Sale Disclosure Package
and the Prospectus to be conducted (the <B><I>&ldquo;Company IP&rdquo;</I></B>)<FONT STYLE="background-color: white">, except as would
not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect</FONT>. <B><I>&ldquo;Intellectual Property&rdquo;</I></B>
means all patents, patent applications, trade and service marks, trade and service mark registrations, trade names, copyrights, licenses,
inventions, trade secrets, domain names, technology, know-how and other intellectual property.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1in">(B)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="background-color: white">Except
where failure to comply would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect, in each
case, (i) </FONT>to the knowledge of the Company, there is no infringement, misappropriation or violation by third parties of any Company
IP, (ii) there is no pending or, to the knowledge of the Company, threatened, action, suit, proceeding or claim by others challenging
the Company&rsquo;s or its subsidiaries&rsquo; rights in or to any Company IP, and the Company is unaware of any facts which would form
a reasonable basis for any such claim, (iii) the Intellectual Property owned by the Company and its subsidiaries, and to the knowledge
of the Company, the Intellectual Property licensed to the Company and its subsidiaries, has not been adjudged invalid or unenforceable,
in whole or in part, and there is no pending or, to the knowledge of the Company, threatened action, suit, proceeding or claim by others
challenging the validity or scope of any Company IP, and the Company is unaware of any facts which would form a reasonable basis for any
such claim. There is no pending or, to the knowledge of the Company, threatened action, suit, proceeding or claim by others that the Company
or its subsidiaries infringe, misappropriate or otherwise violate any Intellectual Property or other proprietary rights of others, and
neither the Company nor any of its subsidiaries has received any written notice of such claim and the Company is unaware of any other
fact which would form a reasonable basis for any such claim<FONT STYLE="background-color: white">, except as would not, individually or
in the aggregate, reasonably be expected to have a Material Adverse Effect</FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1in">(C)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To
the Company&rsquo;s knowledge, no employee of the Company or any of its subsidiaries is in or has ever been in material violation of any
term of any employment contract, patent disclosure agreement, invention assignment agreement, non-competition agreement, non-solicitation
agreement, nondisclosure agreement or any restrictive covenant to or with a former employer where the basis of such violation relates
to such employee&rsquo;s employment with the Company or any of its subsidiaries or actions undertaken by the employee while employed with
the Company or any of its subsidiaries<FONT STYLE="background-color: white">, except as would not, individually or in the aggregate, reasonably
be expected to have a Material Adverse Effect</FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1in">(D)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company and its subsidiaries have taken reasonable security measures to protect the secrecy and confidentiality of their trade secrets
and the value of all of their material Intellectual Property.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1in">(E)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All
patent applications owned by the Company or its subsidiaries and filed with the U.S. Patent and Trademark Office (the <B><I>&ldquo;PTO&rdquo;</I></B>)
or any foreign or international patent authority that have resulted in patents or currently pending applications that describe inventions
necessary to conduct the business of the Company or its subsidiaries as now conducted or as described in the Registration Statements,
the Time of Sale Disclosure Package and the Prospectus to be conducted (collectively, the <B><I>&ldquo;Company Patent Applications&rdquo;</I></B>)
have been or were duly and properly filed<FONT STYLE="background-color: white">, except as would not, individually or in the aggregate,
reasonably be expected to have a Material Adverse Effect</FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(xvii)&#9;<I><U>Privacy
and Data Protection</U></I>. <FONT STYLE="background-color: white">Except where failure to comply would not, individually or in the aggregate,
reasonably be expected to have a Material Adverse Effect, in each case, (i) the Company has operated its business in a manner compliant
with all United States federal, state, local and non-United States&nbsp;</FONT>privacy<FONT STYLE="background-color: white">, data security
and data protection laws and regulations applicable to the Company&rsquo;s collection, use, transfer, protection, disposal, disclosure,
handling, storage and analysis of personal data, and (ii) the Company has been and is in compliance in all material respects with internal
policies and procedures designed to ensure the integrity and security of the data collected, handled or stored in connection with its
business. The Company has taken commercially reasonable steps to maintain the confidentiality of its personally identifiable information,
protected health information, consumer information and other confidential information of the Company and any third parties in its possession
(<B><I>&ldquo;Sensitive Company Data&rdquo;</I></B>). Except where failure to comply would not, individually or in the aggregate, reasonably
be expected to have a Material Adverse Effect, in each case, (i) the tangible or digital information technology systems (including computers,
screens, servers, workstations, routers, hubs, switches, networks, data communications lines, technical data and hardware), software and
telecommunications systems used or held for use by the Company (the <B><I>&ldquo;Company IT Assets&rdquo;</I></B>) are adequate and operational
for, in accordance with their documentation and functional specifications, the business of the Company as now operated and as currently
proposed to be conducted as described in the </FONT>Registration Statements, in the Time of Sale Disclosure Package and in the Prospectus<FONT STYLE="background-color: white">,
and (ii) the Company has used commercially reasonable efforts to establish, and has established, commercially reasonable disaster recovery
and security plans, procedures and facilities for the Company IT Assets and data held or used by or for the Company. To the Company&rsquo;s
knowledge, the Company has not suffered or incurred any security breaches, compromises or incidents with respect to any Company IT Asset
or Sensitive Company Data, except where such breaches, compromises or incidents would not, individually or in the aggregate, reasonably
be expected to result in a Material Adverse Effect; and there has been no&nbsp;unauthorized or illegal use of or access to any Company
IT Asset or Sensitive Company Data by any unauthorized third party, except where such unauthorized or illegal use or access would not,
individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. To the Company&rsquo;s knowledge, the Company
has not been required to notify any individual of any information security breach, compromise or incident involving Sensitive Company
Data, except where the failure to give such notice would not, individually or in the aggregate, reasonably be expected to have a Material
Adverse Effect.</FONT>&#9;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(xviii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>No
Violations or Defaults</U></I>. Neither the Company nor any of its Significant Subsidiaries is in violation of its respective charter,
by-laws or other organizational documents, or in breach of or otherwise in default, and no event has occurred which, with notice or lapse
of time or both, would constitute such a default in the performance of any obligation, agreement or condition contained in any bond, debenture,
note, indenture, loan agreement or any other contract, lease or other instrument to which it is subject or by which any of them may be
bound, or to which any of the property or assets of the Company or any of its subsidiaries is subject, except as would not, individually
or in the aggregate, reasonably be expected to have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(xix)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Taxes</U></I>.
The Company and its subsidiaries have timely filed all federal, state, local and foreign income and franchise tax returns required to
be filed through the date hereof or have obtained or requested extensions thereof and the Company and its subsidiaries are not in material
default in the payment of any taxes which were payable pursuant to said returns or any assessments with respect thereto, other than any
which the Company or any of its subsidiaries is contesting in good faith<FONT STYLE="background-color: white">, in each case, except as
would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect</FONT>. There is no pending dispute
with any taxing authority relating to any of such returns, and the Company has no knowledge of any proposed liability for any tax to be
imposed upon the properties or assets of the Company for which there is not an adequate reserve reflected in the Company&rsquo;s financial
statements included in the Registration Statements, the Time of Sale Disclosure Package and the Prospectus<FONT STYLE="background-color: white">,
except as would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect</FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(xx)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Exchange
Listing and Exchange Act Registration</U></I>. The Common Stock is registered pursuant to Section&nbsp;12(b) of the Exchange Act and is
included or approved for listing on the Nasdaq Capital Market and the Company has not taken any action designed to, or likely to have
the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq Capital
Market, and the Company has not received any notification that the Commission or the Nasdaq Capital Market is contemplating terminating
such registration or listing. The Company has complied in all material respects with the applicable requirements of the Nasdaq Capital
Market for maintenance of inclusion of the Common Stock thereon. Except as previously disclosed to counsel for the Underwriters or as
set forth in the Time of Sale Disclosure Package and the Prospectus, to the knowledge of the Company, no beneficial owners of the Company&rsquo;s
capital stock who, together with their associated persons and affiliates, hold in the aggregate 10% or more of such capital stock, have
any direct or indirect association or affiliate with a FINRA member.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(xxi)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Ownership
of Other Entities</U></I>. Other than (i) the subsidiaries of the Company listed in Exhibit&nbsp;21.1 to the Company&rsquo;s Annual Report
on Form 10-K for the fiscal year ended June 30, 2021 and (ii) such other entities omitted from Exhibit 21.1 which, when such omitted entities
are considered in the aggregate as a single subsidiary, would not constitute a Significant Subsidiary, the Company does not own or control,
directly or indirectly, any corporation, partnership, association, trust or other entity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(xxii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Internal
Controls</U></I>. The Company and its subsidiaries maintain a system of internal accounting controls sufficient to provide reasonable
assurances that (i)&nbsp;transactions are executed in accordance with management&rsquo;s general or specific authorization; (ii)&nbsp;transactions
are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain accountability for assets;
(iii)&nbsp;access to assets is permitted only in accordance with management&rsquo;s general or specific authorization; and (iv)&nbsp;the
recorded accountability for assets is compared with existing assets at reasonable intervals and appropriate action is taken with respect
to any differences. Except as disclosed in the Registration Statements, in the Time of Sale Disclosure Package and in the Prospectus,
the Company&rsquo;s internal control over financial reporting is effective and the Company, is not aware of (i) any &ldquo;significant
deficiencies&rdquo; or &ldquo;material weaknesses&rdquo; (each as defined by the Public Company Accounting Oversight Board) in its internal
control over financial reporting, (ii) any fraud, whether or not material, that involves management or other employees who have a significant
role in the Company&rsquo;s internal control over financial reporting; or (iii) any change in the Company&rsquo;s internal control over
financial reporting that has occurred during its most recent fiscal quarter that has materially affected, or is reasonably likely to materially
affect, the Company&rsquo;s internal control over financial reporting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(xxiii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>No
Brokers or Finders</U></I>. Other than as contemplated by this Agreement or as otherwise disclosed in the Time of Sale Disclosure Package
or in the Prospectus, the Company has not incurred any liability for any finder&rsquo;s or broker&rsquo;s fee or agent&rsquo;s commission
in connection with the execution and delivery of this Agreement or the consummation of the transactions contemplated hereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(xxiv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Insurance</U></I>.
Each of the Company and its subsidiaries is insured with policies in such amounts and with such deductibles and covering such risks as
it reasonably deems adequate for its business, and the real property leased by the Company and any of its subsidiaries is appropriately
insured by institutions the Company reasonably believes to be financially sound.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(xxv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Investment
Company Act</U></I>. The Company is not and, after giving effect to the offering and sale of the Firm Shares, will not be an &ldquo;investment
company,&rdquo; as such term is defined in the Investment Company Act of 1940, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(xxvi)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Eligibility
to Use Form S-3</U></I>. The conditions for use of Form&nbsp;S-3, in connection with the offer and sale of the Securities, as set forth
in the General Instructions thereto, have been satisfied.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(xxvii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Incorporated
Documents</U></I>. The documents incorporated by reference in the Time of Sale Disclosure Package and in the Prospectus, when they became
effective or were filed with the Commission, as the case may be, conformed in all material respects to the requirements of the Securities
Act or the Exchange Act, as applicable, and were filed on a timely basis with the Commission and none of such documents contained an untrue
statement of a material fact or omitted to state a material fact necessary to make the statements therein, in the light of the circumstances
under which they were made, not misleading; during the Prospectus Delivery Period (as defined below), any further documents so filed and
incorporated by reference in the Time of Sale Disclosure Package or in the Prospectus, when such documents are filed with the Commission,
will conform in all material respects to the requirements of the Exchange Act, and will not contain an untrue statement of a material
fact or omit to state a material fact necessary to make the statements therein, in the light of the circumstances under which they were
made, not misleading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(xxviii) <I><U>Sarbanes-Oxley
Act</U></I>. The Company is in compliance, in all material respects, with all provisions of the Sarbanes-Oxley Act and the rules and regulations
of the Commission thereunder, to the extent compliance is required.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(xxix) <I><U>Disclosure
Controls</U></I>. The Company has established and maintains disclosure controls and procedures (as defined in Rules 13a-15(e) under the
Exchange Act) that (i) comply with the requirements of the Exchange Act, and (ii) have been designed to ensure that information required
to be disclosed by the Company in reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported
within the time periods specified in the Commission&rsquo;s rules and forms, including controls and procedures designed to ensure that
such information is accumulated and communicated to the Company&rsquo;s management as appropriate to allow timely decisions regarding
required disclosure.<FONT STYLE="background-color: white">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(xxx) <I><U>Anti-Bribery
and Anti-Money Laundering Laws</U></I>. Each of the Company, its subsidiaries, and their respective officers and directors, and to the
knowledge of the Company, any agent, affiliate or representative of the Company or its subsidiaries , has not violated, its participation
in the offering will not violate, and the Company and each of its subsidiaries has instituted and maintains policies and procedures designed
to ensure continued compliance with, each of the following laws: applicable anti-bribery laws, including but not limited to, any applicable
law, rule, or regulation of any locality, including but not limited to any law, rule, or regulation promulgated to implement the OECD
Convention on Combating Bribery of Foreign Public Officials in International Business Transactions, signed December&nbsp;17, 1997, including
the U.S. Foreign Corrupt Practices Act of 1977, as amended, the U.K. Bribery Act 2010, or any other applicable law, rule or regulation
of similar purposes and scope, or applicable anti-money laundering laws, including but not limited to, applicable federal, state, international,
foreign or other laws, regulations or government guidance regarding anti-money laundering, including, without limitation, Title 18 U.S.
Code Section 1956 and 1957, the Patriot Act, the Bank Secrecy Act, and international anti-money laundering principles or procedures by
an intergovernmental group or organization, such as the Financial Action Task Force on Money Laundering, of which the United States is
a member and with which designation the United States representative to the group or organization continues to concur, all as amended,
and any executive order, directive, or regulation pursuant to the authority of any of the foregoing, or any orders or licenses issued
thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(xxxi) <I><U>OFAC</U></I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1in">(A)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Neither
the Company nor any of its subsidiaries, nor any of their respective directors and officers, nor, to the Company&rsquo;s knowledge, any
agent, affiliate or representative of the Company or its subsidiaries, is an individual or entity that is, or is owned or controlled by
an individual or entity that is:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 1in">(1)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
subject of any sanctions administered or enforced by the U.S. Department of Treasury&rsquo;s Office of Foreign Assets Control, the United
Nations Security Council, the European Union, Her Majesty&rsquo;s Treasury, or other relevant sanctions authority (collectively, <B><I>&ldquo;Sanctions&rdquo;</I></B>);
nor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 1in">(2)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;located,
organized or resident in a country or territory that is the subject of comprehensive sanctions (currently including the Crimea Region
of the Ukraine, Burma/Myanmar, Cuba, Iran, Libya, North Korea, Sudan and Syria).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1in">(B)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Neither
the Company nor any of its subsidiaries will, directly or indirectly, use the proceeds of the offering, or lend, contribute or otherwise
make available such proceeds to any subsidiary, joint venture partner or other individual or entity:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 1in">(1)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to
fund or facilitate any activities or business of or with any individual or entity or in any country or territory that, at the time of
such funding or facilitation, is the subject of comprehensive sanctions; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 1in">(2)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;in
any other manner that will result in a violation of Sanctions by any individual or entity (including any individual or entity participating
in the offering, whether as underwriter, advisor, investor or otherwise).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1in">(C)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For
the past five years, neither the Company nor any of its subsidiaries has knowingly engaged in, and is not now knowingly engaged in, any
dealings or transactions with any individual or entity, or in any country or territory, that at the time of the dealing or transaction
is or was the subject of Sanctions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(xxxii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Compliance
with Environmental Laws</U></I>. Except as disclosed in the Time of Sale Disclosure Package and the Prospectus, neither the Company nor
any of its subsidiaries is in violation of any statute, any rule, regulation, decision or order of any Governmental Authority or any court,
domestic or foreign, relating to the use, disposal or release of hazardous or toxic substances or relating to the protection or restoration
of the environment or human exposure to hazardous or toxic substances (collectively, <B><I>&ldquo;Environmental Laws&rdquo;</I></B>),
owns or operates any real property contaminated with any substance that is subject to any Environmental Laws, is liable for any off-site
disposal or contamination pursuant to any Environmental Laws, or is subject to any claim relating to any Environmental Laws, which violation,
contamination, liability or claim would, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect; and
the Company is not aware of any pending investigation which can be reasonably expected to lead to such a claim nor is the Company or any
of its subsidiaries anticipating incurring any material capital expenditures relating to compliance with Environmental Laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(xxxiii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<I><U>[Reserved]</U></I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(xxxiv) <I><U>ERISA
and Employee Benefits Matters</U></I>. Except as would not reasonably be expected to have a Material Adverse Effect, (A) no &ldquo;prohibited
transaction&rdquo; as defined under Section 406 of ERISA (as defined below) or Section 4975 of the Code (as defined below) and not exempt
under ERISA Section 408 and the regulations and published interpretations by the United States Department of Labor thereunder has occurred
with respect to any Employee Benefit Plan (as defined below); (B) at no time in the past six years has the Company or any ERISA Affiliate
(as defined below), maintained, sponsored, participated in, contributed to or has or had any liability or obligation in respect of any
Employee Benefit Plan subject to Part 3 of Subtitle B of Title I of ERISA, Title IV of ERISA, or Section 412 of the Code or any &ldquo;multiemployer
plan&rdquo; as defined in Section 3(37) of ERISA or any multiple employer plan for which the Company or any ERISA Affiliate has incurred
or could incur liability under Section 4063 or 4064 of ERISA; (C) no Employee Benefit Plan provides or promises retiree health, life insurance,
or other retiree welfare benefits except as may be required by the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended,
or similar state law; (D) each Employee Benefit Plan is and has been operated in compliance with its terms and all applicable laws, including
but not limited to ERISA and the Code; and, to the knowledge of the Company, no &ldquo;reportable event,&rdquo; as such term is defined
in Section 4043 of ERISA, has occurred; (E) each Employee Benefit Plan intended to be qualified under Code Section 401(a) has obtained
a favorable determination letter as to its qualified status (or the qualified status of the master or prototype form on which it is established)
from the Internal Revenue Service (<B><I>&ldquo;IRS&rdquo;</I></B>), and nothing has occurred, whether by action or failure to act, which
would reasonably be expected to cause the loss of such qualification and (F) with respect to each Foreign Benefit Plan (as defined below),
such Foreign Benefit Plan (1) if intended to qualify for special tax treatment, meets the requirements for such treatment, and (2) if
required to be funded, is funded to the extent required by applicable law. As used in this Agreement, <B><I>&ldquo;Code&rdquo;</I></B>
means the Internal Revenue Code of 1986, as amended; <B><I>&ldquo;Employee Benefit Plan&rdquo;</I></B> means any &ldquo;employee benefit
plan&rdquo; within the meaning of Section 3(3) of ERISA under which (1) any current or former employee, director or independent contractor
of the Company or its subsidiaries has any present or future right to benefits and which are contributed to, sponsored by or maintained
by the Company or any of its subsidiaries or (2)&nbsp;the Company or any of its subsidiaries has any present or future obligation or liability;
<B><I>&ldquo;ERISA&rdquo;</I></B> means the Employee Retirement Income Security Act of 1974, as amended; <B><I>&ldquo;ERISA Affiliate&rdquo;</I></B>
means any member of the Company&rsquo;s controlled group as defined in Code Section 414(b), (c), (m) or (o); and <B><I>&ldquo;Foreign
Benefit Plan&rdquo;</I></B> means any Employee Benefit Plan established, maintained or contributed to outside of the United States of
America or which covers any employee working or residing outside of the United States.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(xxxv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<I><U>[Reserved]</U></I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(xxxvi)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<I><U>Labor Matters</U></I>. No labor problem or dispute with the employees of the Company or any of its subsidiaries exists or, to the
knowledge of the Company, is threatened or imminent, and the Company is not aware of any existing or imminent labor disturbance by the
employees of any of its or its subsidiaries&rsquo; principal suppliers, contractors or customers, that would, individually or in the aggregate,
reasonably be expected to have a Material Adverse Effect. Neither the Company nor any of its subsidiaries has any obligations under any
collective bargaining agreement with any union and no organization efforts are underway with respect to employees of the Company or any
of its subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(xxxvii) <I><U>Restrictions
on Subsidiary Payments to the Company</U></I>. No subsidiary of the Company is currently prohibited, directly or indirectly, from paying
any dividends to the Company, from making any other distribution on such subsidiary&rsquo;s capital stock, from repaying to the Company
any loans or advances to such subsidiary from the Company or from transferring any of such subsidiary&rsquo;s property or assets to the
Company or any other subsidiary of the Company, except as provided by applicable state law or described in or contemplated by the Time
of Sale Disclosure Package and the Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(xxxviii) <I><U>Statistical
Information</U></I>. Any third-party statistical and market-related data included in the Registration Statements, the Time of Sale Disclosure
Package and the Prospectus are based on or derived from sources that the Company believes to be reasonably current and reliable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) <U>Representations and Warranties
of the Selling Stockholder</U>. The Selling Stockholder represents and warrants to, and agrees with, the several Underwriters as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 67.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(i) <I><U>Accurate
Disclosure</U></I>. Neither the Time of Sale Disclosure Package nor the Prospectus or any amendments or supplements thereto includes any
untrue statement of a material fact or omits to state a material fact necessary in order to make the statements therein, in the light
of the circumstances under which they were made, not misleading, provided that such representations and warranties set forth in this subsection
(b)(i) apply only to statements or omissions made in reliance upon and in conformity with information relating to the Selling Stockholder
furnished in writing by or on behalf of the Selling Stockholder expressly for use in the Selling Stockholder Registration Statement, the
Time of Sale Disclosure Package, the Prospectus or any other issuer free writing prospectus or any amendment or supplement thereto, it
being understood and agreed that the only information furnished by the Selling Stockholder consists of the name of the Selling Stockholder,
the number of offered shares and the address and other information with respect to the Selling Stockholder (excluding percentages) which
appears in the Time of Sale Disclosure Package or the Prospectus or any amendment or supplement thereto in the table (and corresponding
footnotes) under the caption &ldquo;Selling Stockholder&rdquo; (the <B><I>&ldquo;Selling Stockholder Information&rdquo;</I></B>). The
Selling Stockholder is not prompted to sell the Shares to be sold by the Selling Stockholder hereunder by any material non-public information
concerning the Company or any subsidiary of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(ii) <I><U>Authorization
of this Agreement</U></I>. This Agreement has been duly authorized, executed and delivered by or on behalf of the Selling Stockholder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(iii) <I><U>Authorization
of Power of Attorney</U></I>. The Power of Attorney, in the form heretofore furnished to the Representative (the <B><I>&ldquo;Power of
Attorney&rdquo;</I></B>), has been duly authorized, executed and delivered by or on behalf of the Selling Stockholder and is the valid
and binding agreement of the Selling Stockholder subject to bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium and
similar laws of general applicability relating to or affecting creditors&rsquo; rights and to general equity principles.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(iv) <I><U>Noncontravention</U></I>.
The execution and delivery of this Agreement and the Power of Attorney and the sale and delivery of the Securities to be sold by the Selling
Stockholder and the consummation of the transactions contemplated herein and compliance by the Selling Stockholder with its obligations
hereunder do not and will not, whether with or without the giving of notice or passage of time or both, conflict with or constitute a
breach of, or default under, or result in the creation or imposition of any tax, lien, charge or encumbrance upon the Securities to be
sold by the Selling Stockholder or any property or assets of the Selling Stockholder pursuant to any contract, indenture, mortgage, deed
of trust, loan or credit agreement, note, license, lease or other agreement or instrument to which the Selling Stockholder is a party
or by which the Selling Stockholder may be bound, or to which any of the property or assets of the Selling Stockholder is subject, nor
will such action result in any violation of the provisions of the charter or by-laws or other organizational instrument of the Selling
Stockholder, if applicable, or any applicable treaty, law, statute, rule, regulation, judgment, order, writ or decree of any government,
government instrumentality or court, domestic or foreign, having jurisdiction over the Selling Stockholder or any of its properties except
for such conflicts, breaches, defaults, liens, charges, encumbrances and taxes, as would not, individually or in the aggregate, have a
material adverse effect on the ability of the Selling Stockholder to consummate the transactions contemplated by this Agreement and, as
applicable, the Power of Attorney (a <B><I>&ldquo;Selling Stockholder Material Adverse Effect&rdquo;</I></B>).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(v) <I><U>Valid Title</U></I>.
The Selling Stockholder has, and at each Closing Date will have, valid title to, or a valid &ldquo;security entitlement&rdquo; within
the meaning of Section 8-102 of the New York Uniform Commercial Code (the <B><I>&ldquo;UCC&rdquo;</I></B>) in respect of, the Securities
to be sold by the Selling Stockholder free and clear of all security interests, claims, liens, equities or other encumbrances and the
legal right and power, and all authorization and approval required by law, to enter into this Agreement and the Power of Attorney and
to sell, transfer and deliver the Securities to be sold by the Selling Stockholder or a security entitlement in respect of such Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(vi) <I><U>Delivery
of Securities</U></I>. Upon payment of the purchase price for the Securities to be sold by the Selling Stockholder pursuant to this Agreement,
delivery of such Securities, as directed by the Underwriters, to Cede &amp; Co. (<B><I>&ldquo;Cede&rdquo;</I></B>) or such other nominee
as may be designated by The Depository Trust Company (<B><I>&ldquo;DTC&rdquo;</I></B>) (unless delivery of such Securities is unnecessary
because such Securities are already in possession of Cede or such nominee), registration of such Securities in the name of Cede or such
other nominee (unless registration of such Securities is unnecessary because such Securities are already registered in the name of Cede
or such nominee), and the crediting of such Securities on the books of DTC to securities accounts (within the meaning of Section 8-501(a)
of the UCC) of the Underwriters (assuming that neither DTC nor any such Underwriter has notice of any &ldquo;adverse claim,&rdquo; within
the meaning of Section 8-105 of the UCC, to such Securities), (A) under Section 8-501 of the UCC, the Underwriters will acquire a valid
&ldquo;security entitlement&rdquo; in respect of such Securities and (B) no action (whether framed in conversion, replevin, constructive
trust, equitable lien, or other theory) based on any &ldquo;adverse claim,&rdquo; within the meaning of Section 8-102 of the UCC, to such
Securities may be successfully asserted against the Underwriters with respect to such security entitlement; for purposes of this representation,
the Selling Stockholder may assume that when such payment, delivery (if necessary) and crediting occur, (I) such Securities will have
been registered in the name of Cede or another nominee designated by DTC, in each case on the Company&rsquo;s share registry in accordance
with its certificate of incorporation, by-laws and applicable law, (II) DTC will be registered as a &ldquo;clearing corporation,&rdquo;
within the meaning of Section 8-102 of the UCC, (III) appropriate entries to the accounts of the several Underwriters on the records of
DTC will have been made pursuant to the UCC, (IV) to the extent DTC, or any other securities intermediary which acts as &ldquo;clearing
corporation&rdquo; with respect to the Securities, maintains any &ldquo;financial asset&rdquo; (as defined in Section 8-102(a)(9) of the
UCC) in a clearing corporation pursuant to Section 8-111 of the UCC, the rules of such clearing corporation may affect the rights of DTC
or such securities intermediaries and the ownership interest of the Underwriters, (V) claims of creditors of DTC or any other securities
intermediary or clearing corporation may be given priority to the extent set forth in Section 8-511(b) and 8-511(c) of the UCC and (VI)
if at any time DTC or other securities intermediary does not have sufficient Securities to satisfy claims of all of its entitlement holders
with respect thereto then all holders will share pro rata in the Securities then held by DTC or such securities intermediary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(vii) <I><U>Absence
of Manipulation</U></I>. The Selling Stockholder has not taken, and will not take, directly or indirectly, any action which is designed
to or which constituted or would be expected to cause or result in stabilization or manipulation of the price of any security of the Company
to facilitate the sale or resale of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(viii) <I><U>Absence
of Further Requirements</U></I>. No filing with, or consent, approval, authorization, order, registration, qualification or decree of
any arbitrator, court, governmental body, regulatory body, administrative agency or other authority, body or agency, domestic or foreign,
is necessary or required to be made or obtained by the Selling Stockholder for the performance by the Selling Stockholder of its obligations
hereunder, or in connection with the sale and delivery of the Securities hereunder or the consummation of the transactions contemplated
by this Agreement, except such as have been already obtained or as may be required under the Securities Act, the Rules and Regulations,
the rules of the Nasdaq Capital Market, state securities laws or the rules of FINRA except for such consents, approvals, authorizations,
orders or qualifications as would not, individually or in the aggregate, reasonably be expected to have a Selling Stockholder Material
Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(ix) <I><U>No Registration
or Other Similar Rights</U></I>. The Selling Stockholder does not have any registration or other similar rights to have any equity or
debt securities registered for sale by the Company under the Selling Stockholder Registration Statement or included in the offering contemplated
by this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(x) <I><U>No Free
Writing Prospectuses</U></I>. The Selling Stockholder has not prepared or had prepared on its behalf or used or referred to, any free
writing prospectus, and has not distributed any written materials in connection with the offer or sale of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Effect
of Certificates.</U></I> Any certificate signed by any officer of the Company and delivered to you or to counsel for the Underwriters
shall be deemed a representation and warranty by the Company to each Underwriter as to the matters covered thereby, and any certificate
signed by or on behalf of the Selling Stockholder as such and delivered to you or to counsel for the Underwriters shall be deemed a representation
and warranty by the Selling Stockholder to each Underwriter as to the matters covered thereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Purchase,
Sale and Delivery of Securities</I></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Firm
Shares</U></I>. On the basis of the representations, warranties and agreements herein contained, but subject to the terms and conditions
herein set forth, the Company agrees to sell the Firm Shares to the several Underwriters, and each Underwriter agrees, severally and not
jointly, to purchase from the Company the number of Firm Shares set forth opposite the name of such Underwriter in Schedule I hereto.
The purchase price for each Firm Share shall be $7.05 per share. In making this Agreement, each Underwriter is contracting severally and
not jointly; except as provided in paragraph (b) of this Section 3, the agreement of each Underwriter is to purchase only the respective
number of Firm Shares specified in Schedules I and II.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">The Firm Shares will be delivered
by the Company to you for the accounts of the several Underwriters against payment of the purchase price therefor by wire transfer of
same day funds payable to the order of the Company at the offices of Canaccord Genuity LLC, 99 High Street, Boston, Massachusetts 02110,
or such other location as may be mutually acceptable, at 10:00&nbsp;a.m. Eastern time on the second (or if the Securities are priced,
as contemplated by Rule 15c6-1(c) under the Exchange Act, after 4:30 p.m. Eastern time, the third) full business day following the date
hereof, or at such other time and date as you and the Company determine pursuant to Rule 15c6-1(a) under the Exchange Act, such time and
date of delivery being herein referred to as the <B><I>&ldquo;First Closing Date.&rdquo;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Option
Shares</U></I>. On the basis of the representations, warranties and agreements herein contained, but subject to the terms and conditions
herein set forth, the Selling Stockholder hereby grants to the several Underwriters an option to purchase all or any portion of the Option
Shares at the same purchase price as the Firm Shares, for use solely in covering any over-allotments made by the Underwriters in the sale
and distribution of the Firm Shares. The option granted hereunder may be exercised in whole or in part at any time (but not more than
once) within 30 days after the effective date of this Agreement upon notice (confirmed in writing) by the Underwriters to the Company
setting forth the aggregate number of Option Shares as to which the Underwriters are exercising the option and the date and time, as determined
by you, when the Option Shares are to be delivered, such time and date being herein referred to as the <B><I>&ldquo;Second Closing&rdquo;</I></B>
and <B><I>&ldquo;Second Closing Date,&rdquo;</I></B> respectively, and each such time and date for delivery (including any First Closing
Date or Second Closing Date) is herein called a &ldquo;<B><I>Closing Date</I></B>&rdquo;; <I>provided, however</I>, that the Second Closing
Date shall not be earlier than the First Closing Date nor earlier than the second business day after the date on which the option shall
have been exercised. Each Underwriter agrees, severally and not jointly, to purchase the number of Option Shares (subject to such adjustments
to eliminate fractional shares as you may determine) that bears the same proportion of the total number of Option Shares to be purchased
on such Second Closing Date as the number of Firm Shares set forth in Schedule I hereto opposite the name of such Underwriter bears to
the total number of Firm Shares. No Option Shares shall be sold and delivered unless the Firm Shares previously have been, or simultaneously
are, sold and delivered.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">The Option Shares will be delivered
by the Selling Stockholder to you for the accounts of the several Underwriters against payment of the purchase price therefor by wire
transfer of same day funds payable to the order of the Selling Stockholder at the offices of Canaccord Genuity LLC, 99 High Street, Boston,
Massachusetts 02110, or such other location as may be mutually acceptable at 10:00&nbsp;a.m., Eastern time, on the Second Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Delivery</U></I>.
Delivery of the Firm Shares and the Option Shares shall be made by credit through full fast transfer to the accounts at DTC designated
by the Representative.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d) <I><U>Purchase by Representative
on Behalf of Underwriters</U></I>. It is understood that you, individually and not as Representative of the several Underwriters, may
(but shall not be obligated to) make payment to the Company or the Selling Stockholder on behalf of any Underwriter for the Securities
to be purchased by such Underwriter. Any such payment by you shall not relieve any such Underwriter of any of its obligations hereunder.
Nothing contained herein shall constitute any of the Underwriters an unincorporated association or partner with the Company or the Selling
Stockholder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Covenants</I></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Covenants
of the Company and the Selling Stockholder</U></I>. The Company covenants and agrees, and solely with respect to paragraphs (xv), (xvi),
(xvii) and (xviii), the Selling Stockholder covenants and agrees, with the several Underwriters as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Required
Filings</U></I>. During the period beginning on the date hereof and ending on the later of the Second Closing Date or such date, as in
the opinion of counsel for the Underwriters, the Prospectus is no longer required by law to be delivered (assuming the absence of Rule
172 under the Securities Act), in connection with sales by an Underwriter or a dealer (the <B>&ldquo;<I>Prospectus Delivery Period&rdquo;</I></B>),
prior to amending or supplementing either of the Registration Statements, the Time of Sale Disclosure Package or the Prospectus, the Company
shall furnish to you for review a copy of each such proposed amendment or supplement, and the Company shall not file any such proposed
amendment or supplement to which the Underwriters or counsel to the Underwriters do not consent (not to be unreasonably withheld or delayed).
Subject to this Section 4(a)(i), immediately following execution of this Agreement, the Company will prepare the Prospectus containing
the Rule 430B Information and other selling terms of the Securities, the plan of distribution thereof and such other information as may
be required by the Securities Act or the Rules and Regulations or as the Underwriters and the Company may deem appropriate, and if requested
by the Underwriters, an issuer free writing prospectus containing the selling terms of the Securities and such other information as the
Company and the Underwriters may deem appropriate, and will file or transmit for filing with the Commission, in accordance with Rule 424(b)
or Rule 433, as the case may be, copies of the Prospectus and each issuer free writing prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Notification
of Certain Commission Actions</U></I>. During the Prospectus Delivery Period, the Company shall promptly advise you in writing (A) of
the receipt of any comments of, or requests for additional or supplemental information from, the Commission, (B) of the time and date
of any filing of any post-effective amendment to either of the Registration Statements or any amendment or supplement to any Preliminary
Prospectus, the Time of Sale Disclosure Package or the Prospectus, (C) of the time and date that any post-effective amendment to either
of the Registration Statements becomes effective, (D) of the issuance by the Commission of any stop order suspending the effectiveness
of either of the Registration Statements or any post-effective amendment thereto or of any order preventing or suspending its use or the
use of any Preliminary Prospectus, the Time of Sale Disclosure Package, the Prospectus or any issuer free writing prospectus, or (E) of
any proceedings to remove, suspend or terminate from listing or quotation the Common Stock from any securities exchange upon which it
is listed for trading or included or designated for quotation, or of the threatening or initiation of any proceedings for any of such
purposes. During the Prospectus Delivery Period, if the Commission shall enter any such stop order at any time, the Company will use commercially
reasonable efforts to obtain the lifting of such order at the earliest possible moment. Additionally, the Company agrees that it shall
comply with the provisions of Rules 424(b) and 430B, as applicable, under the Securities Act and will use its reasonable efforts to confirm
that any filings made by the Company under Rule 424(b), Rule 433 or Rule 462 were received in a timely manner by the Commission (without
reliance on Rule 424(b)(8) or Rule 164(b)).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Continued
Compliance with Securities Laws</U></I>. (A) During the Prospectus Delivery Period, the Company will comply with all applicable requirements
imposed upon it by the Securities Act, as now and hereafter amended, and by the applicable Rules and Regulations, as from time to time
in force, and by the Exchange Act so far as necessary to permit the continuance of sales of or dealings in the Securities as contemplated
by the provisions hereof, the Time of Sale Disclosure Package and the Prospectus. If during the Prospectus Delivery Period any event occurs
as a result of which the Prospectus (or if the Prospectus is not yet available to prospective purchasers, the Time of Sale Disclosure
Package) would include an untrue statement of a material fact or omit to state a material fact necessary to make the statements therein,
in the light of the circumstances then existing, not misleading, or if during such Prospectus Delivery Period it is necessary or appropriate
in the opinion of the Company or its counsel or the Underwriters or counsel to the Underwriters to amend either of the Registration Statements
or supplement the Prospectus (or, if the Prospectus is not yet available to prospective purchasers, the Time of Sale Disclosure Package)
to comply with the Securities Act or to file under the Exchange Act any document which would be deemed to be incorporated by reference
in the Prospectus (or if the Prospectus is not yet available to prospective purchasers, the Time of Sale Disclosure Package) in order
to comply with the Securities Act or the Exchange Act, the Company promptly will (x)&nbsp;notify you of such untrue statement or omission,
(y)&nbsp; amend either of the Registration Statements or supplement the Prospectus (or, if the Prospectus is not yet available to prospective
purchasers, the Time of Sale Disclosure Package) or file such document (at the expense of the Company) with the Commission so as to correct
such statement or omission or effect such compliance, and (z) notify you when any amendment to either of the Registration Statements is
filed with the Commission or becomes effective or when any supplement to the Prospectus (or, if the Prospectus is not yet available to
prospective purchasers, the Time of Sale Disclosure Package) is filed with the Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(B)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If at
any time following issuance of an issuer free writing prospectus there occurred or occurs an event or development as a result of which
such issuer free writing prospectus conflicted or would conflict with the information contained in either of the Registration Statements,
the Preliminary Prospectus or the Prospectus or included or would include an untrue statement of a material fact or omitted or would omit
to state a material fact necessary in order to make the statements therein, in the light of the circumstances prevailing at that subsequent
time, not misleading, the Company (x)&nbsp;has promptly notified or promptly will notify the Underwriters of such conflict, untrue statement
or omission, (y)&nbsp;has promptly amended or will promptly amend or supplement, at its own expense, such issuer free writing prospectus
to eliminate or correct such conflict, untrue statement or omission, and (z)&nbsp;has notified or promptly will notify you when such amendment
or supplement was or is filed with the Commission where so required to be filed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Blue
Sky Qualifications</U></I>. The Company shall cooperate with the Underwriters and counsel for the Underwriters to qualify or register
the Securities for sale under (or obtain exemptions from the application of) the securities laws of such jurisdictions as you reasonably
designate and to continue such qualifications in effect so long as required for the distribution of the Securities, except that the Company
shall not be required in connection therewith to qualify as a foreign corporation or to execute a general consent to service of process
in any state.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(v)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Provision
of Documents</U></I>. The Company will furnish, at its own expense, to the Underwriters and counsel for the Underwriters copies of the
Registration Statements, and to the Underwriters and any dealer each Preliminary Prospectus, the Time of Sale Disclosure Package, the
Prospectus, any issuer free writing prospectus, and all amendments and supplements to such documents, in each case as soon as available
and in such quantities as you may from time to time reasonably request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(vi)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Rule
158</U></I>. The Company will make generally available to its security holders as soon as practicable, but in no event later than 15 months
after the end of the Company&rsquo;s current fiscal quarter, an earnings statement (which need not be audited) covering a 12-month period
that shall satisfy the provisions of Section&nbsp;11(a) of the Securities Act and Rule&nbsp;158 of the Rules and Regulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(vii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Payment
and Reimbursement of Expenses</U></I>. The Company, whether or not the transactions contemplated hereunder are consummated or this Agreement
is terminated, will pay or cause to be paid (A) all expenses (including transfer taxes allocated to the respective transferees) incurred
in connection with the delivery to the Underwriters of the Securities, (B) all expenses and fees (including, without limitation, fees
and expenses of the Company&rsquo;s accountants and counsel) in connection with the preparation, printing, filing, delivery, and shipping
of the Registration Statements (including the financial statements therein and all amendments, schedules, and exhibits thereto), the
Securities, each Preliminary Prospectus, the Time of Sale Disclosure Package, the Prospectus, any issuer free writing prospectus and
any amendment thereof or supplement thereto, and the printing, delivery, and shipping of this Agreement and other underwriting documents,
including blue sky memoranda (covering the states and other applicable jurisdictions), (C) all fees, expenses and disbursements of the
Underwriters&rsquo; counsel incurred in connection with the registration, qualification or exemption of the Securities for offering and
sale by the Underwriters or by dealers under the securities or blue sky laws of the states and foreign jurisdictions designated by the
Representatives, (D) the filing fees and expenses and disbursements of Underwriters&rsquo; counsel incident to any required review and
approval by FINRA of the terms of the sale of the Securities, but in no event, in the case of clauses (C) and (D), shall such fees exceed
$10,000 in the aggregate, (E) the fees and expenses of any transfer agent or registrar, (F) the reasonable out-of-pocket accountable
fees and disbursements incurred by the Underwriters in connection with the offer, sale or marketing of the Securities and performance
of the Underwriters&rsquo; obligations hereunder, including all reasonable out-of-pocket accountable fees and disbursements of Underwriters&rsquo;
counsel, (G) listing fees, if any, (H) fees, expenses and disbursements relating to background checks of the Company&rsquo;s officers
and directors in an amount not to exceed $30,000, (I) the cost and expenses of the Company relating to investor presentations or any
&ldquo;roadshow&rdquo; undertaken in connection with marketing of the Securities, including, without limitation, expenses associated
with the preparation or dissemination of any electronic roadshow, expenses associated with the production of roadshow slides and graphics,
fees and expenses of any consultants engaged in connection with the roadshow presentations with the prior approval of the Company, travel
and lodging expenses of the representatives and officers of the Company and any such consultants, (J) the cost of the Underwriters&rsquo;
use of Ipreo&rsquo;s book-building, prospectus tracking and compliance software and third party research and database services for the
offering, and (K) all other costs and expenses of the Company incident to the performance of its obligations hereunder that are not otherwise
specifically provided for herein. The expenses to be paid by the Company and reimbursed to the Underwriters under this Section 4(a)(vii)
shall not exceed $150,000 in the aggregate. If this Agreement is terminated by the Representatives pursuant to Section 8(a)(i) or 8(a)(ii)
hereof or if the sale of the Securities provided for herein is not consummated by reason of any failure, refusal or inability on the
part of the Company to perform any agreement on its part to be performed, or because any other condition of the Underwriters&rsquo; obligations
hereunder required to be fulfilled by the Company is not fulfilled, the Company will reimburse the several Underwriters for all reasonable
out of pocket accountable disbursements (including but not limited to fees and disbursements of counsel, printing expenses, postage,
facsimile and telephone charges and third party research and database services, but excluding travel and related expenses) incurred by
the Underwriters in connection with their investigation, preparing to market and marketing the Securities or in contemplation of performing
their obligations hereunder. Notwithstanding the foregoing, if this Agreement is terminated due to default by any Underwriter as set
forth under Section 6(g), the Underwriters agree to pay their own expenses incurred in connection with this Agreement and the offering
contemplated hereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(viii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Use
of Proceeds</U></I>. The Company will apply the net proceeds from the sale of the Firm Shares to be sold by it hereunder in the manner
set forth in the Time of Sale Disclosure Package and in the Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(ix)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Company
Lock-Up</U></I>. The Company will not, without the prior written consent of the Representative, from the date of execution of this Agreement
and continuing to and including the date 90 days after the date of the Prospectus (the <B><I>&ldquo;Lock-Up Period&rdquo;</I></B>), (A)
offer, pledge, announce the intention to sell, sell, contract to sell, sell any option or contract to purchase, purchase any option or
contract to sell, grant any option, right or warrant to purchase, make any short sale or otherwise transfer or dispose of, directly or
indirectly, or file or confidentially submit a registration statement to the Commission with respect to, any shares of Common Stock or
any securities convertible into, exercisable or exchangeable for or that represent the right to receive Common Stock or (B) enter into
any swap or other agreement that transfers, in whole or in part, any of the economic consequences of ownership of the Common Stock, whether
any such transaction described in clause (A) or (B) above is to be settled by delivery of Common Stock or such other securities, in cash
or otherwise, except, in each case, for (w) the filing by the Company of a registration statement on Form S-8 or a successor form thereto
with respect to Common Stock or other securities pursuant to any stock option, stock bonus or other stock plan or arrangement described
in the Time of Sale Disclosure Package and the Prospectus, (x) the sale of the Securities as contemplated by this Agreement, (y) issuances
of shares of Common Stock upon the exercise or conversion of options, warrants or convertible securities disclosed as outstanding in the
Registration Statements, the Time of Sale Disclosure Package and the Prospectus, and (z) the issuance of employee stock options or restricted
stock units not exercisable during the Lock-Up Period pursuant to the Company&rsquo;s stock option, stock bonus and other stock plans
or arrangements, as in effect on the date hereof in the ordinary course of business consistent with past practices. The Company agrees
not to accelerate the vesting of any option or warrant or the lapse of any repurchase right prior to the expiration of the Lock-Up Period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(x)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Stockholder
Lock-Ups</U></I>. The Company has caused to be delivered to you prior to the date of this Agreement a letter, in the form of <U>Exhibit
A</U> hereto (the <B><I>&ldquo;Lock-Up Agreement&rdquo;</I></B>), from each individual and entity listed on Schedule IV. The Company will
enforce the terms of each Lock-Up Agreement and issue stop-transfer instructions to the transfer agent for the Common Stock with respect
to any transaction or contemplated transaction that would constitute a breach of or default under the applicable Lock-Up Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(xi)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>No
Market Stabilization or Manipulation</U></I>. The Company has not taken and will not take, directly or indirectly, any action designed
to or which would reasonably be expected to cause or result in, or which has constituted, the stabilization or manipulation of the price
of any security of the Company to facilitate the sale or resale of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(xii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>SEC
Reports</U></I>. During the Prospectus Delivery Period, the Company will file on a timely basis with the Commission such periodic and
special reports as required by the rules and regulations promulgated under the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(xiii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>[Reserved]</U></I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(xiv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>[Reserved]</U></I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(xv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Free
Writing Prospectuses</U></I>. Each of the Company and the Selling Stockholder represents and agrees that, unless it obtains the prior
written consent of the Representative, it has not made and will not make any offer relating to the Securities that would constitute an
issuer free writing prospectus or that would otherwise constitute a free writing prospectus required to be filed with the Commission;
<I>provided</I> that the prior written consent of the Representative shall be deemed to have been given in respect of the free writing
prospectuses included in Schedule II. Any such free writing prospectus consented to by the Representative is hereinafter referred to as
a <B><I>&ldquo;Permitted Free Writing Prospectus.&rdquo;</I></B> Each of the Company and the Selling Stockholder represents that it has
treated or agrees that it will treat each Permitted Free Writing Prospectus as an issuer free writing prospectus and has complied and
will comply with the requirements of Rule 164 and Rule 433 applicable to any Permitted Free Writing Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(xvi)&nbsp;&nbsp;&nbsp;&nbsp; <I><U>Tax Forms</U></I>.
The Selling Stockholder will complete and sign an IRS Form W-9, W-8BEN or other similar IRS form, or any substitute form that may be requested
by the Representative or the Company in connection with the sale of the Option Shares and deliver such form to the Representative or the
Company, as applicable..</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(xvii)&nbsp;&nbsp;&nbsp; <I><U>Subsequent
Powers of Attorney</U></I>. Any subsequent power of attorney executed by the Selling Stockholder will expressly provide that the execution
of such power of attorney will not revoke the terms of the Power of Attorney.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(xviii)&nbsp;&nbsp; <I><U>Selling
Stockholder Use of Proceeds</U></I>. The Selling Stockholder will not use the net proceeds received by it from the sale of Securities
in violation of any Sanctions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Conditions
of Underwriters&rsquo; Obligations</I></B>. The obligations of the several Underwriters hereunder are subject to the accuracy, as of the
date hereof and at each of the First Closing Date and the Second Closing Date (as if made at such Closing Date), of and compliance with
all representations, warranties and agreements of the Company and the Selling Stockholder contained herein, to the performance by each
of the Company and the Selling Stockholder of its respective obligations hereunder and to the following additional conditions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Required
Filings; Absence of Certain Commission Actions</U></I>. If filing of the Prospectus, or any amendment or supplement thereto, or any issuer
free writing prospectus, is required under the Securities Act or the Rules and Regulations, the Company shall have filed the Prospectus
(or such amendment or supplement) or such issuer free writing prospectus with the Commission in the manner and within the time period
so required (without reliance on Rule 424(b)(8) or Rule 164(b)); the Registration Statements shall remain effective; no stop order suspending
the effectiveness of the Registration Statements or any part thereof, or any amendment thereof, nor suspending or preventing the use of
the Time of Sale Disclosure Package, the Prospectus or any issuer free writing prospectus shall have been issued; and no proceedings for
the issuance of such an order shall have been initiated or threatened; any request of the Commission for additional information (to be
included in either of the Registration Statements, the Time of Sale Disclosure Package, the Prospectus, any issuer free writing prospectus
or otherwise) shall have been complied with to your satisfaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Continued
Compliance with Securities Laws</U></I>. No Underwriter shall have advised the Company that (i) the Registration Statements or any amendment
thereof or supplement thereto contains an untrue statement of a material fact which, in your opinion, is material or omits to state a
material fact which, in your opinion, is required to be stated therein or necessary to make the statements therein not misleading, or
(ii) the Time of Sale Disclosure Package or the Prospectus, or any amendment thereof or supplement thereto, or any issuer free writing
prospectus contains an untrue statement of fact which, in your opinion, is material, or omits to state a fact which, in your opinion,
is material and is required to be stated therein, or necessary to make the statements therein, in light of the circumstances under which
they are made, not misleading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Absence
of Certain Events</U></I>. No event or condition of a type described in Section 2(a)(viii) shall have occurred or shall exist, which event
or condition is not described in the Time of Sale Disclosure Package and Prospectus and the effect of which in your judgment, makes it
impractical or inadvisable to offer or deliver the Securities on the terms and in the manner contemplated in the Time of Sale Disclosure
Package and in the Prospectus, and there shall not have been any loss by strike, fire, flood, earthquake, accident or other calamity,
whether or not covered by insurance, incurred by the Company or any subsidiary and that is material to the Company and its subsidiaries,
taken as a whole, which event or condition is not described in the Time of Sale Disclosure Package and Prospectus and the effect of which,
in any such case described above, in your judgment, makes it impractical or inadvisable to offer or deliver the Securities on the terms
and in the manner contemplated in the Time of Sale Disclosure Package and in the Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Opinion
of Company Counsel</U></I>. On each Closing Date, there shall have been furnished to you, as Representative of the several Underwriters,
the opinion and negative assurance letter, dated as of the applicable Closing Date, of O&rsquo;Melveny &amp; Myers LLP, counsel for the
Company, in form and substance satisfactory to you.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e) <I><U>Opinion of Counsel
for the Selling Stockholder</U></I>. On each Closing Date, there shall have been furnished to you, as Representative of the several Underwriters,
the opinion and negative assurance letter, dated as of the applicable Closing Date, of O&rsquo;Melveny &amp; Myers LLP, counsel for the
Selling Stockholder, in form and substance satisfactory to you.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Opinion
of Underwriters&rsquo; Counsel</U></I>. On each Closing Date, there shall have been furnished to you, as Representative of the several
Underwriters, such opinion or opinions and negative assurance letter from Faegre Drinker Biddle &amp; Reath LLP, counsel for the several
Underwriters, dated as of the applicable Closing Date and addressed to you, with respect to such matters as you reasonably may request,
and such counsel shall have received such papers and information as they request to enable them to pass upon such matters.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Comfort
Letters</U></I>. On the date hereof, on the effective date of any post-effective amendment to the Registration Statements filed after
the date hereof and on each Closing Date you, as Representative of the several Underwriters, shall have received an accountant&rsquo;s
&ldquo;comfort&rdquo; letter from Baker Tilly US, LLP, dated such date and addressed to you, in form and substance satisfactory to you.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Officers&rsquo;
Certificate</U></I>. On each Closing Date, there shall have been furnished to you, as Representative of the several Underwriters, a certificate,
dated such Closing Date and addressed to you, signed by the chief executive officer and by the chief financial officer of the Company,
to the effect that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
representations and warranties of the Company in this Agreement are true and correct as if made at and as of such Closing Date, and the
Company has complied with all the agreements and satisfied all the conditions on its part to be performed or satisfied at or prior to
such Closing Date;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No
stop order or other order suspending the effectiveness of the Registration Statements or any part thereof or any amendment thereof or
the qualification of the Securities for offering or sale nor suspending or preventing the use of the Time of Sale Disclosure Package,
the Prospectus or any issuer free writing prospectus, has been issued, and no proceeding for that purpose has been instituted or, to the
best of their knowledge, is contemplated by the Commission or any state or regulatory body; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Affirms
the accuracy of the matters set forth in subsection (c) of this Section 5.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i) <I><U>Certificate of Selling
Stockholder</U></I>. On each Closing Date, the Representative shall have received a certificate of an Attorney-in-Fact on behalf of the
Selling Stockholder, dated as of the applicable Closing Date, to the effect that (i) the representations and warranties of the Selling
Stockholder in this Agreement are true and correct with the same force and effect as though expressly made at and as of the applicable
Closing Date and (ii) the Selling Stockholder has complied with all agreements and all conditions on its part to be performed under this
Agreement at or prior to the Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>CFO
Certificate</U></I>.&nbsp; On the date hereof and on each Closing Date, the Company shall have furnished to you, as Representative of
the several Underwriters, a certificate, dated as of such date, signed on behalf of the Company by its chief financial officer, regarding
certain financial information included in or incorporated by reference into the Preliminary Prospectus and the Prospectus, respectively,
in form and substance reasonably satisfactory to you.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(k)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Lock-Up
Agreement</U></I>. The Underwriters shall have received all of the Lock-Up Agreements referenced in Section 4 and the Lock-Up Agreements
shall remain in full force and effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(l)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>FINRA
No Objections</U></I>. FINRA shall have raised no objection to the fairness and reasonableness of the underwriting terms and arrangements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(m)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Other
Documents</U></I>. The Company shall have furnished to you, as Representative of the several Underwriters, and counsel for the Underwriters
such additional documents, certificates and evidence as you or they may have reasonably requested.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(n)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Exchange
Listing</U></I>. The Securities to be delivered on such Closing Date have been approved for listing on the Nasdaq Capital Market, subject
to official notice of issuance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">All such opinions, certificates,
letters and other documents will be in compliance with the provisions hereof only if they are reasonably satisfactory in form and substance
to you and counsel for the Underwriters. The Company will furnish you with such conformed copies of such opinions, certificates, letters
and other documents as you shall reasonably request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Indemnification
and Contribution</I></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Indemnification
by the Company</U></I>. The Company agrees to indemnify and hold harmless each Underwriter, its affiliates, directors and officers and
each person, if any, who controls such Underwriter within the meaning of Section&nbsp;15 of the Act or Section&nbsp;20 of the Exchange
Act, from and against any losses, claims, damages or liabilities, joint or several, to which such Underwriter may become subject, under
the Act or otherwise (including in settlement of any litigation if such settlement is effected with the written consent of the Company),
insofar as such losses, claims, damages or liabilities (or actions in respect thereof) arise out of or are based upon (i) an untrue statement
or alleged untrue statement of a material fact contained in the Registration Statements, including the 430B Information and any other
information deemed to be a part of the Registration Statements at the time of effectiveness and at any subsequent time pursuant to the
Rules and Regulations, if applicable, or arise out of or are based on the omission or alleged omission to state therein a material fact
required to be stated therein or necessary in order to make the statements therein not misleading, (ii) an untrue statement or alleged
untrue statement of a material fact contained in any Preliminary Prospectus, the Time of Sale Disclosure Package, the Prospectus, or any
amendment or supplement thereto, any issuer free writing prospectus, or any issuer information that the Company has filed or is required
to file pursuant to Rule 433(d) of the Rules and Regulations, or arise out of or are based on the omission or alleged omission to state
therein a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under
which they were made, not misleading, and will reimburse each Underwriter for any documented legal or other expenses reasonably incurred
by it in connection with investigating or defending against such loss, claim, damage, liability or action as such expenses are incurred;
<I>provided, however,</I> that the Company will not be liable in any such case to the extent that any such loss, claim, damage, liability
or action arises out of or is based upon an untrue statement or alleged untrue statement or omission or alleged omission made in reliance
upon and in conformity with written information furnished to the Company by you, or by any Underwriter through you, specifically for use
in the preparation thereof; it being understood and agreed that the only information furnished by an Underwriter consists of the information
described as such in Section&nbsp;6(f).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <I><U>Indemnification by
the Selling Stockholder</U></I>. The Selling Stockholder agrees to indemnify and hold harmless each Underwriter, its affiliates, directors
and officers and each person, if any, who controls each Underwriter within the meaning of Section&nbsp;15 of the Act and Section&nbsp;20
of the Exchange Act from and against any losses, claims, damages or liabilities, joint or several, to which such Underwriter may become
subject, under the Act or otherwise (including in settlement of any litigation if such settlement is effected with the written consent
of the Selling Stockholder), insofar as such losses, claims, damages or liabilities (or actions in respect thereof) arise out of or are
based upon (i) an untrue statement or alleged untrue statement of a material fact contained in the Registration Statements, including
the 430B Information and any other information deemed to be a part of the Registration Statements at the time of effectiveness and at
any subsequent time pursuant to the Rules and Regulations, if applicable, or arise out of or are based on the omission or alleged omission
to state therein a material fact required to be stated therein or necessary in order to make the statements therein not misleading, (ii)
an untrue statement or alleged untrue statement of a material fact contained in any Preliminary Prospectus, the Time of Sale Disclosure
Package, the Prospectus, or any amendment or supplement thereto, any issuer free writing prospectus, or any issuer information that the
Company has filed or is required to file pursuant to Rule 433(d) of the Rules and Regulations, or arise out of or are based on the omission
or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein, in light
of the circumstances under which they were made, not misleading, and will reimburse each Underwriter for any documented legal or other
expenses reasonably incurred by it in connection with investigating or defending against such loss, claim, damage, liability or action
as such expenses are incurred above; <I>provided</I> that the Selling Stockholder shall be liable only to the extent that such untrue
statement or alleged untrue statement or omission or alleged omission has been made in the Registration Statements, any Preliminary Prospectus,
the Time of Sale Disclosure Package, the Prospectus (or any amendment or supplement thereto) or any issuer free writing prospectus in
reliance upon and in conformity with the Selling Stockholder Information; <I>provided, further</I>, that the liability under this subsection
of the Selling Stockholder shall be limited to an amount equal to the aggregate gross proceeds after deducting underwriting commissions
and discounts, but before expenses, to the Selling Stockholder from the sale of Securities sold by the Selling Stockholder hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Indemnification
by the Underwriters</U></I>. Each Underwriter will, severally and not jointly, indemnify and hold harmless the Company, its affiliates,
directors and officers and each person, if any, who controls the Company within the meaning of Section&nbsp;15 of the Act and Section&nbsp;20
of the Exchange Act, and each Selling Stockholder and each person, if any, who controls any Selling Stockholder within the meaning of
Section&nbsp;15 of the Act and Section&nbsp;20 of the Exchange Act from and against any losses, claims, damages or liabilities, joint
or several, to which the Company may become subject, under the Act or otherwise (including in settlement of any litigation, if such settlement
is effected with the written consent of such Underwriter), insofar as such losses, claims, damages or liabilities (or actions in respect
thereof) arise out of or are based upon (i) an untrue statement or alleged untrue statement of a material fact contained in the Registration
Statements, including the 430B Information and any other information deemed to be a part of the Registration Statements at the time of
effectiveness and at any subsequent time pursuant to the Rules and Regulations, if applicable, or arise out of or are based on the omission
or alleged omission to state therein a material fact required to be stated therein or necessary in order to make the statements therein
not misleading, (ii) an untrue statement or alleged untrue statement of a material fact contained in any Preliminary Prospectus, the Time
of Sale Disclosure Package, the Prospectus, or any amendment or supplement thereto, or any issuer free writing prospectus, or any issuer
information that the Company has filed or is required to file pursuant to Rule 433(d) of the Rules and Regulations, or arise out of or
are based upon the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the
statements therein, in light of the circumstances under which they were made, not misleading, in each case to the extent, but only to
the extent, that such untrue statement or alleged untrue statement or omission or alleged omission was made in reliance upon and in conformity
with written information furnished to the Company by you, or by such Underwriter through you, specifically for use in the preparation
thereof (it being understood and agreed that the only information furnished by an Underwriter consists of the information described as
such in Section 6(f)), and will reimburse the Company for any documented legal or other expenses reasonably incurred by the Company in
connection with investigating or defending against any such loss, claim, damage, liability or action as such expenses are incurred.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Notice
and Procedures</U></I>. Promptly after receipt by an indemnified party under subsection (a), (b) or (c) above of notice of the commencement
of any action, such indemnified party shall, if a claim in respect thereof is to be made against the indemnifying party under such subsection,
notify the indemnifying party in writing of the commencement thereof; but the omission so to notify the indemnifying party shall not relieve
the indemnifying party from any liability that it may have to any indemnified party except to the extent such indemnifying party has been
materially prejudiced by such failure (through the forfeiture of substantive rights or defenses). In case any such action shall be brought
against any indemnified party, and it shall notify the indemnifying party of the commencement thereof, the indemnifying party shall be
entitled to participate in, and, to the extent that it shall wish, jointly with any other indemnifying party similarly notified, to assume
the defense thereof, with counsel satisfactory to such indemnified party, and after notice from the indemnifying party to such indemnified
party of the indemnifying party&rsquo;s election so to assume the defense thereof, the indemnifying party shall not be liable to such
indemnified party under such subsection for any legal or other expenses subsequently incurred by such indemnified party in connection
with the defense thereof other than reasonable and documented costs of investigation; <I>provided</I>, <I>however</I>, that if, in the
reasonable judgment of the Representative (upon written advice received from its outside counsel), it is advisable for the Underwriters
to be represented by separate counsel, the Representative shall have the right to employ a single counsel (in addition to local counsel)
to represent the Representative and all Underwriters who may be subject to liability arising from any claim in respect of which indemnity
may be sought by the Underwriters under subsections (a) and (b) of this Section 6, in which event the reasonable and documented fees and
expenses of such separate counsel shall be borne by the indemnifying party or parties and reimbursed to the Underwriters as incurred.
An indemnifying party shall not be obligated under any settlement agreement, consent to judgment or other compromise relating to any action
under this Section 6 to which it has not agreed in writing. In addition, no indemnifying party shall, without the prior written consent
of the indemnified party (which consent shall not be unreasonably withheld or delayed), effect any settlement of any pending or threatened
proceeding unless such settlement includes an unconditional release of such indemnified party for all liability on claims that are the
subject matter of such proceeding and does not include a statement as to, or an admission of, fault, culpability or a failure to act by
or on behalf of an indemnified party. Notwithstanding the foregoing, if at any time an indemnified party shall have requested an indemnifying
party to reimburse the indemnified party for reasonable and documented fees and expenses of counsel pursuant to this Section 6(d), such
indemnifying party agrees that it shall be liable for any settlement effected without its written consent if (i) such settlement is entered
into more than 45 days after receipt by such indemnifying party of the aforesaid request and (ii) such indemnifying party shall not have
reimbursed such indemnified party in accordance with such request prior to the date of such settlement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Contribution;
Limitations on Liability; Non-Exclusive Remedy</U></I>. If the indemnification provided for in this Section&nbsp;6 is unavailable or insufficient
to hold harmless an indemnified party under subsection&nbsp;(a), (b) or (c) above, then each indemnifying party shall contribute to the
amount paid or payable by such indemnified party as a result of the losses, claims, damages or liabilities referred to in subsection&nbsp;(a),
(b) or (c) above, (i)&nbsp;in such proportion as is appropriate to reflect the relative benefits received by the Company and the Selling
Stockholder, as applicable, on the one hand and the Underwriters on the other from the offering of the Securities or (ii)&nbsp;if the
allocation provided by clause&nbsp;(i) above is not permitted by applicable law, in such proportion as is appropriate to reflect not only
the relative benefits referred to in clause&nbsp;(i) above but also the relative fault of the Company and the Selling Stockholder on the
one hand and the Underwriters on the other in connection with the statements or omissions that resulted in such losses, claims, damages
or liabilities, as well as any other relevant equitable considerations. The relative benefits received by the Company and the Selling
Stockholder on the one hand and the Underwriters on the other shall be deemed to be in the same proportion as the total net proceeds from
the offering (before deducting expenses) received by the Company and the Selling Stockholder bear to the total underwriting discounts
and commissions received by the Underwriters, in each case as set forth in the table on the cover page of the Prospectus. The relative
fault shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the
omission or alleged omission to state a material fact relates to information supplied by the Company, the Selling Stockholder or the Underwriters
and the parties&rsquo; relevant intent, knowledge, access to information and opportunity to correct or prevent such untrue statement or
omission. The Company, the Selling Stockholder and the Underwriters agree that it would not be just and equitable if contributions pursuant
to this subsection&nbsp;(e) were to be determined by pro rata allocation or by any other method of allocation which does not take account
of the equitable considerations referred to in the first sentence of this subsection&nbsp;(e). The amount paid by an indemnified party
as a result of the losses, claims, damages or liabilities referred to in the first sentence of this subsection&nbsp;(e) shall be deemed
to include any legal or other expenses reasonably incurred by such indemnified party in connection with investigating or defending against
any action or claim which is the subject of this subsection&nbsp;(e). Notwithstanding the provisions of this subsection&nbsp;(e), no Underwriter
shall be required to contribute any amount in excess of the amount by which the total underwriting discounts and commissions received
by such Underwriter with respect to the Securities purchased by it hereunder exceeds the amount of any damages that such Underwriter has
otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission. No person guilty
of fraudulent misrepresentation (within the meaning of Section&nbsp;11(f) of the Act) shall be entitled to contribution from any person
who was not guilty of such fraudulent misrepresentation. The Underwriters&rsquo; obligations in this subsection (e) to contribute are
several in proportion to their respective underwriting obligations and not joint. The remedies provided for in this Section 6 are not
exclusive and shall not limit any rights or remedies that might otherwise be available to any indemnified party at law or in equity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Information
Provided by the Underwriters</U></I>. The Underwriters severally confirm and the Company acknowledges that the statements with respect
to the public offering of the Securities by the Underwriters set forth in the second paragraph, under the caption &ldquo;Underwriting&rdquo;
in the Time of Sale Disclosure Package and in the Prospectus are correct and constitute the only information concerning such Underwriter
furnished in writing to the Company by or on behalf of the Underwriters specifically for inclusion in the Registration Statements, any
Preliminary Prospectus, the Time of Sale Disclosure Package, the Prospectus or any issuer free writing prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(g) <I>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Defaulting
Underwriter</U></I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in; background-color: white"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in; background-color: white">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>If, on the First Closing Date or the Second Closing Date, as the case may be, any Underwriter defaults on its obligation to purchase
the Securities that it has agreed to purchase hereunder on such date, the&nbsp;non-defaulting&nbsp;Underwriters may in their discretion
arrange for the purchase of such Securities by other persons satisfactory to the Company on the terms contained in this Agreement. If,
within 36 hours after any such default by any Underwriter, the&nbsp;non-defaulting&nbsp;Underwriters do not arrange for the purchase of
such Securities, then the Company shall be entitled, but shall not be obligated to, for a further period of 36 hours, seek to procure
other persons satisfactory to the&nbsp;non-defaulting&nbsp;Underwriters to purchase such Securities on such terms. If other persons become
obligated or agree to purchase the Securities of a defaulting Underwriter, either the&nbsp;non-defaulting&nbsp;Underwriters or the Company
may postpone the First Closing Date or the Second Closing Date, as the case may be, for up to five full business days in order to effect
any changes that in the opinion of counsel for the Company or counsel for the Underwriters may be necessary in the Registration Statements
and the Prospectus or in any other document or arrangement, and the Company agrees to promptly prepare any amendment or supplement to
the Registration Statements and the Prospectus that effects any such changes. As used in this Agreement, the term <B><I>&ldquo;Underwriter&rdquo;</I></B>
includes, for all purposes of this Agreement unless the context otherwise requires, any person not listed in Schedule I hereto that, pursuant
to this Section, purchases Securities that a defaulting Underwriter agreed but failed to purchase.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in; background-color: white"></P>

<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in; background-color: white">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>If, after giving effect to any arrangements for the purchase of the Securities of a defaulting Underwriter or Underwriters by the&nbsp;non-defaulting&nbsp;Underwriters
and the Company as provided in subsection (g)(i)&nbsp;above, the aggregate number of Securities that remain unpurchased on the First Closing
Date or the Second Closing Date, as the case may be, does not exceed&nbsp;one-eleventh&nbsp;of the aggregate number of Securities to be
purchased on such date, then the Company shall have the right to require each&nbsp;non-defaulting&nbsp;Underwriter to purchase the number
of Securities that such Underwriter agreed to purchase hereunder on such date plus such Underwriter&rsquo;s pro rata share (based on the
number of Securities that such Underwriter agreed to purchase on such date) of the Securities of such defaulting Underwriter or Underwriters
for which such arrangements have not been made.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in; background-color: white">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>If, after giving effect to any arrangements for the purchase of the Securities of a defaulting Underwriter or Underwriters by the&nbsp;non-defaulting&nbsp;Underwriters
and, if undertaken by the Company, the Company as provided in subsection (g)(i)&nbsp;above, the aggregate number of Securities that remain
unpurchased on the First Closing Date or the Second Closing Date, as the case may be, exceeds&nbsp;one-eleventh&nbsp;of the aggregate
amount of Securities to be purchased on such date, or if the Company shall not exercise the right described in subsection (g)(ii)&nbsp;above,
then this Agreement or, with respect to the Second Closing Date, the obligation of the Underwriters to purchase Securities on the Second
Closing Date, as the case may be, shall terminate without liability on the part of the&nbsp;non-defaulting&nbsp;Underwriters. Any termination
of this Agreement pursuant to this Section shall be without liability on the part of the Company, except that the Company will continue
to be liable for the payment of expenses as set forth in Section&nbsp;4(a)(vii) hereof and except that the provisions of Sections&nbsp;6(a)-(e)
hereof shall not terminate and shall remain in effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in; background-color: white">(iv)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Nothing contained herein shall relieve a defaulting Underwriter of any liability it may have to the Company or any&nbsp;non-defaulting&nbsp;Underwriter
for damages caused by its default.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Representations
and Agreements to Survive Delivery</I></B>. All representations, warranties, and agreements of the Company, the Selling Stockholder and
the several Underwriters herein or in certificates delivered pursuant hereto, including but not limited to the agreement of the Company,
the Selling Stockholder and the several Underwriters contained in Section 6 hereof, shall remain operative and in full force and effect
regardless of any investigation made by or on behalf of any Underwriter or any controlling person thereof, or the Company, the Selling
Stockholder or any of their officers, directors, or controlling persons, and shall survive delivery of, and payment for, the Securities
to and by the Underwriters hereunder and any termination of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Termination
of this Agreement.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Right
to Terminate</U></I>. You, as Representative of the several Underwriters, shall have the right to terminate this Agreement by giving notice
to the Company and the Selling Stockholder as hereinafter specified at any time at or prior to the First Closing Date, and the option
referred to in Section&nbsp;3(b), if exercised, may be cancelled at any time prior to the Second Closing Date, if (i)&nbsp;with respect
to any termination prior to the First Closing Date, the Company shall have failed, refused or been unable, at or prior to such Closing
Date, to perform any agreement on its part to be performed hereunder, (ii) with respect to any termination after the First Closing Date
and prior to the Second Closing Date, the Selling Stockholder shall have failed, refused or been unable, at or prior to such Closing Date,
to perform any agreement on its part to be performed hereunder, (iii)&nbsp;any condition of the Underwriters&rsquo; obligations hereunder
is not fulfilled, (iv)&nbsp;trading in the Company&rsquo;s Common Stock shall have been suspended by the Commission or the Nasdaq Capital
Market or&nbsp;trading in securities generally on the NYSE American, Nasdaq Stock Market or New York Stock Exchange shall have been suspended,
(v)&nbsp;minimum or maximum prices for trading shall have been fixed, or maximum ranges for prices for securities shall have been required,
on the NYSE American, Nasdaq Stock Market or New York Stock Exchange, by such exchange or by order of the Commission or any other Governmental
Authority having jurisdiction, (vi)&nbsp;a banking moratorium shall have been declared by federal or New York state authorities or a material
disruption in commercial banking or securities settlement or clearance services in the United States, or (vii)&nbsp;there shall have occurred
any attack on, outbreak or escalation of hostilities or act of terrorism involving the United States, any declaration by the United States
of a national emergency or war, any material adverse change in financial markets, any substantial change or development involving a prospective
substantial change in United States or international political, financial or economic conditions, or any other calamity or crisis that,
in your reasonable judgment, is material and adverse and makes it impractical or inadvisable to proceed with the completion of the sale
of and payment for the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Notice
of Termination</U></I>. If you elect to terminate this Agreement as provided in this Section, the Company and Selling Stockholder shall
be notified promptly by you by telephone, confirmed by letter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><U>Effect
of Termination</U></I>. No party shall be relieved of any liability under this Agreement arising from any breach of its obligations hereunder
occurring prior to termination of this Agreement as a result of the termination of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Notices</I></B>.
Except as otherwise provided herein, all communications hereunder shall be in writing and, if to the Underwriters, shall be mailed via
overnight delivery service or hand delivered via courier to Canaccord Genuity LLC, 99 High Street, Boston, Massachusetts 02110, Attention:
Equity Capital Markets, with a copy to (which shall not constitute notice) Faegre Drinker Biddle &amp; Reath LLP, 2200 Wells Fargo Center,
90 South 7th Street, Minneapolis, Minnesota 55402, Attention: Ben A. Stacke; if to the Company or the Selling Stockholder, shall be mailed
via overnight delivery service or hand delivered to it at 7535 Irvine Center Drive, Suite 100, Irvine, California 92618, Attention: David
Goren, with a copy to (which shall not constitute notice) O&rsquo;Melveny &amp; Myers LLP, 2765 Sand Hill Road, Menlo Park, California
94025, Attention: Warren Lazarow; or in each case to such other address as the person to be notified may have requested in writing. Any
party to this Agreement may change such address for notices by sending to the parties to this Agreement written notice of a new address
for such purpose.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">10.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Persons
Entitled to Benefit of Agreement</I></B>. This Agreement shall inure to the benefit of and be binding upon the parties hereto and their
respective successors and assigns and the controlling persons, officers and directors referred to in Section 6. Nothing in this Agreement
is intended or shall be construed to give to any other person, firm or corporation any legal or equitable remedy or claim under or in
respect of this Agreement or any provision herein contained. The term &ldquo;successors and assigns&rdquo; as herein used shall not include
any purchaser, as such purchaser, of any of the Securities from any of the several Underwriters.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">11.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Absence
of Fiduciary Relationship</I></B>. The Company and the Selling Stockholder acknowledge and agree that: (a) the Underwriters have been
retained solely to act as underwriters in connection with the sale of the Securities and that no fiduciary, advisory or agency relationship
between the Company, the Selling Stockholder and the Underwriters has been created in respect of any of the transactions contemplated
by this Agreement, irrespective of whether the Underwriters have advised or are advising the Company on other matters; (b) the price and
other terms of the Securities set forth in this Agreement were established by the Company and the Selling Stockholder following discussions
and arms-length negotiations with the Underwriters, the Selling Stockholder and each of the Company and the Selling Stockholder is capable
of evaluating and understanding and understands and accepts the terms, risks and conditions of the transactions contemplated by this Agreement;
(c) the Company and the Selling Stockholder have been advised that the Underwriters and their affiliates are engaged in a broad range
of transactions which may involve interests that differ from those of the Company and the Selling Stockholder and that the Underwriters
have no obligation to disclose such interest and transactions to the Company by virtue of any fiduciary, advisory or agency relationship;
(d) the Company and the Selling Stockholder have been advised that the Underwriters are acting, in respect of the transactions contemplated
by this Agreement, solely for the benefit of the Underwriters, and not on behalf of the Company or the Selling Stockholder; and (e) the
Company and the Selling Stockholder waive to the fullest extent permitted by law, any claims it may have against the Underwriters for
breach of fiduciary duty or alleged breach of fiduciary duty in respect of any of the transactions contemplated by this Agreement and
agree that the Underwriters shall have no liability (whether direct or indirect) to the Company or the Selling Stockholder in respect
of such a fiduciary duty claim on behalf of or in right of the Company or the Selling Stockholder, including stockholders, employees or
creditors of the Company or the Selling Stockholder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">12.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Recognition
of the U.S. Special Resolution Regimes</I></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<I>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</I>In
the event that any Underwriter that is a Covered Entity (as defined below) becomes subject to a proceeding under a U.S. Special Resolution
Regime (as defined below), the transfer from such Underwriter of this Agreement, and any interest and obligation in or under this Agreement,
will be effective to the same extent as the transfer would be effective under the U.S. Special Resolution Regime if this Agreement, and
any such interest and obligation, were governed by the laws of the United States or a state of the United States.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
the event that any Underwriter that is a Covered Entity or a BHC Act Affiliate (as defined below) of such Underwriter becomes subject
to a proceeding under a U.S. Special Resolution Regime, Default Rights (as defined below) under this Agreement that may be exercised against
such Underwriter are permitted to be exercised to no greater extent than such Default Rights could be exercised under the U.S. Special
Resolution Regime if this Agreement were governed by the laws of the United States or a state of the United States.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
used in this Section 12:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>BHC Act Affiliate</I></B>&rdquo;
has the meaning assigned to the term &ldquo;affiliate&rdquo; in, and shall be interpreted in accordance with, 12 U.S.C. &sect; 1841(k).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Covered Entity</I></B>&rdquo;
means any of the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">a &ldquo;covered entity&rdquo; as that term is defined in, and interpreted in accordance with, 12 C.F.R.
&sect; 252.82(b);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">a &ldquo;covered bank&rdquo; as that term is defined in, and interpreted in accordance with, 12 C.F.R.
&sect; 47.3(b); or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iii)</TD><TD STYLE="text-align: justify">a &ldquo;covered FSI&rdquo; as that term is defined in, and interpreted in accordance with, 12 C.F.R.
&sect; 382.2(b).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Default Right</I></B>&rdquo;
has the meaning assigned to that term in, and shall be interpreted in accordance with, 12 C.F.R. &sect;&sect; 252.81, 47.2 or 382.1, as
applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>U.S. Special Resolution Regime</I></B>&rdquo;
means each of (i) the Federal Deposit Insurance Act and the regulations promulgated thereunder and (ii) Title II of the Dodd-Frank Wall
Street Reform and Consumer Protection Act and the regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">13.<B><I>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Governing
Law; Waiver of Jury Trial</I></B>. This Agreement shall be governed by and construed in accordance with the laws of the State of New York.
The Company (on its behalf and, to the extent permitted by applicable law, on behalf of its stockholders and affiliates), the Selling
Stockholder and each of the Underwriters hereby irrevocably waive, to the fullest extent permitted by applicable law, any and all right
to trial by jury in any legal proceeding arising out of or relating to this Agreement or the transactions contemplated hereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">14.</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Counterparts</I></B>.
<FONT STYLE="font-size: 10pt">This Agreement may be executed in one or more counterparts and, if executed in more than one counterpart,
the executed counterparts shall each be deemed to be an original and all such counterparts shall together constitute one and the same
instrument. The words &ldquo;execution,&rdquo; &ldquo;signed,&rdquo; &ldquo;signature,&rdquo; and words of like import in this Agreement
or in any other certificate, agreement or document related to this Agreement, if any, shall include images of manually executed signatures
transmitted by facsimile or other electronic format (including, without limitation, &ldquo;pdf,&rdquo; &ldquo;tif&rdquo; or &ldquo;jpg&rdquo;)
and other electronic signatures (including, without limitation, DocuSign and AdobeSign). The use of electronic signatures and electronic
records (including, without limitation, any contract or other record created, generated, sent, communicated, received, or stored by electronic
means) shall be of the same legal effect, validity and enforceability as a manually executed signature or use of a paper-based record-keeping
system to the fullest extent permitted by applicable law, including the Federal Electronic Signatures in Global and National Commerce
Act, the New York State Electronic Signatures and Records Act and any other applicable law, including, without limitation, any state law
based on the Uniform Electronic Transactions Act or the Uniform Commercial Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 25 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">15.<B><I>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;General
Provisions.</I></B> This Agreement constitutes the entire agreement of the parties to this Agreement and supersedes all prior written
or oral and all contemporaneous oral agreements, understandings and negotiations with respect to the subject matter hereof, including
that certain engagement letter (other than section 5 and, if this Agreement is terminated pursuant to Section 8 hereto prior to the First
Closing Date, sections 7 and 8), dated November 12, 2021, by and among the Company and the Representative. This Agreement may not be amended
or modified unless in writing by all of the parties hereto, and no condition herein (express or implied) may be waived unless waived in
writing by each party whom the condition is meant to benefit. The Section headings herein are for the convenience of the parties only
and shall not affect the construction or interpretation of this Agreement. The invalidity or unenforceability of any Section, paragraph
or provision of this Agreement shall not affect the validity or enforceability of any other Section, paragraph or provision hereof. If
any Section, paragraph or provision of this Agreement is for any reason determined to be invalid or unenforceable, there shall be deemed
to be made such minor changes (and only such minor changes) as are necessary to make it valid and enforceable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>Signature Page Follows</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 26 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">Please sign and return to the
Company the enclosed duplicates of this letter whereupon this letter will become a binding agreement between the Company, the Selling
Stockholder and the several Underwriters in accordance with its terms.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.25in; text-align: justify">Very truly yours,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.25in; text-align: justify"><FONT STYLE="font-variant: small-caps"><B>Lantronix,
Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.25in; text-align: justify">By <U>/s/ Jeremy Whitaker</U>_______________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.25in; text-align: justify">Name <U>Jeremy R. Whitaker</U>_____________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.25in; text-align: justify">Its <U>Chief Financial Officer</U>_____________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in; text-align: justify"><FONT STYLE="font-variant: small-caps"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.25in; text-align: justify"><FONT STYLE="font-variant: small-caps"><B>TL
Investment GmbH</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.25in; text-align: justify">By <U>/s/ David Goren</U>__________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.25in; text-align: justify">Name <U>David Goren</U>__________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.25in; text-align: justify">Its <U>Attorney-in-Fact</U>__________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Confirmed as of the date first</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">above mentioned, on behalf of</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">itself and the several Underwriters</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">named in Schedule I hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-variant: small-caps"><B>Canaccord
Genuity LLC</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">By <U>/s/ Jennifer Pardi</U>____________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name <U>Jennifer Pardi</U>____________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Its <U>Managing Director</U>__________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 27 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SCHEDULE I</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Company Firm Shares</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 75%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; border-bottom: Black 1pt solid">Underwriter</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Number of Firm Shares</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 58%; text-align: left">Canaccord Genuity LLC</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD><TD STYLE="width: 13%; text-align: center">2,491,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Craig-Hallum Capital Group LLC</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: center">2,209,000</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-bottom: 2.5pt">Total</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: center">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: center">4,700,000</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 28 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SCHEDULE II</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Certain Permitted Free Writing Prospectuses</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">None.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 29 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SCHEDULE III</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Pricing Information</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Company Firm Shares: 4,700,000 shares</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Selling Stockholder Option Shares: 705,000 shares</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Price to the public: $7.50 per share</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Price to the Underwriters: $7.05 per share</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 30 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SCHEDULE IV</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>List of Individuals and Entities Executing Lock-Up
Agreements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">1.</TD><TD>TL Investment GmbH</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">2.</TD><TD>Margaret A Evashenk</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">3.</TD><TD>Paul F. Folino</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">4.</TD><TD>Mohammed F. Hakam</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">5.</TD><TD>Roger Holliday</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">6.</TD><TD>Heidi Nguyen</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">7.</TD><TD>Paul H. Pickle</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">8.</TD><TD>Hoshi Printer</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">9.</TD><TD>Jeremy R. Whitaker</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P>

<!-- Field: Page; Sequence: 31 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Form of Common Stock Lock-Up Agreement</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Date: _____________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Canaccord Genuity LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">As Representative of the several Underwriters
named</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">in the Underwriting Agreement</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">c/o Canaccord Genuity LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">99 High Street</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Boston, Massachusetts 02110</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As an inducement to Canaccord
Genuity LLC to execute an underwriting agreement (the <I>&ldquo;<B>Underwriting Agreement</B>&rdquo;</I>) in its capacity as representative
for the several underwriters named in Schedule I thereto (the <B><I>&ldquo;Representative&rdquo;</I></B>) providing for a public offering
(the <I>&ldquo;<B>Offering</B>&rdquo;</I>) of shares of common stock, par value $0.0001 per share (the <I>&ldquo;<B>Common Stock</B>&rdquo;</I>),
of Lantronix, Inc., a Delaware corporation (the <I>&ldquo;<B>Company</B>&rdquo;</I>), the undersigned hereby agrees that without, in each
case, the prior written consent of the Representative, during the period specified in the second succeeding paragraph (the <I>&ldquo;<B>Lock-Up
Period</B>&rdquo;</I>), the undersigned will not: (1) offer, pledge, announce the intention to sell, sell, contract to sell, sell any
option or contract to purchase, purchase any option, grant any option, right or warrant to purchase, lend, make any short sale or otherwise
transfer or dispose of, directly or indirectly, any shares of Common Stock or any securities convertible into, exercisable or exchangeable
for or that represent the right to receive Common Stock (including without limitation, Common Stock which may be deemed to be beneficially
owned by the undersigned as defined in Rule 13d-3 under the Securities Exchange Act of 1934, as amended (the &ldquo;<B><I>Exchange Act</I></B>&rdquo;),
promulgated by the U.S. Securities and Exchange Commission (the <I>&ldquo;<B>SEC</B>&rdquo;</I>) and securities which may be issued upon
exercise of a stock option or warrant) whether now owned or hereafter acquired (the <I>&ldquo;<B>Undersigned&rsquo;s Securities</B>&rdquo;</I>);
(2) enter into any swap or other agreement that transfers, in whole or in part, any of the economic consequences of ownership of the Undersigned&rsquo;s
Securities, whether any such transaction described in clause (1) or (2) above is to be settled by delivery of Common Stock or such other
securities, in cash or otherwise; (3) make any demand for or exercise any right with respect to, the registration of any Common Stock
or any security convertible into or exercisable or exchangeable for Common Stock; or (4) publicly disclose the intention to do any of
the foregoing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The undersigned agrees that
the foregoing restrictions preclude the undersigned from engaging in any hedging or other transaction which is designed to, or which reasonably
could be expected to lead to or result in a sale or disposition of the Undersigned&rsquo;s Securities, even if such securities would be
disposed of by someone other than the undersigned. Such prohibited hedging or other transactions would include without limitation any
short sale or any purchase, sale or grant of any right (including without limitation any put or call option) with respect to any of the
Undersigned&rsquo;s Securities or with respect to any security that includes, relates to, or derives any significant part of its value
from the Undersigned&rsquo;s Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Lock-Up Period will commence
on the date of this Lock-Up Agreement (this &ldquo;<B><I>Lock-Up Agreement</I></B>&rdquo;) and continue and include the date ninety (90)
days after the date of the final prospectus supplement used to sell the Common Stock in the Offering pursuant to the Underwriting Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Notwithstanding the foregoing,
the undersigned may transfer the Undersigned&rsquo;s Securities (i) as a <I>bona fide</I> gift or gifts, (ii) to a member of the undersigned&rsquo;s
immediate family (as defined below) or to any trust for the direct or indirect benefit of the undersigned or the immediate family of the
undersigned, (iii) if the undersigned is a corporation, partnership, limited liability company, trust or other business entity (1) transfers
to another corporation, partnership, limited liability company, trust or other business entity that is a direct or indirect affiliate
(as defined in Rule 405 promulgated under the Securities Act of 1933, as amended) of the undersigned or (2) distributions of shares of
Common Stock or any security convertible into or exercisable for Common Stock to limited partners, limited liability company members or
stockholders of the undersigned, (iv) if the undersigned is a trust, transfers to the beneficiary of such trust, or to the estate of a
beneficiary of such trust, (v) transfers by testate succession or intestate succession, (vi) transfers not involving a change in beneficial
ownership, or (vii) pursuant to the Underwriting Agreement; <I>provided,</I> in the case of clauses (i) through (vi), that (x) such transfer
shall not involve a disposition for value, (y) the transferee agrees in writing with the Representative to be bound by the terms of this
Lock-Up Agreement, and (z) no filing by any party under Section 16(a) of the Exchange Act reporting a reduction of beneficial ownership
of shares of Common Stock shall be required (other than a filing on Form 5 required and filed after the expiration of the Lock-Up Period)
or shall be made voluntarily in connection with such transfer prior to the expiration of the Lock-Up Period. For purposes of this Lock-Up
Agreement, &ldquo;immediate family&rdquo; shall mean any relationship by blood, current or former marriage, domestic partnership or adoption,
not more remote than first cousin.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 32 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, the foregoing
restrictions shall not apply to (i)&nbsp;the exercise of stock options granted pursuant to the Company&rsquo;s equity incentive plans;
<I>provided</I> that such restrictions shall apply to any of the Undersigned&rsquo;s Securities issued upon such exercise, (ii) the surrender
to, forfeiture to or withholding by the Company of Common Stock on behalf of the undersigned in connection with the vesting or exercise
(including on a &ldquo;net exercise&rdquo; or &ldquo;cashless&rdquo; basis) of options or restricted stock units or similar awards under
any existing compensation or incentive plan of the Company, including to cover any federal, state and local withholding tax obligations
due in connection with such vesting or exercise, provided that if the undersigned is required to file a report under Section 16(a) of
the Exchange Act reporting a reduction of beneficial ownership of shares of Common Stock during the Lock-Up Period related to such exercise
or vesting, the undersigned shall include a statement in such report that the filing relates to the circumstances described in this clause
(ii), (iii) the transfer of shares of Common Stock or any security convertible into or exercisable or exchangeable for shares of Common
Stock that occurs by operation of law pursuant to a qualified domestic order or in connection with a divorce settlement, divorce decree,
separation order or other final court order provided that the transferee signs and delivers a lock-up agreement substantially in the form
of this Lock-Up Agreement, and provided further, that any filing under the Exchange Act that is required to be made during the Lock-Up
Period as a result of such transfer, states that such transfer has occurred by operation of law and that such transfer is pursuant to
a qualified domestic order or in connection with a divorce settlement, as applicable, or (iv)&nbsp;the establishment of any contract,
instruction or plan (a <I>&ldquo;<B>Plan</B>&rdquo;</I>) that satisfies all of the requirements of Rule 10b5-1(c)(1)(i)(B) under the Exchange
Act; <I>provided</I> that no sales of the Undersigned&rsquo;s Securities shall be made pursuant to such a Plan prior to the expiration
of the Lock-Up Period, and such a Plan may only be established if no public announcement of the establishment or existence thereof and
no filing with the SEC or other regulatory authority in respect thereof or transactions thereunder or contemplated thereby, by the undersigned,
the Company or any other person, shall be required, and no such announcement or filing is made voluntarily, by the undersigned, the Company
or any other person, prior to the expiration of the Lock-Up Period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="background-color: white">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="background-color: white">Further,
this&nbsp;Lock-Up&nbsp;Agreement shall not restrict the transfer of the Undersigned&rsquo;s Securities pursuant to a bona fide Change
of Control (as defined below) of the Company that has been approved by the board of directors of the Company,&nbsp;<I>provided</I>&nbsp;that
all of the Undersigned&rsquo;s Securities that are not so transferred shall remain subject to the restrictions set forth in this&nbsp;Lock-Up&nbsp;Agreement,
and&nbsp;<I>provided</I>&nbsp;<I>further</I>&nbsp;that it shall be a condition of such transfer that in the event that the Change of Control
is not completed, the Undersigned&rsquo;s Securities shall remain subject to the restrictions set forth in this&nbsp;Lock-Up&nbsp;Agreement.
&ldquo;<B><I>Change of Control</I></B>&rdquo; means the consummation of any&nbsp;<I>bona fide</I>&nbsp;third-party tender offer, merger,
consolidation or other similar transaction or series of related transactions, the result of which is that any &ldquo;person&rdquo; (as
defined in Section&nbsp;13(d)(3)&nbsp;of the Exchange Act), or group of persons, other than the Company or its subsidiaries, becomes the
beneficial owner (as defined in Rule&nbsp;13d-3&nbsp;and&nbsp;13d-5&nbsp;of the Exchange Act) of 50% or more of the total voting power
of the voting capital stock of the Company (or the surviving entity).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If the undersigned is an officer
or director of the Company, the undersigned further agrees that the restrictions imposed by this Lock-Up Agreement shall be equally applicable
to any issuer-directed shares of Common Stock the undersigned may purchase in the Offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In furtherance of the foregoing,
the undersigned consents to the entry of stop transfer instructions with the Company&rsquo;s transfer agent and registrar against the
transfer of shares of Common Stock or securities convertible into or exchangeable or exercisable for shares of Common Stock held by the
undersigned except in compliance with the foregoing restrictions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The undersigned hereby represents
and warrants that the undersigned has full power and authority to enter into this Lock-Up Agreement. All authority herein conferred or
agreed to be conferred and any obligations of the undersigned shall be binding upon the successors, assigns, heirs or personal representatives
of the undersigned.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The undersigned understands
that the undersigned shall be released from all obligations under this Lock-Up Agreement if (i)&nbsp;the Company notifies the Representative
that it does not intend to proceed with the Offering, (ii)&nbsp;the Underwriting Agreement is not entered into between the Company and
the Representative, or if the Underwriting Agreement (other than the provisions thereof which survive termination) shall terminate or
be terminated prior to payment for and delivery of the Common Stock (or other securities) to be sold thereunder, or (iii)&nbsp;the Offering
is not completed by January 31, 2022.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The undersigned understands
that the Representative is entering into the Underwriting Agreement and proceeding with the Offering in reliance upon this Lock-Up Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Lock-Up Agreement shall
be governed by, and construed in accordance with, the laws of the State of New York.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">[<I>The remainder of this page
has intentionally been left blank.</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 33 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 4.25in">Very truly yours,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 4.25in">____________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 4.25in">Printed Name of Holder</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 4.25in">____________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 4.25in">Signature</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 4.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 4.25in">____________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 4.25in">Printed Name and
Title of Person Signing</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 4.25in">(<I>if signing as
custodian, trustee or on behalf of an entity</I>)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 4.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 4.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 4.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 4.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 4.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 4.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 4.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 4.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 4.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 4.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 4.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 4.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 4.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 4.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 4.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 4.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 4.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 4.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 4.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 4.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 4.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 4.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 4.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 4.25in"></P>

<!-- Field: Page; Sequence: 34; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 4.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>3
<FILENAME>lantronix_ex0501.htm
<DESCRIPTION>LEGAL OPINION AND CONSENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"><B>Exhibit 5.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 33%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">&nbsp;</FONT></TD>
  <TD STYLE="width: 34%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">&nbsp;</FONT></TD>
  <TD STYLE="text-align: right; width: 33%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">&nbsp;<IMG SRC="image_008.jpg" ALT=""></FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">&nbsp;</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">&nbsp;</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">O&rsquo;Melveny &amp; Myers LLP</FONT></TD>
  <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">T: +1 415 984 8700</FONT></TD>
  <TD STYLE="text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Two Embarcadero Center 28<SUP>th</SUP> Floor</FONT></TD>
  <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">F: +1 415 984 8701</FONT></TD>
  <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">San Francisco, CA 94111</FONT></TD>
  <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">omm.com</FONT></TD>
  <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">November 22, 2021</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Lantronix, Inc.<BR>
7535 Irvine Center Drive, Suite 100<BR>
Irvine, California 92618<BR></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;<BR></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>Re:</B></TD><TD><B><I><U>Offering of Common Stock of Lantronix, Inc.</U></I></B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have acted as special counsel
to Lantronix, Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), in connection with the issuance and sale by the Company
of 4,700,000 shares (the &ldquo;<U>Firm Shares</U>&rdquo;) of the Company&rsquo;s common stock, par value $0.0001 per share (the &ldquo;<U>Common
Stock</U>&rdquo;), and the grant to the Underwriters (as defined below) by TL Investment GmbH (&ldquo;<U>TL Investment</U>&rdquo;) of
an option to purchase an additional 705,000 shares of Common Stock (the &ldquo;<U>Option Shares</U>&rdquo; and, together with the Firm
Shares, the &ldquo;<U>Shares</U>&rdquo;) from TL Investment pursuant to that certain underwriting agreement, dated November 18, 2021 (the
&ldquo;<U>Underwriting Agreement</U>&rdquo;), by and among the Company, TL Investment and Canaccord Genuity LLC, as representative of
the several underwriters named therein (together, the &ldquo;<U>Underwriters</U>&rdquo;). The Firm Shares are being issued and sold pursuant
to a registration statement on Form S-3 (File No. 333-259454) (the &ldquo;<U>Registration Statement</U>&rdquo;) initially filed by the
Company with the Securities and Exchange Commission (the &ldquo;<U>Commission</U>&rdquo;) on September 10, 2021 and declared effective
by the Commission on October 19, 2021 for the purpose of registering the issuance and sale from time to time of up to a maximum aggregate
public offering price of $100,000,000 of Common Stock under the Securities Act of 1933, as amended (the &ldquo;<U>Securities Act</U>&rdquo;).
The Option Shares are being sold pursuant to a registration statement on Form S-3 (File No. 333-227127) (the &ldquo;<U>Resale Registration
Statement</U>&rdquo; and, together with the Registration Statement, the &ldquo;<U>Registration Statements</U>&rdquo;) initially filed
by the Company with the Commission on August 31, 2018 and declared effective by the Commission on September 12, 2018 for the purpose of
registering, among other things, the resale from time to time of up to 2,100,000 shares of Common Stock held by TL Investment under the
Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In rendering the opinion below,
we examined originals or copies of those corporate and other records and documents we considered appropriate. We have assumed the genuineness
of all signatures, the authenticity of all documents submitted to us as originals and the conformity with originals of all documents submitted
to us as copies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Based on this examination,
we are of the opinion that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 57pt"></TD><TD STYLE="width: 18pt">1.</TD><TD STYLE="text-align: justify">The issuance of the Firm Shares has been duly authorized by all necessary corporate action on the part
of the Company and, upon payment for and delivery of the Firm Shares in accordance with the Underwriting Agreement, the Firm Shares will
be validly issued, fully paid and non-assessable.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="image_009.jpg" ALT="">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&nbsp;<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 33%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">&nbsp;</FONT></TD>
  <TD STYLE="width: 34%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">&nbsp;</FONT></TD>
  <TD STYLE="text-align: right; width: 33%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">&nbsp;<IMG SRC="image_008.jpg" ALT=""></FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">&nbsp;</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">&nbsp;</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 57pt"></TD><TD STYLE="width: 18pt">2.</TD><TD STYLE="text-align: justify">The Option Shares offered for sale by TL Investment have been duly authorized by all necessary corporate
action on the part of the Company and are validly issued, fully paid and non-assessable.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The law governed by this opinion
letter is limited to the present General Corporation Law of the State of Delaware. We express no opinion herein as to any other laws,
statutes, regulations or ordinances of any other jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This opinion is being furnished
in accordance with the requirements of Item 601(b)(5) of Regulation S-K promulgated under the Securities Act, and no opinion is expressed
herein as to any matter pertaining to the contents of the Registration Statements, the prospectuses included in the Registration Statements
or any prospectus supplement, other than as expressly stated herein with respect to the Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We hereby consent to the use
of this opinion as an exhibit to a Current Report on Form 8-K and the incorporation by reference of this opinion as an exhibit to the
Registration Statements and to the reference to this firm under the heading &ldquo;Legal Matters&rdquo; in a prospectus supplement to
the prospectuses constituting part of the Registration Statements. This opinion is expressly limited to the matters set forth above, and
we render no opinion, whether by implication or otherwise, as to any other matters. This letter speaks only as of the date hereof and
we assume no obligation to update or supplement this opinion to reflect any facts or circumstances that arise after the date of this opinion
and come to our attention, or any future changes in laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD>
    <TD STYLE="width: 50%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Respectfully submitted,</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">/s/ O&rsquo;Melveny &amp; Myers LLP</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>ltrx-20211110.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.10b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +Kopo7xRiXgen8uEbXpMOaWGqaPty552KYkxvmR2fVma3yMp9JFnIC4tv5g2QeIH -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:LTRX="http://lantronix.com/20211110" elementFormDefault="qualified" targetNamespace="http://lantronix.com/20211110">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://lantronix.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="ltrx-20211110_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="ltrx-20211110_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2021" schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd" />
    <import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd" />
    <import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd" />
    <import namespace="http://fasb.org/srt-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>ltrx-20211110_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.10b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>ltrx-20211110_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.10b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://lantronix.com/role/Cover" xlink:href="ltrx-20211110.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://lantronix.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>image_008.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_008.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  9 'D# 2(  A$! Q$!_\0
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;\Y5WS$=W/)_+I^%;5%%1*3DW)]2XQ44DC__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>image_009.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_009.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  Y I,# 2(  A$! Q$!_\0
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M/^ASUS_OS9?_ "/0!T%%<_\ \(]JG_0YZY_WYLO_ )'H_P"$>U3_ *'/7/\
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MS9?_ "/0!T%%<_\ \(]JG_0YZY_WYLO_ )'H_P"$>U3_ *'/7/\ OS9?_(]
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M!T%%<_\ \(]JG_0YZY_WYLO_ )'H_P"$>U3_ *'/7/\ OS9?_(] '045S_\
MPCVJ?]#GKG_?FR_^1Z/^$>U3_H<]<_[\V7_R/0!T%%<__P (]JG_ $.>N?\
M?FR_^1Z/^$>U3_H<]<_[\V7_ ,CT =!17/\ _"/:I_T.>N?]^;+_ .1Z/^$>
MU3_H<]<_[\V7_P CT =!17/_ /"/:I_T.>N?]^;+_P"1Z/\ A'M4_P"ASUS_
M +\V7_R/0!T%%<__ ,(]JG_0YZY_WYLO_D>C_A'M4_Z'/7/^_-E_\CT =!17
M/_\ "/:I_P!#GKG_ 'YLO_D>C_A'M4_Z'/7/^_-E_P#(] '045S_ /PCVJ?]
M#GKG_?FR_P#D>C_A'M4_Z'/7/^_-E_\ (] '045S_P#PCVJ?]#GKG_?FR_\
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MI3J9 G'V@,6@VR9A41;P0 A.Y0 2,UL2:1J!\+VF])9M3TRY-S;+),'=]CL
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M4 %%%% !17/^'O\ D.>+/^PK'_Z16M=!0 4444 %%%% !1110 4444 %%%%
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M!Y"SJQ8[5"@_(H& !@=.]5O#/A[5=,UJ]NM0NHY+8*T-E%'+O"1F1FZ>6I7
MVC!:0]?FP!0!TBWMHU\]BMU";M(Q*UN)!YBH3@,5Z@9XS5>+4@^L7M@T81;6
M"*8REN#O,@QCMCR^N>_M4XL;-;]K];6 7C1B)K@1CS"@.0I;KC/.*SKKP_\
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M=K)C?#/&)$;!!&5/!P0#^% $&LZBVE:1<7J0><T0!"%MJ\D#+-@[5&<LV#@
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MD"_=#-U..V>E9U[X>6^U$7$NIW_V8R1S/8;HV@=XR"I^9"Z\JIPK*"1G'+9
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<H **** "BBB@ HHHH **** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>lantronix_i8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="ltrx-20211110.xsd" xlink:type="simple"/>
    <context id="From2021-11-18to2021-11-18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001114925</identifier>
        </entity>
        <period>
            <startDate>2021-11-18</startDate>
            <endDate>2021-11-18</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2021-11-18to2021-11-18">0001114925</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2021-11-18to2021-11-18">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="From2021-11-18to2021-11-18">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2021-11-18to2021-11-18">2021-11-18</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2021-11-18to2021-11-18">LANTRONIX, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2021-11-18to2021-11-18">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2021-11-18to2021-11-18">1-16027</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2021-11-18to2021-11-18">33-0362767</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2021-11-18to2021-11-18">7535 Irvine Center Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2021-11-18to2021-11-18">Suite 100</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2021-11-18to2021-11-18">Irvine</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2021-11-18to2021-11-18">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2021-11-18to2021-11-18">92618</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2021-11-18to2021-11-18">949</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2021-11-18to2021-11-18">453-3990</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2021-11-18to2021-11-18">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2021-11-18to2021-11-18">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2021-11-18to2021-11-18">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2021-11-18to2021-11-18">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2021-11-18to2021-11-18">Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2021-11-18to2021-11-18">LTRX</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2021-11-18to2021-11-18">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2021-11-18to2021-11-18">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140083549078488">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Nov. 18, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Nov. 18,  2021<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-16027<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">LANTRONIX,
INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001114925<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">33-0362767<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">7535 Irvine Center Drive<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Irvine<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92618<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">949<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">453-3990<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">LTRX<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>11
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M    $               @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0
M   ( )F"=E.,T<-)[@   "L"   1              "  :\   !D;V-0<F]P
M<R]C;W)E+GAM;%!+ 0(4 Q0    ( )F"=E.97)PC$ 8  )PG   3
M      "  <P!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ F8)V
M4UWC41@M!   L1   !@              ("!#0@  'AL+W=O<FMS:&5E=',O
M<VAE970Q+GAM;%!+ 0(4 Q0    ( )F"=E.?H!OPL0(  .(,   -
M      "  7 ,  !X;"]S='EL97,N>&UL4$L! A0#%     @ F8)V4Y>*NQS
M    $P(   L              ( !3 \  %]R96QS+RYR96QS4$L! A0#%
M  @ F8)V4ZK$(A8S 0  (@(   \              ( !-1   'AL+W=O<FMB
M;V]K+GAM;%!+ 0(4 Q0    ( )F"=E,D'INBK0   /@!   :
M  "  941  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    (
M )F"=E-ED'F2&0$  ,\#   3              "  7H2  !;0V]N=&5N=%]4
?>7!E<UTN>&UL4$L%!@     )  D /@(  ,03      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>96</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="lantronix_i8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://lantronix.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="lantronix_i8k.htm">lantronix_i8k.htm</File>
    <File>lantronix_ex0101.htm</File>
    <File>lantronix_ex0501.htm</File>
    <File>ltrx-20211110.xsd</File>
    <File>ltrx-20211110_lab.xml</File>
    <File>ltrx-20211110_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "lantronix_i8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "lantronix_i8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "ltrx-20211110_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "ltrx-20211110_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "ltrx-20211110.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd"
     ]
    }
   },
   "elementCount": 59,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 96,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "LTRX",
   "nsuri": "http://lantronix.com/20211110",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "lantronix_i8k.htm",
      "contextRef": "From2021-11-18to2021-11-18",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "role": "http://lantronix.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "lantronix_i8k.htm",
      "contextRef": "From2021-11-18to2021-11-18",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://lantronix.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://lantronix.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://lantronix.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://lantronix.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://lantronix.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://lantronix.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://lantronix.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://lantronix.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r9",
      "r11",
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://lantronix.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://lantronix.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://lantronix.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://lantronix.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://lantronix.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://lantronix.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://lantronix.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://lantronix.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://lantronix.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://lantronix.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://lantronix.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://lantronix.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://lantronix.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://lantronix.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://lantronix.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://lantronix.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://lantronix.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://lantronix.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://lantronix.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://lantronix.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://lantronix.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://lantronix.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://lantronix.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://lantronix.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://lantronix.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://lantronix.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://lantronix.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://lantronix.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://lantronix.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://lantronix.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://lantronix.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://lantronix.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://lantronix.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://lantronix.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://lantronix.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://lantronix.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://lantronix.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://lantronix.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://lantronix.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://lantronix.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://lantronix.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://lantronix.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://lantronix.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://lantronix.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://lantronix.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://lantronix.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://lantronix.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://lantronix.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://lantronix.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://lantronix.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r10": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r11": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r12": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r13": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r14": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r15": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r16": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "Section",
   "Publisher": "SEC",
   "Section": "12"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001683168-21-005906-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001683168-21-005906-xbrl.zip
M4$L#!!0    ( )F"=E,R59X(9:<  /KX P 4    ;&%N=')O;FEX7V5X,#$P
M,2YH=&WLO7ESVUB6+_@_(_@=,#7=%6($Y)2\Y.9\&2%O67KMM#VVLVHZ.EY,
M@ 0H(0T"3 "4S/KT<]:[ !=<9'F3U=%1:9$@[G;NV<_O_/*/M[\__W4\^N4?
M3T^>P'\C_+]?WIZ^??[TUU^^X__"M]_)U[\\>OGDOZ,W;__[^=/_];=Y5;8_
M1\='RS9ZFR^R)GJ174:OJT52QOQ!'+W)ZGS^-_@A_/25_FZ1U&=Y^7-T]+=?
M?WGTZ]/WY_DT;Z/C.\>_?/<(!GVU\?&_E]-F^3#\Y*X3>AB9=\*C1P^C-GO?
M'B9%?@8?S;*RS6H:ZW[\P]%1?'1T%+TY3^JL^>79RQ=OW<$.Y\DB+]8_;UO_
M+V_^>/4K+ __\\MW^)9?/^(*_EPU;3Y??^+MZNW-15+G"8[0+)*B.)PERX:F
M]!P^K*LR?Q^/1Z?E[ Y/3C;E8Q_IXVJQJ,KH35O-WL71,JFCBZ189=%_'-V!
M<SZ.EED=-7C8T8T[H$>__O'BR=/7_WI]^O;TQ6_1R6^OGS[]_>F+MY]BH;K*
MCS)*G9^=MW_[]45UD2VF<'['/\;1W:.[QU_UHLPHCT]>G#Q^_/+UD^BWIR_^
M.'W[W]'SYX\_[J#R85ZF&;[TZ,Z#O/S;KR=-]#I; AN$#Y,VO\BB:AZUYUG4
M9!=9G12?8TY_P)_U99T#A3=1F2RR-,KA=L_.LW159,!?HO.LSMKJ9I#"[+LJ
M>IR4R6Q6U6GT6U:N\G;]\<GA;[_^]%/T#[ADP#;K+&L_]FB/JJ:MX)>_)TV3
MS,Y73=:V3007^OCH9ISC\R3-X1U)28?8%MDB*W^^"4L+7U(K\".4]W&41$^R
M(KD$*3L> 2DOJQKX"4CE ^0F(*=^.?WU[T7ZUZIZ".)ZF93KO]?TUR_?G9+>
M- ')75?+JH'9MA7PGZ+ _SJ\*%IM9 R1\H7 D"Y+Z8X['B5EE)R=U=E9TA+_
MLRHB:0U-X(7/\GHA"F3W??B&&6LDS7:-)+@]\-OQB-29_B8)?Y9-O!.]?0X'
M<)$U+=!;&_VVF/X#S^*WK(;#CHI\ 6M.X;_)-"^0L<SX=X%QW\".Y^49JU'G
M50$[UAM]/#I/@,:+IHK.:J  >+6<D<>T8>1J2:</WRY7]0Q^E46K)?[YP]$#
MVMHD37-\!,Y5=AE6YFIR$?X<W@QO7/"]FE<U?0)O)#H9CX"+X*?M.1%"-L,7
M\IVX1\0 K^PO]"5/+7QZL*'PO'.\-#+NF/<SLZH4_]6L8"_&(]J*O+%[@=MY
M H25T=D<T)?>5,R7/2)"VL 5P+IF55'@TBZR LX/U&[<]?[IS58X8M;<D7>A
MA7?Z24R2S\>%WMJ;$-.>!(@8[W?J\1&/5G&3IW@ORCD>.CR7U\ .]- N<R N
M./ EG(#A1TEA]"2[[Q&\Q;F9D8XJ4Y(+S7."*SHCZI I%?QX6;71GU4.T@.7
M4PU..J:K<'E>+<*J0P1T)@/ =:T]!6\\.O (9UVM.L07R37S'O.UQ#Y;@G'F
M0*?59?.)A-[G([KC.^X,-O\O[^'K["QO6A&(;V +B;:8M;RJ*R(NT(@:W4]F
M0DI(R')A\T&*9"GSP1Q8P'A$I-FA0?SZZ7O@3.49O6"1-\V@%)8O^[P'2,:9
M<*,31H[\K$+.>'@O.G@&LXA>5'?&HWOW[AW>??#3_0?W)RRCN[,Z@;L#]^7X
MIWOWB%) =,-C:5 (N3_:A3#[CZ&8TLM7@V+ NP)+6A6TH) \?VV>>VV?"TEV
MN>&ZKRVR#UIS3+]N5K-S7AZ=,,D$^FQ@1V$S%@D>,5A>TRPKX;F_5GEMY6HJ
M.@G)#B,N[D1O-KP4"89>EF:S JEF/,KF<Q8A#I>2-=R)GH)"CDH*'=*&V<8@
M96?%*D6^@N_(V,MG1:1=.&^&:&8-;U-;P<'0FJK9BI^"]XFJ""N&F=79'!XL
M9QG_ H2?2E?<CU.81G1\%V=IR'"0WI0"[&#X25X"YUS0NL:C"@>YS$$U27%;
M:<^G&9 _[44K"@00'2^;Q2[-"J:*%!/=OW?T:'@*83+C'YW:B?054AC2SLW=
M 7QAD%3I6@EYML#EF/C#Y#'-9G!0D2&)&,6%ZAH#ZH7PHO$HS,KN=&]JEW^1
MRMAG8I'A8<Z=VH7]@!13_A,1^[G[P_'='USVX]) <,OVO\U1Z#*#$OJ);W.T
MZ3*/1U>]S7:=<?]F]Z]RM/$FCT<?X2IW+TZT_9ZP)/B$%R6@@$:O/7(QET;N
M3*27AI99G66X(N]BT"T*7SRR$W8R$ 9TD.[-O0FVPLT:Y?_K_]_-6-AU1MYV
MU\A?%2OB"E?Q4,"7LPK,L0C_!]935"U?HIMQ(#=I%//^_^OP,'J69T7Z<_0J
M.<L>PDO^6J%<@K&BPT,)C__RY/2??FSZL*V6/T??+UL=[W!:M6VUD,^F8'(#
M#>AGCXID]BXZA@DU59&G,/[;DT?/GT:/GSY__NKDR9/3%[_]K[\=_8W^?O/J
MY+'^+4/*VY"1)\L&IJ;_>@B"(&W/<5^._O-A1+>DR?^=\4;A,*_U'4"2;0[<
M7[<"YN_O39'-Z1=/]!?RZGOW_M.>RMLGH2?N_^= _-'97=W7A]';]1(F>%(G
MTWSV,'H!,I3W_D6%&W[L_N@[_15^,S3ZO<[H$AMTI_S=V]?X/[CG\%\XS,"Y
M3NLL>7<XS4!_@ DMB1AV.&M893]M8=FZA.R-Z*X.5\U$]G7?IV'OV])Q7Q@[
M:3S*V7<[Y/B0KU&3PW]?GN>@IF:HN**VNZB:%G0R)#)0:$CW';866 U<UCDZ
M!_I:]GAD';"N3W5 2WJ$8L!UR?0L&U:OZPQ=ZV52KYT= &U[N2QX+)E*[WU@
MN/AJ=^\)5%";RGE7ED[@R:0% Z"9U?F4E?"NUP<_JD!3K>7%:+O&_+MJD;=M
M9DTA4J0Q3\-JTOP&>/821E^16]O=4=A^?*WHS?,<96)XW:3VB\5C3AG]@NSM
MA-7@9>_JT2"0_7-XY6RPW9S>8<!7BR4223('?@1F"^R)64\*KP"FN.X;7+&G
M65_F1:&V*=L+2&T#INFFM0^=.6P*6A]X+M6N1T=7B#V[">Z8F0T,?9$W:L!:
MAP+9.?37W?L'4^.K"IJ^8G!N6HNE4O;9[$2FL7>QA^^L:ZHY<][%OAHF!KCI
MI>M!DA<-'4I,=FV8SM31Z'P"&B!0R=1U%0FWVV (CT?7[-,RIJNR.++O[0G>
M"$4T+&R>(9>7P%_@1L/%A?,Q>]T8+T!8 L7[$T7<)0F8D.?TQ _L=2#7+WZO
M3!.TCK.*N.!F4II5R_6.=P<]-$_1],=(_"QZDK1)]%N"9 ;CQ-$)7.]UDQLG
M2%OGV07<^#?K!JE.Y@\D!/O5X.3Y<_'PW(E._!VEN^UN.DX!>4@YR]%&\N,:
MUF.$?Y&;!GF:%3DL].%]<K-G0$))7F9IK(X1^4*U"OT89BK?T)#F\\TZASWQ
M\>@#^,"!^IS<G8$C+O)W(-86</';2>B$%UE2B@>:CQJ>&(\:9<.[;F$4W,%A
M-WK><9+)A,1O:(0#^76-8]1S@W<\X+MN\@?P6KS+K.+,\$7H49V"JDZNR!TH
MTO'7>A?RJBP!;\^'"8K>V5-<=S5MR/9I'>T*1U)1$A0#XY&)[MF@VOTM037W
M)_W([0Y4I(++):7Q:("6HD%2$M7F!@NINU<(#=NX.FP8L^I_)35FU^19TTGW
MZ285N&YF$SR^@=M[C)M[D$SVV%W8C#_VW-U?OOOC5]Q%/_QNTB>8NB_YUTC:
M'"2B7)&&9'4\G&;RR?,CKFT4_E^D[]U/*K_"205C)*$<"3VD%U5$;C.TW2[@
M6>*AR/'AV=+8U_ ;Y:Q["7F*=KK&'6M%$QN/ X5L9?F?:R52*@^JY;,LHXEP
MYAJ8UZ+!.B\I@:\3QT4IVT0Z]:HV&4#ORNH2M,$S8+D^O2*YU1G\N Q- _0W
M/]*5N8'!3=X9B7O!A.!?%5**C3BZ=B&]4*2 ?8),DU#:E'<?^B8@&K&>KC)D
M!H',8K,'EX)Y6Z 0H:V%*5%HRLM'J!V@* 9E":@Z*70Z1@^0X*RH"O/=HL9W
MHC^6DIBH8KN&?]5-2Y2&Z\Y+-IE1[#M>DZ&X_3!AZD3ZE-GQ.F0Y;MK$;D8D
M>X&IN!]U,]YN(",)@R,%N0DH6\.\AKK[YF[7C8/7")/FV%P"-:-JVD,[E#7-
M>)5#Z0M-/^$*\V2+W$;NW72IAFR/J(&W-/-DQKHX$CRKIZ#4-6THO0"Y@ TJ
M$<':<X0S<71[XFY-6RV%Q768FEEB"9;;MNLL).,EM9"Z)Z]AJ>@QK(;FRK?,
M<"Q-:LA+8/SM2G@6.E4W,:VHR[/P!QOYUE<F'[^!478)IMV]#:9]AF#:W=M@
MVI=\GZZD.^^O/)_,0) "/QV/GN3-K*B:59U9/9DB5D,^S:2U"B)P:M%I6IO[
MZ'_KZSG1D)H32+M*<\YO%S<?UHBLRK9>96Z"'^CI5D5!T4H:X2(G 4[/]1YP
M4^RF\C*3J$DRMLS0OXD+1U],\D[\+U9 RL,F>E'@E=#US/)ZMEK T^1Q8N6%
M72;P[3JZA)_"2],LIM6!#"NR!(4A2'!6RS8J'O"CKA>YU00[.1JKSN@Q6$7>
MQ/GDV6=T0(^! O!$GN!^'8 RDV;SG&1M!@8HYY?*#T %J^"DMOPBCJQS5O_9
M1(Z^?843A5.*82:+O+5O^H"3CO8XZ.Y)C4?64GHK>_P&:SQ".U'*J1Z<3/H_
ML-</>/3L'3*L_COHS \>3>C<R8@$"P)4VO%(:X:<D%QH"I?G&58%E4T.Q)B%
MD@:W3,HYS]"ID9TY?&S#)V0/@ Z$]/P/O7+CT17OG&LVE0&SR5PS.GLD0SH+
MLC5Z?)&\ <(<]XAH;K/]!F_MQAL:DUGW$>YCM,]U-(=-H>IK.NV]&.Q;LEL#
M'KY+Z^'3$(%7''CW()F@G!5G/;XW <)8F\6:+!7>G(;C[?.Z6FP-$,K5&X^&
M&,*@NRE G1-:.4X$1Z1$@-42RZ@YFJ &/Y9]L?\1.4A+-II3YS!?U67>G'O&
M+!FZ8'NMJU5,GIXU3<'QT:"15JW.SOD1G&L^1Y48M@F-0]0"Y#@Y=T)2LB4F
MK5$,.'-,I"9_$9TM&+55:AVGDG:"KZG*8LT_=H-<=O*!*1(3=(QM]X>:+9-2
MI@*_5LE@//K^8#ZY/DMS/SWO"/6\SZIIT@Q(+W2"/!6EQ7J1(T<Z17WAU,W&
M$>F*"B'5 &_^=>1(-OB5. 'OT=T9]CA]90;UEF,A!!>[W0-B>SP2WM'=<-YI
MYB9!#V)**I(%4?DA%@9X=/>878]#AV,KJRL/>^/4N.G<NU:Y9?BGIS%YP@(:
MRB>[<9_^('NW*>JDM VI>)MOT5ZWY^C!YK2O;^;R]%+#>#=_^/G>493<6=R)
M#IXF#0B0DA2\B4(-#)1G7>^"CK\>,:$.B7T\$JY?XI0$P'CT#&GX7T+#X6 >
MFE-TA;8(C;3*V.5O\FC0B')8$:D3J!<5.88WC++N:436_-F6S[)/W) U4B?1
M2]-=S:0#6J9HSR$U<\M63 E^ O7! 74PI U&0\H@Y2J"JK==&0SK@E;'%WTO
M^C!UC^9S7?I>=+WJWA?!_H)W]='>-_7@>!*=M*QR94E=@-'4LMG+.=5NI-//
M11FH2#0'K,^1=</9:R;+&;U7^2Q?HLE,)@X(R]-?IU69H)F=9L@4^.GH(.QK
M)(EW_/W]@_/)P=UAW %C@G=RKO$W,D_B^C9AWKD1EQ)>I.NE_[1IB< 5SO)I
MD<E%-7F+ Z)Y:(K=0EQOW]:4*):GN1K:8G#-,GD>F<,:#HZG=YY<X,<4IX/+
M<@$\$,-T:/7/LZ+BMP*G23/<2F0[M?<;.@M)3_LSFXG#X$^8'"4H4@ 3.*&<
M^P5E@<UP"O0J7!\M7F_BKIH)'W*U@@-)WA%LR6Q6K<1?@3EQ&:(  0<F6NMG
M7'@8/+N-2&0*O$K.U?$==NEWFKFJ+-HUW9-'MR"=EM)&]MX4PM #&R@#2'B0
M,JY;\]B-DQP>?R&*Q^.]F1EJ$+KGPZ8-Q>US]'>%?'\LK%HR89PDS986*S+3
MU379V&'^AJZZ7#,?QR,C%Y&,79M*#K^AT\?QT/#]1%2P\R$<2E+C9Z6$VTET
M)[%+,/[>;3#^,P3C[]T&X[^9VRBF\<7$)'/O81Q_1WX+,)#?@K(-TND0F/[A
MOS"Z N;@[Q)E(>/X#J&#/'T_RY94_@4&9%U=L/J@HDT3\#V$MM@$*-VL-M)@
M00T$5;\\@Q.D]["NR=J=6HP(8+DJX=*QO4S6Y+)J,<N6$M40<+*J32&O([!(
MBH$61V:G#5M41MVY]RB@DA-<DN_."6S-8W=6 6A,":L&@[GQALVP-C%^UQ\Y
M>NQO!^N.Z)T+[A?7>UH+VUGG!EMFDXG0V9M_\:CCT;:I&D0YV:P)*1MF\2O0
MN6O@N;1NW @LZ.*]H)V0<;;NR#5Z%K^(:WTQB?9U=;T =>\EZ8 OU<;U+G*_
MKD!/(45C*I]2/B4%+W,)2=HO.'_3\SQU[&D3FLW9NU5F3EHJ>5OT22HL"P-8
M5A(Z3\I=HYR#60]5S1Z%5X%)ZUPQV;V6E +A82><+8[54\ZN^,":#]%30%70
M*:KPY]4EUEO$Y#' BXGH5<HN0>,>CWIAC @C%"%NP)X(]PPHFLU5G'.J^1LL
MY.;J^6I5I&0M<H9LQW\_'BV=?91I[E3G[86O[V/X^OW%Y&.ZJK]<%]?%_OEQ
MS[3"TJTL\6]EL BS5V[12[113@^T@FMTHF;UQJI,"7%NJD3<=L4"U0&4M+X>
MSO5WIFVS_4U5R4 ZOE=P2.@(25X7R(](VX@'AXO%=Z@;:XSC4%%;CA/!BX-&
M!NV8\7OE##;@E *@WI&B[!&6R4MJ5@6?605\1;P\^"U/GW2560*2;8Y56!9,
M&B9=I38W3)S; F+2]:B?9:7B]<[P]N($V%7%3@8X\WQ99$8Q^J,D_&TZVZ8C
MQ7\[.7G5@Q@5#S=#GV"X@&8BWG=RD#ES!CVL*D ;?"@NNR66'U/DP50.[UBX
MN_NA,N6ZCO>->7D/(\ZP*0]QN0XUN&_8J[IX:X+-T,60=* ]K@;I9L9G&/U&
MKV;$AB/_.YC-X7_YZ)-4L>P*HY2G:I>Y_PV/>5NIAJ*L[#) .AU.DP(ER'@$
MBFR&8#<UDCVOXZ#C>+1KZDT[Y@7>.[J'4N8^Y4E-U!>ME>_B1#W/E[)SJ]*[
MNV@G<+FRD?I LPTEO9&@-#"93E89<)^:813B3FS*E-R8JI+8249;M;AIG":K
MD=S.#S&HT&-#<9AGQ%&1 PG ,\#Q9\DRQ]*<[#W5N.!(C?T4_JA6-2$ U%$#
MDHNB8F5+] ;ZM) 0E2>N6"FB%R&N$)4OTLZ$14_MEO_76?>67>7*#.:5!$.9
M6T_@$>A&-;P;N>$?;^+H^?-76DV."A6L%/:'R!W7L\Q+HY#ZA8%DUWF#)*N4
MV.8.R A2^=4X< 6;V)Q3A1_<.E=!N*H8)AB;@_<3#A6D&5(.TO5R-2WRF2LO
M"'$^5"II(U"#>?9;B_/BZ&!ML;PI=C$P@PYWT)@I94D>WYV8C*PW23U-RJPY
M?/F^R-8*0'#WZ.AN",F[]W!7UK$Q>O#OR0ZWG2/^X]%%7A6)JT,0J9"RI1L]
M"Q<S]N?S;2C+NVG+K">_K,^ QOXM-X%:V6#T'JX$U?=U2DK"6IR&P( 8WC@<
M\8VCS3D.B9YD(A_1X='=@\M)7\+^OT[U-5Q_=%O1A$4-A&MW 7N2PA?9^[S1
M_@=P#4D>D6)\A@MJ9$&.Y"N22Q,+^A/4X ;T2Z6SRMD6!5@>6/S0DFG>\Q5E
MQ8E-$"W!<JTYVL2.F)920ZK+DEZ%W7#0\2TW&\76:M;25]-5DV/E)P&EB-@D
MI#Q<TPPD/Q:N2EI(-Q[[$>P.P=N'[:=#^6L%AS"7VMFT,K-E+HT^:MBDP2/!
MLE3<8.\0#$9@WN+^D'@LLH2QU1C##/=J3?J&>1AGJ=LF1VOF@H:]I(G(?,5W
M9P/!DE1CWP4Z<H$[@?D[E?QLS39_3!;)19ZNT#C0:1"#TLY"J&XDH (E4SHJ
M4BEFXB7LJD))>@'JDE%J5EIRKM./[4+4H]"@2E0F9U(9;:F'JP7$\CJP(M6M
MM2<%S]/@PN;4 -6[IEH<L?.7#OORO,(R&D\PJ%ML/#J153ZE5?8Z\7P;['D?
M_GPR;3)2\;%5$GK9@<:>7OC.#!LKP"2W#.P>.L\]3 YYU%5HW#BXX@70EYP"
M0L8MF^AR35WCKHG.L%+]0ZR>TBGK4>+3FAZYV2X-<ILJT/-6=2U.?7.UM!56
MSEI[!1K1F:U1K#.NB,&] VY$5PG^I* @[:* NIG7 1<M&\8 :.A1@]*/VOXR
MR7EXX@V@GM"8XF9<6R>G"!K\[%U>ICV=$!>H1@<U%7NHVU1GQGM)8A%?(?X:
MV6_Y'?8IP*Y:!ZZ7M_-HN:(T<;SSJ]9PY('V7.DJ4V+ Y F.\LSU:<.RLO=9
M/4,X#[1HLK8M;(F9.PBC<3=DD\&>$&/D":]*K4E2Y!T^'^0=LF_\5TL9.8WC
MSZ[=2<YPAH5JCVC%IG [I!.(G3=I!$9]0$62I!3&A;$&$ZY3V7"LR:,#?R,;
M$.?M(>8LD:2J,':"?Z39M/5/H"$-'7FM4;-W69N=@;OW9A-UJ^(-6R.V/$:<
M&P\%G4PRC]JZ?'_XYHD!Z(O#*"@-V5>^628B+JS*B\@7%U^;>/@&1MDE,^7^
M;6;*9\A,N7^;F?(EWZ<KI9Z\OV)1AJM$OK*(/R$-TDM8_ #UD?44R;3UP8)8
MY VC!3E(0:*6J4K+M1FL>J&&FK<,!&] UPX2\BQ9^VV[^,+<4?$DTF-8PFT]
MFH)*JJG1)K.3P\/Y+*-T:E8BJWI :-IT;EX +J=:9XBM5&9S6 1J&*"L+=$:
MJWO1[_YK#+Z3V,#T=P-'UZ"IS/M&MO(.K^*+:DM T'1<U;2QOV'/DU*0JDZ,
MPR*$3Z"0%O4T1R<#'O2U: 64W2VF\I!6@,%<&R )A!2&24T(,X;=.DN*.#IS
M5TP*(_FB*DS$-QH_TEWC$QX[?_>D/+P=)N>^)M?M+H2'M_B#*0\I+OH@@D-'
MU)4H3L)!@0#'E9Q6>P4%G9P3)OA!5WIDVB,0]1ECJZGL-+\V??0J,F=_D=,7
M/__S.FNR^B)+_X^1.-_"SEVUA%(X+3N?'XY'H,\]UN+&AY8/N\DL'B"V[R^W
M&7^Q-,L0U[GTRNC=V%A]SY+0A-*1?.SQ>$1LDKZ?YB+2C3.EQUPS] C-LH2*
M9OH93\@.J=&W&S"WMBENYJ)$>6,Z- HN.$Q#>IS#Q.=@TDLB*V.6.!8O.?AQ
MLDYV&'I_S<2X/SJ_-7)>.DW*=_5JV<[6*+\:3+@H\=_ @KUP"86 %WF1U#(6
MXS9)49>L!0UZV.6<DF>=9!)J-BG<O=(OW'P2A'TB7P2G*YE.)[%M<X(O 89,
MGC=5\#KPZ,H%\4!7BX5W5*XGR[8>=UR()BD.,XNUPI:/CZ0C.3'P;"/4^F?T
MJ8G7,::0;8? 7=U9;MH\MUC]T"9]#G2+!-\K73F]@6@EJ!Z*1P?A]YO<=:85
M>08[-#N'ZYNQ'V^V6DQKWAZIG UK3KLZ/#SD'ZY%QGL/HB>.%J ZGQ'<4IIQ
M%5Y; X\ !:-"UX^>BI,D80, YLA(2P*YMU(<TWVU"D>=!6K>\&M0?@,_GU:K
MDB2Z&=HYQ0_:.:OQQ)2W;0Z6$?=[H5X_(S(4,,:#;ED7FJX/.:0'NM3C28=H
MO%<3G227RC16@KZ$NM6?J_1L(3Y@(C]L)QT[K:3%X4L%D/PFHR];[9<0@IDS
MQ<R7D )FS*<T'.8IFT SP&)Z.J=1NJ5BTX]37G3\XQMVWG[54KM[)]1H#_(
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M6]",;_7<Q#I'UJA>X:_Z3F,U[^4<G,B;[/,9GHI6K[,&<X#\G4L=BC5KT=[
M)W"6:6"L?;5,UEP[E&U;STJ+)S%)I%Q_N*OC^>8:_7.L,NM6&9"2;4I/G8V,
M_<W'"?"JI1*0=HUM!/Z"? 6(GMKQ4^$=0/M2M&9RD1#FMEMF9=Z&\P&SCUZ(
M+P-#VN0)R$)L<R1,6$-'DBG?LH5VFB-H_#ZQ0&D5((/9.),PD#K<IA6."5/0
ME*JF=W6H:0>OSP:L4S=.@.M%7"A$N#$XD!SV8I>''$EC>SCW)F*7XU@4%P@V
MXJ-U43BKL02>T*99KP:'%XW'C+?X(">KSCFIX9P0TW-JS2OA;A&.=^*2(D)I
M,+NCXV#,G+V/^O=6VBK#83J/F?0-&Q'E\ _=8;?@U_7O=5ZB#N^N:UOL\M@4
M'V*XDHAD#Y%"CNE/(%.^C1C.Q1YZR&,3VQ"DNN=PJ%8=V>T,16FY)'%-ET3+
M/:^H,(Q'>YUNE_@.\HD<^ [E\;Y,3XVWBU!U?/<6\!GA$WFCI9U<=ML)$;&#
M9H[>FO.\P=,]4Y7%C4P27L:,,"UB ?3""P5KL$H-,Z?Q:(9F#U7:2HXEF5*-
M>I<&4HS)VU',#YV;/ZW2=3^P/E3KJ^R$3]4N:#SZP!5%=D$F3526A H?^0U5
M9:58,J6:\0G)H2.\"G"._>H;R>V%&. 4_P+*S&<F :7.+JJ9\<PLJM26-LL3
M%CE%MT*.-C8Y)AITEGW0;;"[$-L4"F\/G,2)6F9) 1N2UD6>81=#2O@M!?O_
MTTS&C3'569E=6HL$'F"(.\S<:21.13TOW--@8>=<JY[#?R#&VI<^G1P@-^3*
MPJAV,3R4G$@>8Z+13>OB$N;_N[%_#[OBLH2-.L^7I"*=4 Y3&'@Q5+7.S-E&
MK2A]W2N1IR87>*(@+1;B.Y?C,Z%*DPZ'- XD0YWKM%"8F;AA2CN4T@<JZ1V7
M<Z]&& P7,E16SDQ -.0MA@E," MC4VFJR#PEEW9SX VV/9],?$$4"@04122^
M?O']!^,"?9<_%0JDV9PLE$XR$:4^?./>@F_C9N^?G7/J4/9X]$I(^_K+![Z0
M+GX[MFG@_3S98S??[E!M-ZA'=C)(!83E7$J3B',BH2.7]%*B'2W(J0'@1FAH
MNXI4MQXO*BM 6]2I&*#7LT+J$D.DM!#LLFM,YX!^&'1*A7BP?&OX-H?*80/U
M;5SN=-TH.T%G$+L\[+C#3K#3'K#D;MS.C5!_6J/67T?PD >:NB%1++%$%+>6
M_Z%:E^A0< :"ZXN51Z@KPZ5[-_B%E[A@GBH3NK687L9J@F,E8%0385C<YQO4
MUO"I%&X]]ISFW[?9[+R$/3^#VX;W\/ <2,GZ/(-"_/.T@?EH76#VXF_[-+3:
MQ] '!D26OH/I).BYGT3B&R4+D3;$W(_D+FPM5&UM.34Z>3&S1^R@1=Z0!W$)
M0ZH%9%,T.1VX3KG[5F;L;F/CG+YB@]0;P:_7WCHU+=>.O=+LV"W,QJ0#5!QQ
M0D3VE)@%9%^>$4AVR-F!NS_ FFV(A+/+G"5%N*)N9G>.N0GH(#4V\YQB+JP?
M\_&CYQS!1\SY9MAN+^=<)V.\TBIBQUH,"R<NBNWD<H:QLR1WW-ODKNLYWC"4
ML*1>I^?P:#YR4(KE+B2^6&3#2E>E(X6)S8DAPI<!Z<CL[X<2S#[T K?&$@SG
M"N*4U5L$3#KK$/<'44(T3 CH7E-*T.+S3[8-4;=7&0//];P3PB,Z_*%CWS*?
M8&"J 3HV6+[TAJQ%Y<H6-O*<:)<_T*.%#ZE^:+U;=J-W.$B:S'A$G>KW.$YG
MD"MJ3$')83KW?8G&XE>G%'SKX^^2+_7];;[49\B7^OXV7^H;N8-[-:=4Q\M&
M@&N+Q[)7"36KO02XCA7 7/956K]SM]899D*PA"PF>4Q*$=#D(V-$I]8KD=@2
M%V/I8ITP[!*7/-KOL=4#6E)9RY7XG:^0A<SR5C !_"]# ^KJ38'(!7I 8 KB
M7ZJD&0L!"R_0X<R[6$LDEWSN).%5@[ ;PLU;&G*.,Q:$G( Y(&=[3"+#CO75
M4NGIM$,3 \ <,V@0A?F3,3\],MDPPG7J)M<9Q+[530Z>[,,7G.8'&\)23#Z.
MRFK"+0OX#%M24$I@7;6"#L7.IQF_$VO2$'L6._>1@:15_YZ?RCH<P9):91KG
M,0\;?A(T#;[*R,5>Q_ITCV,]*0HL@^QY(L..@)#%1D%AZFQAV,X?=][< 4VC
MU0KSMWAZY*Y\20A@ 6_PJ[<ONVY@4W"G(>>*?8XUM]9."N-!M;7N!O>*T178
MP2T>5S)*#0"]FKS>HNGWZARWXJ-!&]'TW*Z,<WY3D#2X51_HC6>6>X5F6SUO
M_)8\45V$G.&)LT?]4[)5:"C@,E,7CM%FNG/P!Q'(QY4$X]$78Z5^T2'-?/+W
M__LGB5:^JO.+9"89(T^2-D&B:3G$_D%):1_FJK[Z408RT[Q;B;HG)Y))KQ]S
M?0F'!;:\I-;HG!S32HX>2A>_.]IP?@PJCMZS>NI$8TO>\%UO0HI'HA*43XD^
M6II3ZB6;<G*7S>09JBX6!H#>NQ7NE)8MQ\[+$66^658-+M0JO#%>^3(M*#D9
M6^LJTTF )Z]%?35Y)CA?DZC4/PP!@D_[:4F;VY^)($#A15JZ"")R0::D9@!7
MA>O 1).5Q"$YT[S-SDA8<"Q-M)/*=.Q+=&^H8R<NE!DUKE3Q*?R>I92YJ(34
MK_EDE0BSJ[$DDHC>U8_:;$D,&B-OU"5!PK]=18CZK,BN8CH]?3O/!:7.I,_'
MU+BSY?MRGB5%Z[4XB 7KA>)W-N?>1O7<D;U' DE ^%\_2I-+/YB*JHG);O(1
M<M[ 4>1D&>F+D.WT^FE$U\A-KC7/E?/#D_*,JDZQU#0_HR(4=ZMLX#1JU@WE
M8!W81&]<P@KQ.^"H&DR3(VQ6Q)E$C_1E5;]K6HWG EN@)Z-ST"/@*:"WV7E&
M729:>C)6DG5;'$<%DJ($<-$7Q0_AD9TG=8J^9RSZJ.8MN:')"0Z:<M9YB\Y]
MU? -.,_8*4V)$QW-<$-\_ZUDN/7Z1]+8:?;72N%<3/<6O-=S#$:$$_1!QT^K
M&>$=6/*=K\J9Z(72%],&U3<EL[%.9H1"PGV(C*)(UVE9-:8>Q6I1(=5-^/Q'
MR0;;46I(L4.(V]))#G&B;(XE0,2+,J# :9$WY[$036,_0K8X] H0$@GV;Z-:
M?00+X[D8+KOD"AV'2W.!T$R[G&CZ2X]X(B/[B J9",D^<<#&;&E74.B-1P-I
MZ!I;;%8(/L'$[G5D,0M@M$A.KEC ,A:8G"V/$]=L>KF.7F!/ED.F39@5&O77
MR>[?9=1K8H@[H-)U^[F0""\KUG-6I5-1A(,7#+VZ8DP]\C:A)=79F?%(MR8:
MW!G!^8Z\(:SX68=V;N-TS%SLYF'PZV/E4>S2I]*+CWHA;[<J#N.,<]X,.UUU
MD[J"J$.W+OVXY!-Q<UX43KVM'X\"5(G3=(0RHJWP?DL$]./DI72[<-T19DOV
MS U#);B"7;=_LNJ+:CSZI[J8B:$\80A;)QO]Q?;@^& C0=;I/:\^/F_[<1F0
M(^!#%N6(%5$7L1@U&!'XW+D*7JO O7,_-2 O%8<W%GL,@PV"+EW-A*D+QC_Q
M:HW:(Q;RLI$4%I+/=32ML+B(R=G!^N5,< /X*S3= <6D'3(HT[$?)[!M[C"6
MD6A/2?S-M"H)$FTJV+R4UYC%+EJO#\IKG.^JP$MLQ"\,"()$Y6T'S-\ 0%G0
MU86!KR:DIUA2ESX>P.Y6_\]5>Q;>MF?Z6D;9)6W@A]NT@<^0-O##;=K EWR?
MKE;!O$^S#%8=WB;O,ZLEC$>[%:VA6-5H@ OKNJ'.$'34:B%HKUIV&;7)>^#V
M( O+QE6,R9KAE[?G8!N?G5O8!@&TI/P#F$DU%:$K%?E@WF;8;Z%%_9=#0=JX
MQD_?"RY.X5:=9 :J'O.T@V2M$&CD-\,-U'0_U*GA>[*AW8J4!@'Z=*$B/1FH
M;Q&P-1GK0*O9&.N-&K/OB0=)X(J-EEI3RV-0]MOS7;W6OM/,2'.8R*<L4 LF
MN*(_&Q0X]>OS.5 8T,0076A(V212]^08^IFY;*;Y";.)M&H@OY%%A=7,3:1?
M\B:!O;G@APQR7A#@OJ-(X7O,J=IV97C@ZD^KN74-_'?.SFS=XJ[U:;HL(]*-
M@>-D=^5':\.]LROK@[-";D.!0UQ_?Z;_]#TC1XY'S[5E/9RL?DK=J5PZZ94T
M6Q1)ZC6 3Y*[S65Y;SBRPL,>W\6N=D+\WC@<,B*(1J;32@%I!&2AD!G*K1+$
M?0%/5\S]\%5NM9BYU)Y];C")[)\B?X>"S+1^I60I;H".L+^8MI:7B>VHTX&7
M;;O[8?L1>*O$^$*F*^G]R(!H^8L;CWAU0YRJ]9/7R9FD* 1NDOXB;QJIRQG>
MP=S%XJ59VJ5+O4&W'X6LIQ\HX^"?&,+#H3^ZZC; Z>+IZ-Z&-X3H@L)LF)+'
M1CK13S-T+*P$E"Y,W++.+O)JU11K#8GZ..WJBW:!VK6,^TI@KC[CW*$^HZP<
M?%S*XZF'NM!T>R=?GE<XP%E&&H03;@$Q5,UR"I!P#%*02N8([HQ1[IC06GJ<
M&%C9?S*V1^W41;ACQMH\N5P[/<V1P]._=6"A'3.@9E)2QXUHD2'@U+?!M?=W
M\_EP$R_I;)^6+45<+(]^:;5&C7/ZB:*^"H*WF*_JT_?G^31O><2[QW>.AW(.
M3LH2_=2OLR7< 9A+&3W#"I?CH\/_,M=F#I< GEDC?@/H;##"_UZ5673O*([N
M'MT]MHD$1$F*V] *\B_AEZ7,&&5:$<U(_7W8=(!_*8_J;QD! UU\>9K568"2
M"=JB <95.!NSCJU>XC<#"SI%.V7K:94Q0T:$NTI<=U4!:@]3OVHW^A?CR2M8
M'#D5,?(AIQN[ER7F_ETNGG6;?Z7)C_M?D:OA-G ^R6,^A'T 64SJ1B(Q<Y8L
M_$8*8*_*ED/__&Z*-&+6"NL\U"TLS9Q(*C4I70D4"0GE UV3UYP'B=8 X06"
MY;"_"1?<FENH#?LPI47BY#ZFU$.Z8/W!^(HP"CM'O[VD2$8Z0OD(-&DT'6-=
M1)YQH=TGT"BBB?YV<O)**TKM=O+.>=83V4,/QZ,#&_!P(HIL+>6-S(9R+$L!
MG[R6K6'^HY _+29%VQT9FBYK24! M6;)&JAQ>2!IW3 ZD<Y%4HB0=:H@11W-
M-:O(=0!0;0"+40IC(^UX +=&7?F8D#5QN'S$W :Y MP#SE)'34*!7 Z-@Y39
MT6!C8^EJ_22**ERS))TTENN2 X;NV(P*L.E[/%IYU&B7EUGRCN$R]"%J)Q>Y
M,!V<[/)J-06MT_""$WNQ7Q(L/>**/$(XSHDF0MDTM6WKEFIVLN[K9,4=<B00
M1DO6^4H;8@[9$O-1.G:8O=1MH(/)F+S>WM15D0UY!'8^*]I.KB@GP>2U%=CI
MK>-1B 0DC=N)UZ4KZ@F"6[JH&K9@8,&B+?RUXEZ*YG>Z5YB&3+24<=@J;US/
M@#7B[// Y"3UZX-VYL9U"KB"#+Y://I17;T3D^D9OK,.JZA;V\=);KW3NZ3+
M_K;"VEC/TE!K$C6HO62AOKMO3@MQ\2&FM$KK@\LX'>7,E48S8X)3278WZY1<
M#MJ>,7) <-?]UEAJP^_5C3'B7G_?B,JX/XK?:2D:FA,&>=IOW1-6&2DU LE-
M% *3Q9R+@9(L4+:P!D!/T*>@9JQFU/&DD8*I"^Z6Q)Z6O'G7D*<A;UU&EV:8
MQFE<PW.I3=&42.LH(IA $\>G_($@&,B&X(&CK1340H47B7C88AUI>,6\T7/6
M$O"F5JP8S@I?->@@_MJ(\1L899=0_8^WH?K/$*K_\394_R7?IZL)JJO(*6"H
M+7=OMZ9+&_9OF$@B@F+-4:D^RRDQ5*(;XMHS7?J23H??9WF]B-Y0FX[8@S(&
MG4T,K]R9STSL.K6\L.,92C*J^\^M 29ZF%V*8X112/WXI_M'W"IA06[#KTU0
M7)$8]M>QG\)[<]9/R6'P!ZC&Y(9]<WC/)PF3HMB8H@_8:'R6WP<_B$/E4(8^
M>L1A>SC&7F\[ SGTFSA@3BE5<=;:3 R,N]E"TP8TV&:>?SO'?!6'IFDJDHY'
M3S1[UC]BDU1+:3;Z.#>O%1?2ASF#V.,.'Z)J-X.[.1Y9YXZ6"W>JQVWHD:B$
M[!9,9.4L5-.X=E.<T'3U[(<&WSB=U27$V@V[]ENNH YN9XKFEJ8R,5Y'8.Y:
M#&K#7G:S;<HO<$70\NM5YB1?4/Z( S:?\"PU8H%I0=P N_.,YXU=).\X3=]Q
MN])%RDOCWRO(8:7-E/(:IH>=&6>X-1R0-CDF:UX_-DV)V1N5-V >I.0$$N>,
M?_31$[5&7\$<JS0 >\OAC/FJ)K/>;D]3:888%J9],&6&S7@;"K(#)QN)$9.&
MBD+)[TK$UZ$R;4@MP2/V>2M%1 ,$(4!Q0A&?A!RB(#6,1R%R^&8X,H*@<FNY
MI)XF8$<?OGQ?9&OB*H.ZE5?B' _24&R;,E!LB%,2E8-YXYEL&**YE3H&G&IP
M%Y-3F5-K>H:9A +*?6R]"FR;7/EMG&K^7L_4LI%M <%.;21MO@:P&A>7RL3^
M.G7J+E\$>GA-1WA\+SD\?G"036QFT'CD<H^)B0J:DFAE6;LQ'HHV. VD0]7R
M%&;H-V8CO7'J>E0[+J*\%$^XQ"[SEM@J>3Z;U12;U QE/!'-<3Q-ZD2Q^0,B
MC"[@@*F,C\D;7X]3P64+ Z.BG25)FT8#>%[>HU"_\;#:ZX*+]+IQ#9W6P#Y)
MJI.[6SDWPENL"E-7;.NK>ZBW9DY.."?QO&D4WRQ ;JKJD<("F3%@A@*VACG#
M8*1D0UO*N[-;LJ6'4W%M%_$+N=GF8I^4;7[X"$NVM3B9/OD=%+5U]#PAJL3S
M]]MR!=RZ\1 B,N5+.25N%4$>:5\<[='GPB<[=<F]0<CC>D:H<S;WB7+6I=UB
M(H-T\[M[OED+H2SHN2DO@: ;9ODR:372X!GX1D&17_6S"C<V7\ Q<[_EH.6.
MVZ [B-'(+<,+F9<KKE_W>W]ESNG,*[PB.'&L)OS9311,\*"G?/32OLC>]^FJ
MI546^2)O)<^3%F=^/Q[!;V+B&3&?@$I83?BFXH4<"Y$WO9<?'7H55N>NBC/E
M$#DLE9D!+N[ET\=/2!XIK"'\/YS"E#,OA:K%2*?B"0E8$^I6COD$<+JG'H36
M(X5%>.N$@>)(F-P3T"$QLTZR<7^(H^.??OK!61\'^PGO2\=\7-7U"N[H*RQ"
MS%%[-"Z:'WYP730<2OOCSG_=,5/')^\>'1_%?DFCWUN1-\[?-])Q&MCC(JDQ
MG1ASZIFL"& [EO1@CQ06=.<+>^=WHHGA'ED>-EE, !8*6R;=0KHML_"K,]-(
M+CI;Y9R?8OAY>*)>=U"\ M5*)BFI7V^QCU)T_",=#!),FFE>-9S"@^]I8^ ?
M/_ 1O$I:D)DMZP;XP:.D?(<_(%P^HS'XV&OA+01150(O$5GO7.DI<5M^QYG;
M.P]ET9*[G]EZW]CT6F*?HL;73W@-;Y/F'=+;C+JQ=GEWC,1F:UY\X";,&4\D
M7]3&UOAI9CN:"-W]98?CBO@.3M\PJT;0XF:KFCO".-3/TH> 33F*2QX1TLA9
M2L '/>[@),I3=J)M/#AW2W&1],XJW@NY2-*]L#:=0& KFA7Q6&,+?&U:_C<P
MRB[1M9]NHVN?(;KVTVUT[4N^3U>T$XQ7Y^6SD\<?J6W;Y\_F^FAMVP0MQ,>&
MWM!+(W:_[)E.QEIB=# QI.@W\9#][(#I4/'KM1A/E'=*ZHM%V]&4>G%Q-)I@
MR,"Y-IN_(/^(:#_#/__Y*Y-7^U$R4]+Q'I1$=K$!)F'MIDE*S7M/%WFIY8.T
ME]3ZQWBBR")Y@IGHK7K0W]8$0&TI1;"('7-)H,;$X1<[2N!X]$)4]C<*J?2X
M6H%2*D\]76'2%!PQ/([JZS] N_P]^3-K6CN>3B"V%D&=%=D%ZG/.RHQ*UP'I
M]6$4]?DNJ-Y#1(NI/^<I?P%T=G</.D.CO25U7#1XQ01H%!HK2JBXKZV)-0#)
MP>E@8V^YN%HII81*$%O9.>((("J6.=@#BSUM34SB.S6L/J%L?#%DB>[>U1@B
MC,%"KQ?)=[^ODQ+V)8X>KZ9)')W6N&W/\^D:_GA!)87_!40,?[Q9I0D'']^L
MZSR9?"[9]64@W._3DF]?V46N,376^J5:F"_1<CT_=L4RKGCUK'$=<582G")0
M5SY===I<88#M'1AY%TE>,%8L&L7F?>)*<FO1_@2;KXTN&"9*:\-<!*B^_+F5
M.QVY4XU'\U5)3$" *;73&/JS+G)%9G !12OM[-%!Y#-"GF/07+TWP$KB2$JO
M&7ML+B$%G(MT5#/3(1&S,^?!*HT;QP0^GD#(2RY&YBLCB.#$Z\D5[@)D>LAV
M1B0K3F60$!P<X,%G'(\\>E@['GE;&)1(%(VKS(%^THN\8=1<3).K:H^;?..2
M8)\>2,\JD0++I,'0)=PF+$@FV.7]6P6B18)EP]@F^BSAKI7B4>5X#.(/#SVT
MQC*V!+'6B>EXQ1H;64Z\A>=(&9G/<^C?,EYG.*!#FL%ETN,[AO)OG)U\!?_!
M_IEZCTT\2V")GI87>5VI@[P3B1PNY[P*F,0 /0L''.SBU6W412&0%0<'UQ+7
MLF[KV(2JV5&.@7_YW6]N*.#$>K-KI=L:,7G3:H%X5#/!>D9;+?9PFG#ZU,5
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MAR7O+-'@6%$UMMNY[(= T5*1RK-)KY\6G:I&[+=(E5B"*.''CR=1/O=(@6?
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M"8U=>B$1]RU +>X6F:5L?:6WG&B7U? KR>,7F! 7O?GK,MX4LI9%.^L.(?;
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M!ET3@Y]&<\M,6T\D/*K/98,EGWOX4&88N@ 4N,>X7@73PY<L*BHKC$X,]Z-
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M@M+6Y0&;J[$),Y%\QO:W+0>*N?I8NK"Y4_S:X,^NUH1]#[+!8E4GPF_\N]V
MOR\EKQCOWQ3>8D'902O?#%"NG9]V3!78*<BM[?+V2Q6(B="=)(&XGR0@>BN0
MZ')5$SJ._8VIJXVP!2TSN_%H:C, \CIZ5U:7 B.4AP [NHUP31,F@??&[!>4
MP],J75,.PS=Q%?:Y"R<@?<AE[N;P*>&H#>#!B5%6+X>V#F83 W*@X:X'7[ ;
M<Q\I),X/1SWA=-5^RNP.:DNX^JRCPKIJ"&OC)B,99G?X+&$8DVD&/YZ;%,N@
MMV%G!T=?QS"I$+O)U6 .\8Y"UDG3I^:EB#1!*!4\&S(,J]79N9,"WI?(_O)
M"G=5-I.:$$JR#,OJCISFUGX[268+(ST>.:OW1#3S+6>:-]<^^'-_2_;9R[!-
M()GK?7MVT+@<3GG<R6)@EKB+R>!=-V,U&M.@>V?-E"@EOADR"!" ^RRI.?-P
M)AD)]BG7A>(FOU'H5%L:*KXW=B="XQ0!V"2>&>R-&P*'L@G(Q9ICO &KUW$/
M?5V1K=UI^=W>M"P0,@XG\*LIO.3ZH$@H3/N"'AQ-8X_52S>Y;PZQ_Q,%LI><
M5SS*55'T..^-X$<W:Y2=@IL_W08W/T=P\Z?;X.97=Z."'+[8'R8$NV&-1T (
M+ZD8RJ\0X5Y9+F-/*/L83.1*'S>E.TE>DX>!48&TEX3K=/ :N-ED.A?T\-LH
MDN/36NSO>VX)\G5+\^&]%<5-KN4M+8G%6^?4-C@M>QT54QKO8/4KLA:)R?$+
M.2 GBD.W&^]UMG[_TJYKN3<!*);6>/2<.Y-UJULM"$X'XU%CCYYUZ2264K,I
MZ;6C7<\DS/8B:=+DK^AQLLQ;.&!&R8NU?)+AZE#C1Z6^K%II+:XU-3=!=3XI
M"B]6WJ%M,"HX(N="NYI[P/7%TXQ+_/T*$-Q>IP^P^E5+H'_NC<2I[T/&2="4
MH0/!V[7M[@ZW+*>?TP2U)YAX!VP#\DW;(?%)26/M;H?<?57D/U[[[2_GNDM1
M]/=[%T6?P@L6I?&M\X9B15&=3U<,1REUT#=PUZY:&=O;-#][/2PT%>X)6R+R
MSSEA'=ULP"?K!<&;D8O&N4,Q^3^2.=;1,NG;GHU>RSV"=:)?8PH)%>A(,\G+
M<RZVJJNBX5OEEGXY=:6++"FE6-=O%OY 1;B4T'K?WCW2;ZWL@.<$8I>KQK'(
MJ#6U!;B*69'D"TK+621GW)<*%D@=U CS_<\JEX):UAK(#\MI^[TE," *<#Y3
M<1^S)LC^*9FT15MS>HJALYZPZ4W5&<XQUP9;N(<TG/-0WH@/P$5?&T!4D[.?
MD%.HJ>8)][?"-^ZV$1%6&6O+;P=M30)D$V#>!*;.W=0JAAW IF0I9P.AISI0
MW,50X$61G9%#=GOQG2WA%UH9+!GUNVG<OW?T*#IU4YFD%63%BJ;KHK,P<]CW
M/G+;YPT%$P7DI)7HG1^(%#0%K2,1F!4NGO:1U<>C@8)PO$+&<<YE=8/[+;I,
MY<;:9(?-9Z8Z3@L%._N,H?J=:Q!S+2'>LQB1O/W!BC\SX_%H;Z(@(+CK;!->
M28?8K0 !N\1A_7"M2W4&*<?-3>!,+?03VZI$TGH(]]:E'H7%.T@GAEC#M'1M
MQ".%M7WJN;X"UIWJ)['$"_DQ*9&7V4 !96Q!-FVKR*Z4X_)UV'Q5XF#:L'JI
MZ"7USG3S<Q0ZK1XC 9RW(8@KIU\BYP"DV5P2 E0L&78LS%AY<6P8,=>CS307
MDWY@&_[6F9F(#[T9@VR_1/$5^R"<W?Y'>%8X%'69Z92'F48&;::]7\P#F^?,
M/%XFC837.)0'=.U(B<W,(/C=1DJE$"1)*S9%@)TLA??S$5&OR5:@)U5VNK?2
M<RMT D+D9:CJ4//(]KRF:"BGG;F]<9' 5DUF^J6XC9Y%F#Y$$IIF2!I$WTU;
M5:F%O4GM ;+Y%)PN3<J;DS3(,#XJYW?CD5/])W1EXQ2L7GU_,)_<! MW*[!!
M%-2M37O4C644;P=BU]>N<XO!Z2C=T7:=N\?M]M:Y<9R.TFV DEST\\^A<Z.#
MSE6Z74/A4^K<9D,"A#!!@?:I]&^01EL5\,WL]5KT;[XVFQ7PZ./KW]H_;*,"
M/J0S7;/^32K<1@5\'Q7J0_1OW)7K)8HKZM\&+F!( =\.T'4]^K>?'!Q2P*-/
MIW][]O'.UMO'T+\-5QL$,/DT^O=XM$D!CSZ9_@T79Y,"SB *I$N$ ?!#6H(!
MNA<EG-2[@.)-P_+%Q.SHZ]"43:ZOJLP;>?N&.WXUP+.#W>[X9$=DM+Q$!X:$
M'S:I_$,GX0@J[PQCU+!Q,GB8L3U-2R VJ]#)OMVD$KBG#A.35@$PXP662$49
MIIP;X,ZS,TPT@YM_5B,VBH%NY68#,$%LWJ5V@V[,S.1=B]J(70OQY7"2TQ6:
M&IB58.C89)J&)KL!%-9T.QY,X%0<S!OAPK]9H^R2M'3WZ#9IZ3,D+=T]NDU:
M^NINU#4AG0T%^-S@=J?+D6_?<W=NLJ*+M13]M&Q@%P1X,^R-<+Q=/4?$>#0<
M_=O!$>$['S^2#R*VDPFZ9'::*>&:!Y'4 [/&"H]]IMV-5UZ3YX2,AK[KQ-WT
MP4CEASI-XH#7A# 6=PI5=KT[U^TN,5"@5XU77JN[! MQKA:OO%YW"9A45XQ7
M?@1WR<>W>'=TEW!WZ#WCE1_'74+L;<]XY9YXYCMZ3/Q ^<XARVOWF( =X]_7
M#XYX7]%GXMC?5P%]W>HSR:58JA^#8]M-7 2"=RY?=)T$UQ1-NTR:7D1MP+K&
MQFX?%E'K.?JWAM2B?D3-0C\??.J0FHNGJ;G#3ND/1M,F09>8NR4?%HWN8IDB
M3[N"6VS',.^NH>D;8?Q?$RCG"\HA9J<,=?%)@;,["CU\MEAB+VUM)CG+<I@3
M$Z+J[E@.BT)??4]NT7<"-'8P);<9%H"34Q*)U28O$WNJ%@LT*1<:O;*]NF,-
M!G?'(J\52WHFB4!4"D4 <U.N!1:"XILBA@>)&V_V%.73)<0DAM% &?@5C*I2
M*[ :&U)'9ND)B:;"N6U^N04F1GX'&K4T4>@_*5K[VKD/VD_3I/Q+E\K^7F;O
M9]FR[7AZO7UW1E)/K<63IW9;V9^@/,[XTG.3M"0O4$\X4,:)[P:&,L_R%C\G
M=9L2J:DV@EP$C>$ <&LG=T !9<%C6(!<<..RG-*K,;;F,(O> IG/P5:8_=RP
MYQM.,=Y\3MA; E$UVH*%"WZ7S_(E2GV4RC")..1.-Q,#6^<\5N-82LP=E;L_
M++?+@V=I27G&[T<4N860BFRF70&]U>"O=>IOPW>-MX]9@%Q<XX8-S"KPGO'(
MV]O^CQ2&*\H*81U\/7@I47 E6^^,#63(E%!['.)9WJTW@F](VEF[I"/O!KB5
M%Q 2Y22P*!D&J*)T"KMH^QT1/*M$Y#O"LQ,GX/  ?"")5TZX()_'HJE@C,*,
MH2C;UG3S2I<.2,]2?0KAMF=.\3&1 [IH0$%NL.V>$-B$.DT#%[;XW.'2)N;2
M!D9"]I+U*/.V;? 8^"VQ$<(%7"R+"J1(A#4XA7D'NA),#14^5U0S:GS%\Z69
MF&F$QE.0!Z\@&UTVTHW2:75F63%:#P1QHURZ)[$<:'VB'51A]8W$XJ* YZTG
M<!N4N(QD,>W#K7Q/!^]"OM..#=+9/,LTG5[IOC+.%?]H'(Z,("0ZV1![K9DO
M9EJ^*'JG4<>]!2:-U=O&HY-RZX67OF<&7H,DA_47&;2.V+A]8%A+^P:^'_2>
M&D5UYK4_MWH))@:;0)O98.OL<AJLBX9O%062:TJ#:'(-KHK9=;7:T+/<N![[
M3.> IZ(+]?9I53H*.PYRGA6I8.8GZRR%FZO0*OX.*O2C!9.RO9FHIXK".4F;
M^EX&$^-/2*L5 Y62H D"5F=C.T/U%S1GJ]#5^4MQQ#%O(^B8<YN)):A$YI7.
M])C6,SXBF11R"V.-(J2,>BG@M(QA"NQSGJP*I*!5L72-#Z/R(*7,6LK80XIR
M,3U">C,V"VGQ#% 9,AXX#'J<56R$S]4?1DZPH.[M84)(/:?[Y)I[WJB$]NV]
M\%9OYPR1RQB4%?@^.O=Z'"!9^8+8H?A.&_AN,H**9(>6/)\NWA(405VW;CXG
M9VHHDPYC8DBU!'6RJ(AX8,ON/P#K<MWTC9XAE5BAA?#(FB1/#3ZMP10:^J7?
M>00%LF&'PYH$HI?6J2UMI"=U2 \Y2,%:.XN_$2;PS1IEI_CW\6W\^W/$OX]O
MX]]?W8T::%.P-\284P#\$*$ %KEBW(% >ZYZ"!!-51X^?0]:1(-&PFN,B*V]
M_J^>F)64?K762+8I$)Y?](!R:E4F%Z!9<$H>/MBL" 2 M#_@]'[8?"?/'+\]
MZ)XC*TN\_H,2:Z;[HD$!+$^C?+$ERC]2\M<TX6&;F/I0@<#\_]M[TMZVL22_
M"]!_(!HS PM0W#[BG+,!'"?I>)!.@M@]O8W%8O%$/EF<4*2&AQW/K]^ZWL%#
MLISV%9L[V+0LD>^H5U6O[@)9RMR@:SI7J9J5N$IJ52;=MH:#]KYLO> XM>+@
M(LN-R1C55*S- #>HXGW!/(F8$T4-H"(.J9YRMV77KMPW<S<:-=?*'5)5D)IK
M4EQ'*9:(2"/[<DT+,@^1:F)-+Z[.:ZL,+.[;EO:,I?HCG%O61+P)J:)5H05R
ML;'12O^OA49WBNCC7F7(1)V-@\N"$0=$]P9;IKH 6CO6[H6A'54E158_%)+(
MFS7S5G;,%@O()0#?$=3;\-QZ#BR18QF]6?M;%3Y BD(MD@(@>::QOF3AV0!1
M13I5')4)C&A"=HT4+2[L;Y)"$U>#J]^!FU9FK\4$B%^,*G?6<86" #(L=9+J
MTD63(HI+DQ:#XQL2).I"3(WJ,5IW<[7SGVAEI61>02UDU4:HLF_$BV!MS5:O
MXE/SEZI&.5R:3"*KQ<B,[>D6U.RTV1B\?I3# :.X!V$LZQ2GS;*-E(@PSY M
MB"T1&S!C5)&6O[7QO%XR;""3GC7KN;G;[NV$BA,1;3LO)04&Q*VS&R\GW"[S
MH3EIL2R9GB^67$#!(YN/5R,:E"@*,JLOAV+)%HBA51JSIFPJT&:V;/92U[:#
M3:WBQ?+-=%(4Z<%6#3[+JB0R5AL4;ECOMO0?3]UE3/AIU&]I"E"+ Q=FJD?L
M\C>5BWQ, B(,@)FHP+LN7(XIX]0<4"F+"$?<0VQLLB85[#5I^FQ8&]4RMM5D
M_63_B'/,B4#!/36NPN[-,+!]^6.)@Y)R)JY&YKC<"IN,D<[&&IU6^!F6>-77
M\3*LZU_GO#1QK,$#;)H6*R:S:&--6WD&738LK^#2BG?)!.J1@"D].M&UH!A/
MYN3X(CIO9+C?0J_TG7P/4')AAZLX?+",P5.P:V>9&+\!4D/R NH+9Q06Q)E
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M%$.A\U,Z&$'YWU(2GBG0@04\4OD%09&,_*UDH>G@1U1=ENAH16AD54D./1Q
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MM.-37Q\DBT(GR5C^A?65N0K+^O?P\CD<$6>M $3\IQ95'LX(8N83/AWPP^,
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M!7&MLUG&6 F?@9^4C.S"I9#C9'/@_L2]6)$F$L MY<4L7I@G.U8]'+AECRU
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M'JBJG&4Y"SG.JR2#90U?&GW/!R#Q-GJ^$![/04SCCB /L7A;V8.9)Z\$R*!
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MRXJX"@F-MQ8!^"P^VC);>#J64V8*)S W38'V<76B*78\LG&9^)W"49C+K&=
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ME>Z0):1(8)XGZ#F:<Z>^G5?<K$?/'/#:D)M3)1W/02X#CNOEU'JD>%2'7NY
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M48'Y>XJ^Q*[VQO#_W-4AZ_EL!(,(H1-F+6N19 V <LGGBJ;>^,@7@;"M$6T
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MN=T[-M>[R!SO@CF^ %!>"$;MSC_\O"<3\[+FWM[;Y1? *A3O""@NS ;^'AK
MSVD=&&5CO6FH9')"IG<".#=1S)>EPDO@ED-P:T-BJ/"_<Z3C_ET/ZY2\ %3Q
M +C>N!/O?)_CP81'+X$AW74&V";T3KKC+M8#0OFSE\!I,%HN?%BY)9(2@<NF
M.D74F>KD2ZH'REA!HF YJ*L-H4N+C%';'&)CQWNP P386H^KO:J-@G&J1BT=
M3RO(, W"&[5)A>DOL9EA\&^:JA*#FPG["AU;[A!@*9X%3)PV<TI'MCGDABC"
MWUW'G'].(0-F#:B(5HG5AE1UK@[[V0B*7\'J^><O*?#I%=D$_X4-KB9A>B):
ME*KR]E@2LA%&,(K V1(;XC^A7@_FTRN4!VL@#?$(7!EPAZT[]B0=&&5F0M64
MW\Q<XY<4U8:63CSGX:.* O?04=.U VS0C6M%Q6<&TM0GF1$XN6 8X7*8/9T]
MUU36TM.(C?A42&PDK#=/HC);'#Q'EXW%YV.S@+^FNDP%I".VT\ .J<ZG$$":
MMRT- U$F# I:%LF*$! \]%D:Y;-K:!Z3P2"7N#DDF+HVJ?J66X$^ ;"@*8J"
M04N [[F!1!0^$WBG5^.8NYLE/. :0(S+O&5CN4%@Q[1#S2_GP2*-<5!#2!O$
M,(>:\1S:Y_FRB#<.<- >X<(20WT+#=FCYQX"K[F?A?'PD_VW;[W40^^A(;;[
MFE%!K"OD*?M9J[H64'N(Z74:ZUH?'BE@D\0&\-3"1AARFFH_(4B)NY8#K7+U
MLM7L'C90IUOK'G;VLS(0Q(;\[71U#NN7[6:W>=A!M59C<^/PIOZUUCH^1/7S
ML[-FI],\;[TCM7+U&M,!E(*.">,;F7KFS_^(1>@M"85\V2/DK2GP,$9P#>P
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M]TVE'LD5DS3A3:+_R\E@QP)G,6USP\N'B UYJQ5W.H5;EY\? 6\K:]W?7<6
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M86\$'-O8>MJN\W%K<:*0?^4-Y!A@+[XX$,3"0ART.G##YFMP8%9@!%CA5M+
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MMXAKK]UEZG0Q /8[1K;4,DHT%?)1@"E.H^4CZ )3#URL2U/+E-*VU\$K$K%
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MS5']VW%L(MM;HVUGFFKY%U!+ P04    " "9@G93V<>GZOT*  " A@  %0
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M4+24KKD K)IH&+*@Z+![ P&IY'X960K,TD0-8+V0M*7.3S< LZU3#T,7%">
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M2AHEQPS:0T']H%A*U'K$XOI!XU@+A8V2688-HM >D]4PL:[8E!6/ ^NA>XM
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MUE @WZ94S>R@]D')I9EOUG:&8'L*0*$CSFP-6L6!O_JQCKQ8_Q8D7Z$&OYT
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M;FEX7V5X,#$P,2YH=&U02P$"% ,4    " "9@G93G%K$CR<+  !:0@  %
M            @ &7IP  ;&%N=')O;FEX7V5X,#4P,2YH=&U02P$"% ,4
M" "9@G931G^Q'.D4  #Z?0  $0              @ 'PL@  ;&%N=')O;FEX
M7VDX:RYH=&U02P$"% ,4    " "9@G93#%CH-3H#   J#   $0
M    @ $(R   ;'1R>"TR,#(Q,3$Q,"YX<V102P$"% ,4    " "9@G93V<>G
MZOT*  " A@  %0              @ %QRP  ;'1R>"TR,#(Q,3$Q,%]L86(N
M>&UL4$L! A0#%     @ F8)V4_!$QVI5!P  UU<  !4              ( !
MH=8  &QT<G@M,C R,3$Q,3!?<')E+GAM;%!+!08     !@ & (@!   IW@
"   !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
